
<html lang="en"     class="pb-page"  data-request-id="8eb1be04-48b1-46c6-8364-351f8e2b2325"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-6;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.6b00031"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N′-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercular Agents Effective against Multidrug-Resistant Mycobacteria" /></meta><meta name="dc.Creator" content="Sanjib  Bhakta" /></meta><meta name="dc.Creator" content="Nicolò  Scalacci" /></meta><meta name="dc.Creator" content="Arundhati  Maitra" /></meta><meta name="dc.Creator" content="Alistair K.  Brown" /></meta><meta name="dc.Creator" content="Saiprasad  Dasugari" /></meta><meta name="dc.Creator" content="Dimitrios  Evangelopoulos" /></meta><meta name="dc.Creator" content="Timothy D.  McHugh" /></meta><meta name="dc.Creator" content="Parisa N.  Mortazavi" /></meta><meta name="dc.Creator" content="Alexander  Twist" /></meta><meta name="dc.Creator" content="Elena  Petricci" /></meta><meta name="dc.Creator" content="Fabrizio  Manetti" /></meta><meta name="dc.Creator" content="Daniele  Castagnolo" /></meta><meta name="dc.Description" content="Novel pyrroles have been designed, synthesized, and evaluated against mycobacterial strains. The pyrroles have originally been designed as hybrids of the antitubercular drugs BM212 (1) and SQ109 (2..." /></meta><meta name="Description" content="Novel pyrroles have been designed, synthesized, and evaluated against mycobacterial strains. The pyrroles have originally been designed as hybrids of the antitubercular drugs BM212 (1) and SQ109 (2..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 8, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00031" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00031" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00031" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00031" /></link>
        
    
    

<title>Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N′-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercular Agents Effective against Multidrug-Resistant Mycobacteria | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00031" /></meta><meta property="og:title" content="Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N′-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercular Agents Effective against Multidrug-Resistant Mycobacteria" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0003.jpeg" /></meta><meta property="og:description" content="Novel pyrroles have been designed, synthesized, and evaluated against mycobacterial strains. The pyrroles have originally been designed as hybrids of the antitubercular drugs BM212 (1) and SQ109 (2), which showed common chemical features with very similar topological distribution. A perfect superposition of the structures of 1 and 2 revealed by computational studies suggested the introduction of bulky substituents at the terminal portion of the pyrrole C3 side chain and the removal of the C5 aryl moiety. Five compounds showed high activity toward Mycobacterium tuberculosis, while 9b and 9c were highly active also against multidrug-resistant clinical isolates. Compound 9c showed low eukaryotic cell toxicity, turning out to be an excellent lead candidate for preclinical trials. In addition, four compounds showed potent inhibition (comparable to that of verapamil) toward the whole-cell drug efflux pump activity of mycobacteria, thus turning out to be promising multidrug-resistance-reversing agents." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00031"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00031">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00031&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00031&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00031&amp;href=/doi/10.1021/acs.jmedchem.6b00031" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2780-2793</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b02010" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00039" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1<i>H</i>-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and <i>N</i>-Adamantan-2-yl-<i>N</i>′-((<i>E</i>)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercular Agents Effective against Multidrug-Resistant Mycobacteria</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sanjib++Bhakta">Sanjib Bhakta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicol%C3%B2++Scalacci">Nicolò Scalacci</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arundhati++Maitra">Arundhati Maitra</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alistair+K.++Brown">Alistair K. Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Saiprasad++Dasugari">Saiprasad Dasugari</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dimitrios++Evangelopoulos">Dimitrios Evangelopoulos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+D.++McHugh">Timothy D. McHugh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Parisa+N.++Mortazavi">Parisa N. Mortazavi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander++Twist">Alexander Twist</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Petricci">Elena Petricci</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Manetti">Fabrizio Manetti</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniele++Castagnolo">Daniele Castagnolo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Mycobacteria Research Laboratory, Department of Biological Sciences, Institute of Structural and Molecular Biology, Birkbeck, University of London, Malet Street, London WC1E 7HX, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Applied Sciences, Northumbria University Newcastle, Ellison Place, NE1 8ST, Newcastle upon Tyne, U.K.</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Centre for Clinical Microbiology, University College London, London, NW3 2PF U.K.</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Dipartimento di Biotecnologie, Chimica e Farmacia, Università di Siena, Via Aldo Moro 2, I-53100 Siena, Italy</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Institute of Pharmaceutical Science, King’s College London, 150 Stamford Street, London SE1 9NH, U.K.</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">School of Medicine, Pharmacy and Health, Durham University, Queen’s Campus, Stockton-on-Tees, TS17 6BH, U.K.</span></div><div class="corresp-info"><strong>*</strong>FB: e-mail, <a href="/cdn-cgi/l/email-protection#5d3b3c3f2f3427343273303c33382929341d2833342e34733429"><span class="__cf_email__" data-cfemail="2a4c4b48584350434504474b444f5e5e436a5f4443594304435e">[email protected]</span></a>; tel, +390577234256.</div><div class="corresp-info"><strong>*</strong>D.C.: e-mail, <a href="/cdn-cgi/l/email-protection#264247484f434a430845475552474148494a49664d454a08474508534d"><span class="__cf_email__" data-cfemail="88ece9e6e1ede4eda6ebe9fbfce9efe6e7e4e7c8e3ebe4a6e9eba6fde3">[email protected]</span></a>; tel, +44(0)2078484506.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00031&amp;href=/doi/10.1021%2Facs.jmedchem.6b00031" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2780–2793</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 23, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 January 2016</li><li><span class="item_label"><b>Published</b> online</span>8 March 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 March 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00031" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00031</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2780%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSanjib%2BBhakta%252C%2BNicol%25C3%25B2%2BScalacci%252C%2BArundhati%2BMaitra%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D6%26contentID%3Dacs.jmedchem.6b00031%26title%3DDesign%2Band%2BSynthesis%2Bof%2B1-%2528%25281%252C5-Bis%25284-chlorophenyl%2529-2-methyl-1H-pyrrol-3-yl%2529methyl%2529-4-methylpiperazine%2B%2528BM212%2529%2Band%2BN-Adamantan-2-yl-N%25E2%2580%25B2-%2528%2528E%2529-3%252C7-dimethylocta-2%252C6-dienyl%2529ethane-1%252C2-diamine%2B%2528SQ109%2529%2BPyrrole%2BHybrid%2BDerivatives%253A%2BDiscovery%2Bof%2BPotent%2BAntitubercular%2BAgents%2BEffective%2Bagainst%2BMultidrug-Resistant%2BMycobacteria%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2793%26publicationDate%3DMarch%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00031"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1981</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">30</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00031" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N′-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercular Agents Effective against Multidrug-Resistant Mycobacteria&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sanjib&quot;,&quot;last_name&quot;:&quot;Bhakta&quot;},{&quot;first_name&quot;:&quot;Nicolò&quot;,&quot;last_name&quot;:&quot;Scalacci&quot;},{&quot;first_name&quot;:&quot;Arundhati&quot;,&quot;last_name&quot;:&quot;Maitra&quot;},{&quot;first_name&quot;:&quot;Alistair&quot;,&quot;last_name&quot;:&quot;K. Brown&quot;},{&quot;first_name&quot;:&quot;Saiprasad&quot;,&quot;last_name&quot;:&quot;Dasugari&quot;},{&quot;first_name&quot;:&quot;Dimitrios&quot;,&quot;last_name&quot;:&quot;Evangelopoulos&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;D. McHugh&quot;},{&quot;first_name&quot;:&quot;Parisa&quot;,&quot;last_name&quot;:&quot;N. Mortazavi&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;Twist&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Petricci&quot;},{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Manetti&quot;},{&quot;first_name&quot;:&quot;Daniele&quot;,&quot;last_name&quot;:&quot;Castagnolo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;2780-2793&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00031&quot;},&quot;abstract&quot;:&quot;Novel pyrroles have been designed, synthesized, and evaluated against mycobacterial strains. The pyrroles have originally been designed as hybrids of the antitubercular drugs BM212 (1) and SQ109 (2), which showed common chemical features with very similar topological distribution. A perfect superposition of the structures of 1 and 2 revealed by computational studies suggested the introduction of bulky substituents at the terminal portion of the pyrrole C3 side chain and the removal of the C5 aryl moiety. Five compounds showed high activity toward Mycobacterium tuberculosis, while 9b and 9c were highly active also against multidrug-resistant clinical isolates. Compound 9c showed low eukaryotic cell toxicity, turning out to be an excellent lead candidate for preclinical trials. In addition, four compounds showed potent inhibition (comparable to that of verapamil) toward the whole-cell drug efflux pump activity of mycobacteria, thus turning out to be promising multidrug-resistance-reversing agents.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00031&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00031" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00031&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00031" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00031&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00031" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00031&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00031&amp;href=/doi/10.1021/acs.jmedchem.6b00031" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00031" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00031" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00031%26sid%3Dliteratum%253Aachs%26pmid%3D26907951%26genre%3Darticle%26aulast%3DBhakta%26date%3D2016%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2B1-%2528%25281%252C5-Bis%25284-chlorophenyl%2529-2-methyl-1H-pyrrol-3-yl%2529methyl%2529-4-methylpiperazine%2B%2528BM212%2529%2Band%2BN-Adamantan-2-yl-N%25E2%2580%25B2-%2528%2528E%2529-3%252C7-dimethylocta-2%252C6-dienyl%2529ethane-1%252C2-diamine%2B%2528SQ109%2529%2BPyrrole%2BHybrid%2BDerivatives%253A%2BDiscovery%2Bof%2BPotent%2BAntitubercular%2BAgents%2BEffective%2Bagainst%2BMultidrug-Resistant%2BMycobacteria%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D6%26spage%3D2780%26epage%3D2793%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292610" title="Antibiotic resistance">Antibiotic resistance</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291214" title="Bacteria">Bacteria</a>,</li><li><a href="/action/doSearch?ConceptID=292329" title="Pyrroles">Pyrroles</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/jmcmar.2016.59.issue-6/20160324/jmcmar.2016.59.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Novel pyrroles have been designed, synthesized, and evaluated against mycobacterial strains. The pyrroles have originally been designed as hybrids of the antitubercular drugs BM212 (<b>1</b>) and SQ109 (<b>2</b>), which showed common chemical features with very similar topological distribution. A perfect superposition of the structures of <b>1</b> and <b>2</b> revealed by computational studies suggested the introduction of bulky substituents at the terminal portion of the pyrrole C3 side chain and the removal of the C5 aryl moiety. Five compounds showed high activity toward <i>Mycobacterium tuberculosis</i>, while <b>9b</b> and <b>9c</b> were highly active also against multidrug-resistant clinical isolates. Compound <b>9c</b> showed low eukaryotic cell toxicity, turning out to be an excellent lead candidate for preclinical trials. In addition, four compounds showed potent inhibition (comparable to that of verapamil) toward the whole-cell drug efflux pump activity of mycobacteria, thus turning out to be promising multidrug-resistance-reversing agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68706" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68706" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tuberculosis (TB) was first declared as a global health emergency by the World Health Organisation (WHO) in 1993. More than 2 decades on, the world is still grappling to control the spread of this infectious disease. In 2014, around 9.3 million people were estimated to have fallen ill with TB and 1.5 million deaths were caused by it.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Although mortality due to TB has fallen to 47% since 1990, the increasing resistance seen in the TB-causative organism, <i>Mycobacterium tuberculosis</i> (MTB), is responsible for an estimated 480 000 new cases of multidrug-resistant TB. In fact, multidrug, extensively, and even totally drug resistant tuberculosis (MDR-TB,<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> XDR-TB,<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> and TDR-TB<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a>) cases make the disease, originally difficult to treat, even more so, as most drugs in use today are ineffective to treat these mutant strains. Moreover, 2 billion people are estimated to be latently infected with MTB, and 10% of them reactivate to active TB, with major risk relative to immigrants from endemic areas, people with HIV-1 infection, and individuals with underlying diseases (e.g., silicosis, diabetes mellitus, and malignant conditions). Treatment, if available, is lengthy, severely toxic, and prone to interfere with other therapies such as the antiretroviral therapy in the case of TB–HIV co-infected patients.</div><div class="NLM_p">The need for new, shorter therapeutic regimens and new classes of drugs active against MDR-, XDR-, and TDR-TB drives pharmaceutical research to accelerate the development process of new anti-TB drugs. There is an urgent need to develop novel antitubercular agents with alternative mechanisms of action to control TB, one of the leading causes of mortality due to a single infectious agent.</div><div class="NLM_p">About 15 years ago, the pyrrole compound <b>1</b> (BM212)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> was discovered to be a potent antimycobacterial agent. In an effort to identify new pyrrole analogues with improved solubility and ability to kill MDR and XDR mycobacteria, many derivatives of <b>1</b> were designed and synthesized.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> Congeners of <b>1</b> showed a micromolar activity toward MTB H37Rv. However, the first series of analogues (including <b>1</b> itself) suffered from poor pharmacokinetic parameters (in terms of clearance and microsomal stability) and significant cytotoxicity. Although the most recent derivatives showed an improved pharmacokinetics and cytotoxicity profile, their physicochemical parameters (such as lipophilicity and aromaticity) need further optimization.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Genetic analyses of spontaneous mutants resistant to <b>1</b> led to the identification of its cellular target as the trehalose monomycolate exporter, MmpL3 protein (Rv0206c), a member of the MmpL (mycobacterial membrane protein large) family and a validated drug target in MTB.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> This family has primary structure homology to the resistance-nodulation-cell division (RND) protein family, mainly involved in drug resistance in Gram-negative bacteria.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Although the MTB genome encodes 13 members of the MmpL family, their function has not been clearly elucidated. Despite their annotation as multidrug transporters, they do not contribute to antimycobacterial drug resistance.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> MmpL3 has also been implicated in heme acquisition by MTB, although it might not be its primary role in an endogenous environment.</div><div class="NLM_p">Adamantane-diamine compound <b>2</b> (SQ109)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> was described as an antitubercular drug that is active against susceptible and drug-resistant MTB strains. Compound <b>2</b> exhibited promising activity in drug combination during animal preclinical studies<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> but also experienced poor pharmacokinetic parameters.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Diamine <b>2</b> is currently undergoing phase 2 clinical trials for further development.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The antimycobacterial activity of both <b>1</b> and <b>2</b> was demonstrated to derive from targeting the MmpL3 protein.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Given the ability of <b>1</b> and <b>2</b> to act as antimycobacterial agents through a common molecular target, we pursued the hypothesis that they could share common molecular portions.</div><div class="NLM_p">By means of an in silico molecular modeling approach, the three-dimensional structure of both compounds was studied. Despite the apparent structural dissimilarity between the two compounds, a rough comparison of the molecular structures of <b>1</b> and <b>2</b> showed an unexpected similarity of the topological distribution of their chemical features (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). In fact, apart from the terminal adamantyl moiety of <b>2</b> and the <i>p</i>-Cl phenyl ring at the C5 position of <b>1</b>, the remaining part of the structure of <b>2</b> was superposable to that of <b>1</b>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Graphical representation (left) of <b>1</b> and <b>2</b>, a rough comparison of the topological distribution of their chemical features (middle upper panel), and superposition of their three-dimensional conformers as generated by the common feature hypothesis generation routine (middle lower panel; <b>1</b>, blue; <b>2</b>, red). The flexible structure of <b>2</b> is well-superposable to the skeleton of <b>1</b>. The general structures <b>A</b> and <b>B</b> of the hybrid compounds are also shown (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of this similarity, we chose to apply a molecular hybridization approach to design new putative antimycobacterial compounds.</div><div class="NLM_p">The molecular hybridization approach is one of the strategies included within the rational design protocol for identification of new biologically relevant small molecules. This approach is based on the recognition of structurally comparable or similar molecular portions of two or more bioactive compounds. By means of merging these molecular portions, new hybrid chemical entities that maintain structural elements of the parent compounds could be designed. In this study, we have chosen the more rigid scaffold of <b>1</b> as the template and to adjust it upon comparison with the flexible structure of <b>2</b>. As a result, the <i>N</i>-(substituted-phenyl)pyrrole core of <b>1</b> with a piperazinylmethyl side chain at position C3 was maintained, while the second phenyl substituent at position C5 of <b>1</b> was deleted from the new hybrid compounds. In addition, the adamantyl moiety present in <b>2</b> was inserted as the terminal group bound to N4 of the piperazine ring, leading to the design of the hybrid compound <b>A</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><div class="NLM_p last">Hence, we designed, synthesized, and biologically evaluated a set of novel pyrrole derivatives with general structure <b>A</b> that are hybrid compounds of the antitubercular agents <b>1</b> and <b>2</b>. To explore the chemical space around the C3 piperazinomethyl moiety of the new compounds, the distal piperazine nitrogen is substituted with different bulky R<sup>2</sup> moieties, such as adamantyl, norbornyl, cyclohexyl, or aryl groups. Moreover, the role of the substituent on C5 and its importance for the antitubercular activity were explored. According to our superposition hypothesis, the aryl moiety at C5 of <b>1</b> was replaced by a methyl substituent, thus leading to design a library of 2,5-dimethylpyrroles. In addition, a second series of simplified derivatives <b>B</b> was also designed through molecular simplification in order to evaluate the influence of the piperazine ring on the antitubercular activity. Within this series, also according to previous works,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> the piperazine ring was removed from the structure and replaced with a secondary amine (or hydroxylamine) at C3. In both cases, the methyl substituent at C2 and C5, as well as the N1 aryl groups, were left unchanged.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Computational Design and Hypothesis on the Common Chemical Features Shared by <b>1</b> and <b>2</b></h3><div class="NLM_p">To confirm the superposition pattern above-described for <b>1</b> and <b>2</b>, the Phase software<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> was used to find the three-dimensional arrangements of the common chemical portions shared by the two compounds (thereafter referred to as common feature models or superposition models). As a result, a four-feature representation was obtained, comprised of two hydrophobic groups and two protonable atoms (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). In detail, the <i>p</i>-Cl group at the N1 position of the pyrrole ring of <b>1</b> and one of the terminal methyl groups of <b>2</b> matched one of the common hydrophobic regions (H6). The central methyl group of <b>2</b> and the 2-methyl group of <b>1</b> corresponded to the second hydrophobic portion (H4). On the other hand, the two positively ionizable features (P7 and P8) accommodated the two basic nitrogen atoms of both compounds.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Graphical representation of the four-feature superposition model common to <b>1</b> (thin lines) and <b>2</b> (thick lines). The two protonatable chemical features (P7 and P8) are in blue, while the two hydrophobic regions (H4 and H6) are in green. The conformer of <b>1</b> represented in the picture is 0.013 kJ/mol  from the lowest energy conformation, while the energy difference between the lowest energy conformation of <b>2</b> and the conformer reported in the picture is 4.660 kJ/mol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It is important to point out that this representation of the common chemical features of <b>1</b> and <b>2</b> showed two protonable sites that are chemically unrealistic at neutral pH. However, this qualitative model only accounts for the presence of the two piperazine nitrogens of <b>1</b> and for the two amine nitrogens of <b>2</b>, while it does not take into consideration the mutual influence of the two amines during the protonation steps. This limitation was eliminated in a second-generation, optimized common feature model that is characterized by only one protonable group (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0007.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Graphical representation of the four-feature improved model matched by the most active hybrid pyrrole <b>9c</b>. Changes occurred within the region of space occupied by the C3 side chain: the positively ionized P8 feature previously accommodating the N4 nitrogen atom of the piperazine was omitted, while an additional hydrophobic region was added that corresponded to the terminal bulky substituent of the C3 side chain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analysis of the superposition pattern of <b>1</b> and <b>2</b> prompted us to omit the aromatic portion at position 5 of <b>1</b>. In fact, a visual inspection of the superposed structures of <b>1</b> and <b>2</b> showed that this moiety does not match an analogous group on <b>2</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), and consequently, it does not represent a common feature of both compounds. Moreover, since the three aromatic rings forced the structure of these compounds toward planarity, the removal of one or more of them could be in principle profitable for better solubility and bioavailability. In addition, given the well-established relationship between late-stage drug development problems (i.e., the high attrition rate of compounds entering the clinical phase) and the lipophilicity of compounds,<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> modulation of lipophilicity should be taken into account when new putative antimycobacterial compounds are designed. In addition, since the terminal methyl group of <b>1</b> is partially superposed on the adamantyl moiety of <b>2</b>, a hydrophobic group at this position was maintained. Following these suggestions and taking into account the similarity between <b>1</b> and <b>2</b>, a new class of pyrrole derivatives was designed on the basis of the molecular hybridization routine with the aim of obtaining new putative antimycobacterial compounds.</div><div class="NLM_p last">The rigid scaffold of <b>1</b> was thus chosen as the template for the design of novel antitubercular compounds, and this choice was mainly based on the fact that our research group is well-experienced in the synthesis of pyrrole compounds. Moreover, the adamantyl group already found in <b>2</b> was introduced on the piperazine ring, while the 5-phenyl ring of <b>1</b> was removed.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5"> Synthesis of Derivatives with General Structure <b>A</b></h4><div class="NLM_p">A library of pyrrole derivatives bearing an <i>N</i>-substituted piperazinomethyl chain at C3 was first synthesized according to classical synthetic procedures. Pyrroles <b>3a</b>–<b>e</b> were synthesized through a microwave-assisted Paal–Knorr reaction starting from the appropriate diones and different anilines.<a onclick="showRef(event, 'ref18 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref18 ref23 ref24">(18, 23, 24)</a> Despite computational studies suggesting that a <i>p</i>-Cl moiety fixed on the N1 aryl group be kept, a number of different substituents were also introduced to evaluate their steric and electronic effects on the antimycobacterial activity and to deduce SAR considerations. Pyrroles <b>3a</b>–<b>e</b> were then coupled with differently substituted piperazines in the presence of formaldehyde to afford desired pyrroles <b>7a</b>–<b>m</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Different bulky substituents were introduced on the piperazine ring to explore the chemical space around the pyrrole nucleus. The piperazines <b>6c</b>–<b>e</b> (cyclohexylpiperazine <b>6c</b>, phenylpiperazine <b>6d</b>, 1-adamantylpiperazine <b>6e</b>) are commercially available and were coupled with <b>3a</b>–<b>e</b> as purchased. The piperazines <b>6a</b><b>,b</b> were synthesized as described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> and then reacted with the pyrroles <b>3a</b>–<b>e</b>. The Boc-piperazine <b>4</b> and the appropriate ketones <b>5a,</b><b>b</b> (2-adamantanone <b>5a</b>, 2-norbornanone <b>5b</b>) were reacted in the presence of the reducing agent Na(OAc)<sub>3</sub>BH to yield the corresponding alkylpiperazine intermediates, which were immediately converted into the desired piperazines <b>6a,</b><b>b</b> by TFA-mediated Boc cleavage. Piperazines <b>6a</b>–<b>e</b> and pyrroles <b>3a</b>–<b>e</b> were then coupled via Mannich reaction to afford pyrroles <b>7a</b>–<b>m</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrroles <b>3a</b>–<b>e</b> and Piperazines <b>6a,</b><b>b</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. First Series of Pyrrole Derivatives <b>7a</b>–<b>l</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0001.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">% yield<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">2-adamantyl</td><td class="colsep0 rowsep0" align="left">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">2-adamantyl</td><td class="colsep0 rowsep0" align="left">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-iPr</td><td class="colsep0 rowsep0" align="left">2-adamantyl</td><td class="colsep0 rowsep0" align="left">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="left">2-adamantyl</td><td class="colsep0 rowsep0" align="left">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7e</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7f</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7g</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">2-norbornyl<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7h</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">cyclohexyl</td><td class="colsep0 rowsep0" align="left">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7i</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">1-adamantyl</td><td class="colsep0 rowsep0" align="left">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7j</b></td><td class="colsep0 rowsep0" align="left">4-Cl-phenyl</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7k</b></td><td class="colsep0 rowsep0" align="left">4-Cl-phenyl</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">2-adamantyl</td><td class="colsep0 rowsep0" align="left">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7l</b></td><td class="colsep0 rowsep0" align="left">4-Cl-phenyl</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">1-adamantyl</td><td class="colsep0 rowsep0" align="left">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7m</b></td><td class="colsep0 rowsep0" align="left">4-Cl-phenyl</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">2-norbornyl<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">56</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Isolated yields are reported.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Isolated as side product.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Mixture of exo/endo isomers.</p></div></div></div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> Synthesis of Derivative with General Structure <b>B</b></h4><div class="NLM_p">A second series of pyrrole derivatives with general structure <b>B</b> was synthesized as described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Pyrrole <b>3a</b>–<b>c</b> were formylated through the Vilsmeir–Haack reaction, affording the aldehydes <b>8a</b>–<b>c</b>. The latter compounds were reacted with different primary amines in the presence of Na(AcO)<sub>3</sub>BH to yield pyrroles <b>9a</b>–<b>j</b>. Moreover, aldehydes <b>8a,</b><b>b</b> were reacted with benzylhydroxylamine to afford oximes <b>10a,</b><b>b</b>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> which, after treatment with NaCNBH<sub>3</sub>, led to the corresponding hydroxylamines <b>11a,</b><b>b</b> in excellent yields (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrroles <b>9</b>–<b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Second Series of Pyrrole Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0002.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">% yield<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">cyclohexyl</td><td class="colsep0 rowsep0" align="left">77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2-adamantyl</td><td class="colsep0 rowsep0" align="left">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-Me-Bn</td><td class="colsep0 rowsep0" align="left">82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-Cl-Bn</td><td class="colsep0 rowsep0" align="left">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9g</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-F-Bn</td><td class="colsep0 rowsep0" align="left">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9h</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9i</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">4-Cl-phenyl</td><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9j</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">4-Cl-phenyl</td><td class="colsep0 rowsep0" align="left">cyclohexyl</td><td class="colsep0 rowsep0" align="left">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">82</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Isolated yields.</p></div></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Biology</h3><div class="NLM_p">All the compounds were tested for their biological activity by determining the minimum inhibitory concentrations (MIC) against a panel of fast-growing environmental and slow-growing mycobacterial species and clinical isolates (<a class="ref internalNav" href="#tbl3" aria-label="Tables 3">Tables 3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). This included the fast-growing nonpathogenic strains of <i>Mycobacterium smegmatis</i> and relatively fast-growing intracellularly surviving <i>Mycobacterium aurum</i>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> followed by the vaccine strain <i>Mycobacterium bovis</i> BCG, the nonpathogenic <i>M. tuberculosis</i> mc<sup>2</sup>7000, and finally the pathogenic <i>M. tuberculosis</i> H37Rv. Furthermore, we also tested the activity of these compounds against MDR-TB clinical isolates. In addition, cytotoxicity analysis was carried out. The eukaryotic cell toxicity of each compound was tested against murine macrophage RAW264.7 cells and human monocyte-derived THP-1 cell line to ascertain the 50% growth inhibitory concentration (GIC<sub>50</sub>). Mouse models are routinely used for testing the efficacy of both antitubercular drugs and vaccines and are considered a highly appropriate model. In particular, RAW264.7 are differentiated macrophage cells capable of eliciting a whole host of inflammatory responses and been studied and characterized in great detail over many decades.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The ratio of the MIC observed against MTB H37Rv and the GIC<sub>50</sub> values provided the selectivity index (SI), or the therapeutic window offered by these molecules. It must to be brought to note that there are differences in the assay methods to determine the inhibitory concentrations of the compounds against the bacterial pathogen and the eukaryotic cells. However, these methods have been extensively standardized so as to reduce ambiguity in inferring the selectivity index from these assays. Finally, the effect of these compounds on the efflux pump activity of the model surrogate organism <i>M. aurum</i> was also tested (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Efflux pumps are transport proteins involved in the extrusion of toxic substrates, including virtually all classes of antimycobacterial drugs, from within cells into the external environment. Pumps may be specific for one substrate or may transport a range of structurally dissimilar compounds and can be associated with MDR in MTB. Thus, the identification of efflux pump inhibitors can lead to new antitubercular agents able to reverse drug resistance in TB and to be used in combination therapy together with first-line drugs.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Antitubercular Activity on <i>M. smegmatis</i>, <i>M. bovis</i> BCG, and <i>M. aurum</i> Mycobacterial Strains<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">MIC (μg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>M. smegmatis</i> mc<sup>2</sup>155</th><th class="colsep0 rowsep0" align="center"><i>M. bovis</i> BCG</th><th class="colsep0 rowsep0" align="center"><i>M. aurum</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7e</b></td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7f</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7g</b></td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7h</b></td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7i</b></td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7j</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7k</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7l</b></td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7m</b></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9g</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9h</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9i</b></td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9j</b></td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">25<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></td><td class="colsep0 rowsep0" align="left">0.78<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">7.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">A dash indicates that no inhibition was seen, even at the maximum concentration tested in the experiment (125 μg/mL in the case of <i>M. smegmatis</i> and <i>M. bovis</i> BCG and 500 μg/mL in the case of <i>M. aurum</i>). All experiments have been performed in triplicate.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Biological Evaluation of the Compounds against Bacterial and Eukaryotic Cells<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>M. tuberculosis</i> MIC (μg/mL)</th><th class="rowsep1 colsep0" colspan="2" align="center">GIC<sub>50</sub> (μg/mL) </th><th class="rowsep1 colsep0" colspan="2" align="center">SI</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">mc<sup>2</sup>7000x</th><th class="colsep0 rowsep0" align="center">H37Rv</th><th class="colsep0 rowsep0" align="center">MDR1</th><th class="colsep0 rowsep0" align="center">MDR2</th><th class="colsep0 rowsep0" align="center">RAW264.7</th><th class="colsep0 rowsep0" align="center">THP-1</th><th class="colsep0 rowsep0" align="center">RAW264.7</th><th class="colsep0 rowsep0" align="center">THP-1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">32 ± 1</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">26 ± 1</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="left">72 ± 1</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">37 ± 1</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7e</b></td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">>125</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">25 ± 1</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7f</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">>125</td><td class="colsep0 rowsep0" align="left">500</td><td class="colsep0 rowsep0" align="left">113 ± 1</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7g</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">16 ± 5</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7h</b></td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">16 ± 1</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7i</b></td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">16 ± 1</td><td class="colsep0 rowsep0" align="left">0.006</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7j</b></td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">>125</td><td class="colsep0 rowsep0" align="left">175</td><td class="colsep0 rowsep0" align="left">294 ± 5</td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="left">155</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7k</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">95</td><td class="colsep0 rowsep0" align="left">500 ± 10</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">8.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7l</b></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">35 ± 18</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7m</b></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">429</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">9.9</td><td class="colsep0 rowsep0" align="left">7.3 ± 2.7</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">7.2 ± 3.7</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">7.4 ± 1.4</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">15 ± 10</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">6.1 ± 2.1</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">>125</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">18 ± 1</td><td class="colsep0 rowsep0" align="left">0.006</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9g</b></td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">>125</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">8.4 ± 1.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9h</b></td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">28 ± 1</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9i</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">99 ± 1</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9j</b></td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>125</td><td class="colsep0 rowsep0" align="left">>125</td><td class="colsep0 rowsep0" align="left">>125</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">500 ± 22</td><td class="colsep0 rowsep0" align="left">≅1</td><td class="colsep0 rowsep0" align="left"> < 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">25<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">133</td><td class="colsep0 rowsep0" align="left">67 ± 1</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>125</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">>125</td><td class="colsep0 rowsep0" align="left">123</td><td class="colsep0 rowsep0" align="left">292 ± 41</td><td class="colsep0 rowsep0" align="left">≅1</td><td class="colsep0 rowsep0" align="left"> < 2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">3.23<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">3.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.51<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">INH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">0.24</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Selectivity index (SI) is calculated as the ratio between <i>M. tuberculosis</i> H37Rv MIC and GIC<sub>50</sub>. ND: not determined. A dash indicates that no inhibition was seen, even at the maximum concentration tested in the experiment (125 μg/mL in the case of <i>M. tuberculosis</i> variants). Isoniazid (INH) was used as drug control. All experiments have been performed in triplicate.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Efflux Pump Inhibitory (EPI) Activity<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">EPI <i>M. aurum</i></th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">EPI <i>M. aurum</i></th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">EPI <i>M. aurum</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>7k</b></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left"><b>9h</b></td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>7l</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>9i</b></td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>7m</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left"><b>9j</b></td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7e</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7f</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7g</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7h</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7i</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7j</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>9g</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>INH</b></td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Efflux pump inhibitory (EPI) activity of the compounds is marked from 0 to 4, where 0 indicates no inhibition, 1 indicates low inhibition (efflux substrate accumulation above cell control to 20 000 relative fluorescence units), 2 indicates moderate inhibition (efflux substrate accumulation between 20 000 and 30 000 units), 3 indicates high inhibition (efflux substrate accumulation between 30 000 and 40 000 units), and 4 indicates very high inhibition (efflux substrate accumulation between 40 000 and 50 000 units). ND: not determined.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We first analyzed the data arising from the screening of nonpathogenic <i>M. tuberculosis</i> mc<sup>2</sup>7000 (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). In agreement with our initial hypothesis, the insertion of a 1- and a 2-adamantylpiperazine group in place of the <i>N</i>-methylpiperazine of <b>1</b> led to <b>7l</b> and <b>7k</b> with significantly contrasting activity. In fact, <b>7k</b>, bearing the same 2-adamantyl group found in <b>2</b>, was inactive (MIC value >64 μg/mL). On the contrary, the corresponding 1-adamantyl analogue <b>7l</b> showed a strong ability to inhibit MTB mc<sup>2</sup>7000 growth, with a MIC value of about 0.5 μg/mL. Compound <b>7l</b> was then chosen as the most representative compound to be further studied for deducing SAR considerations of the new class of hybrid compounds on MTB mc<sup>2</sup>7000. In particular, according to the suggestions derived from the superposition pattern between <b>1</b> and <b>2</b>, the <i>p</i>-Cl phenyl moiety at C5 of <b>7l</b> was simplified to a methyl group, leading to <b>7i</b>, with a significant 16-fold drop in activity (8.0 μg/mL). The corresponding 2-adamantyl analogue <b>7a</b> showed a slight increase in activity (3.3 μg/mL). Moreover, small changes in substituents and substitution pattern at its 1-phenyl ring clearly showed that small substituents (isopropyl and fluorine) at para and ortho positions (such as in <b>7c</b> and <b>7b</b>) guaranteed activity retention or enhancement (3.3 and 1.0 μg/mL, respectively). Differently, a <i>m</i>-methyl group as in <b>7d</b> caused a significant drop in activity (32 μg/mL), in agreement with that previously found for derivatives of <b>1</b>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Decreasing the bulkiness of the hydrophobic moiety on the piperazine ring from an adamantyl (such as in <b>7i</b> or <b>7a</b>) to a norbornane group led to a slight improvement of activity (MIC of <b>7g</b> was 2.0 μg/mL). On the contrary, a further simplification to a cyclohexyl ring (<b>7h</b>) and its aromatization to a phenyl ring (<b>7e</b>) further reduced activity to 8.0 and 32 μg/mL, respectively. Introduction of a second <i>p</i>-Cl phenyl moiety at C5 of <b>7e</b> restored a 1.0 μg/mL activity in <b>7j</b>. SAR considerations on both <b>7j</b> and <b>7e</b> (1.0 and 32 μg/mL, respectively) suggested that in several cases the presence of the <i>p</i>-Cl phenyl moiety at C5 could improve antimycobacterial activity. On the other hand, a comparison between the activity of <b>7e</b> and its adamantyl analogues <b>7i</b> and <b>7a</b> (8.0 and 3.3 μg/mL, respectively) clearly showed that the <i>p</i>-Cl phenyl moiety at C5 was not mandatory for obtaining active compounds, as suggested by the common feature model. Also, the comparison of the biological profiles of the norbornyl derivatives <b>7g</b> and <b>7m</b> clearly shows that the <i>p</i>-Cl phenyl moiety at C5 in <b>7m</b> is detrimental for the antitubercular activity. Moreover, the comparable antimycobacterial activities of <b>7j</b> and <b>7l</b> (1.0 and 0.5 μg/mL, respectively) allowed us to hypothesize that the distal nitrogen atom of the piperazine ring (which is protonatable in <b>7l</b> but has anilino character in <b>7j</b>) could be unimportant for activity. This result was in agreement with previous pharmacophoric-based calculations and the in vitro activity of piperidine analogues of <b>1</b>.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> To validate this hypothesis, compounds with a linear amino spacer instead of the piperazine ring were synthesized. Among them, <b>9a</b> had an overall size comparable to that of <b>7e</b> and lacked the distal nitrogen atom of the parent piperazine ring. Its activity was 8-fold better than that of the piperazine analogue <b>7e</b> (4.0 and 32 μg/mL, respectively). Attempts to modify the phenylethylamino side chain of <b>9a</b> by introduction of an oxygen atom (as in <b>11a</b> and <b>11b</b>) or by partial rigidification into an aryl oxime (as in <b>10a</b>) led to inactive compounds (>64 μg/mL). Alternatively, shortening the phenylethylamino spacer led to very active compounds. As an example, the benzylamino analogue <b>9b</b> showed a 0.5 μg/mL MIC value. Decoration of the para position of the terminal phenyl ring with small substituents (such as a F, Cl, and Me) led to <b>9g</b>, <b>9f</b>, and <b>9e</b> with comparable or slightly lower activity (0.7, 2.0, and 2.0 μg/mL, respectively), further confirming that the distal nitrogen atom of the piperazine ring was not necessarily required for the antimycobacterial activity of the new hybrid compounds. On the contrary, replacement of the <i>p</i>-Cl of <b>9b</b> with a <i>p</i>-F group as in <b>9h</b> caused an 8-fold drop in activity (from 0.5 to 4.0 μg/mL). A further reduction of the amino side chain length to a cyclohexylamino and to the bulky 2-adamantylamino moiety as in <b>9c</b> and <b>9d</b>, respectively, also maintained a 0.5 and 1.0 μg/mL activity. Interestingly, when the methyl group at C5 of compounds <b>9b</b> and <b>9c</b> was replaced with a <i>p</i>-Cl phenyl moiety leading to derivatives <b>9i</b> and <b>9j</b>, a significant drop in activity was observed (16 and 8 μg/mL, respectively). Compounds <b>9b,</b><b>c</b> proved to be much more active than <b>1</b> against MTB mc<sup>2</sup>7000. These latter data confirm the initial hypothesis that an aryl substituent at C5, such in <b>1</b>, is not mandatory to obtain derivatives active against <i>M. tuberculosis</i>. Also the new compounds bearing a secondary amine show a better activity profile than <b>2</b>, thus pointing out that a diamine backbone could be unessential for antitubercular activity.</div><div class="NLM_p">The same compounds were also assayed on additional mycobacterial strains. Activity against the pathogenic MTB H37Rv (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) followed the same trend already shown for the MTB mc<sup>2</sup>7000 strain. The only exceptions were represented by <b>9f</b> and <b>9g</b>, which were inactive or weakly active toward MTB H37Rv (16 and >125 μg/mL, respectively), while their congener compounds <b>9e</b> and <b>9b</b> showed a 1.0 and 0.5 μg/mL activity. The hybrid compounds <b>7a</b>, <b>7b</b>, <b>7e</b>, and <b>7h</b> showed a good profile with MIC = 7.8, 3.9, 7.8, and 3.9 μg/mL, respectively. The derivative <b>7j</b> bearing a <i>p</i>-Cl-phenyl substituent at C5 showed an improved biological profile (1.9 μg/mL). On the other hand, the simplified compounds <b>9</b> showed higher activity against MTB H37Rv than derivatives <b>7</b>. In particular, compounds <b>9b</b> and <b>9c</b> proved to be very active, again showing activity (0.5 and 0.2 μg/mL, respectively) comparable to or better than that of <b>1</b> and <b>2</b>.</div><div class="NLM_p">Moreover, as a general trend, the hybrid compounds showed weak activity toward <i>M. smegmatis</i> mc<sup>2</sup>155 (MIC values ranging from 4.0 to >64 μg/mL, with only two compounds showing better activity, 3.3 and 2.0 μg/mL, respectively). <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. Similarly, <i>M. aurum</i> was scarcely sensitive to the test compounds: only four compounds (namely, <b>9b</b>, <b>9e</b>, <b>9f</b>, and <b>9g</b>) showed a MIC value of about 2.0 μg/mL (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). As the whole genome sequence of <i>M. aurum</i> has been published recently, comparative genomic analyses of these transporter proteins should elucidate why the difference in their drug susceptibilities is observed.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In general, fast-growing mycobacteria (<i>M. aurum</i> and <i>M. smegmatis</i>) were inhibited at higher concentration than other strains. A better antimycobacterial activity profile was found toward <i>M. bovis</i> BCG (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), with 10 compounds showing activity value in the range below 4.0 μg/mL and three compounds (namely, <b>9b</b>, <b>9c</b>, and <b>9g</b>) with a MIC value of 0.5 μg/mL. Among MDR-TB strains (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), MDR2 was poorly sensitive to the test compounds, with the only exceptions being <b>9a</b> and <b>9b</b>, which showed a good activity at 7.8 and 3.9 μg/mL. On the other hand, MDR1 growth was blocked by at least seven compounds with MIC values lower than 4.0 μg/mL. Of particular interest were compounds <b>9b</b> and <b>9c</b>, which showed MIC values of about 1.0 and 0.5 μg/mL, respectively, much better than those of the parent compound <b>1</b> and isoniazid.</div><div class="NLM_p">An analysis of antimycobacterial data clearly showed that the best compounds (<b>9a</b>–<b>c</b>) were characterized by structural features significantly different from those of the parent compound <b>1</b>. In particular, they lacked both the second aryl moiety at position C5 of the pyrrole nucleus and the distal nitrogen atom of the original piperazine ring. Moreover, the overall activity underwent an improvement when the basic linear side chain was shortened from the phenylethylamino of <b>9a</b>, to the benzylamino of <b>9b</b>, to the cyclohexylamino of <b>9c</b>.</div><div class="NLM_p">The C5 aryl moiety was not a mandatory substituent for active compounds, and small groups are allowed as decoration of the N1-phenyl ring. A bulky terminal group, such as an adamantane and a norbornane, improve the activity of piperazine analogues, while a significant gain of antimycobacterial activity resulted from piperazine replacement by linear aryl and alkylamino side chains.</div><div class="NLM_p">The high antimycobacterial activity maintained even after a significant structural simplification of 1,5-diarylpyrroles (derivatives and analogues of <b>1</b>) into the corresponding 1-aryl hybrid analogues could be accounted for by a comparison of the original pharmacophoric model for antimycobacterial compounds belonging to the pyrrole class of <b>1</b><a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> with the simplified common feature model described here. In fact, the original pharmacophoric model<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> was able to accommodate <b>1</b> and its derivatives in two different orientations, rotated by about 180° around the pyrrole plane. Following this, the aryl moieties at positions N1 and C5 of <b>1</b> could reciprocally change their spatial location and, consequently, match with the pharmacophore. These results suggested that the pharmacophoric portions able to accommodate the substituents at positions N1 and C5 are redundant and could be simplified, as also suggested by the superposition between <b>1</b> and <b>2</b>.</div><div class="NLM_p">In a further attempt to codify the structural features of the new hybrid pyrroles, a second-generation common feature model was built starting from a larger set of compounds, comprised of <b>1</b>, <b>2</b>, and the most active pyrroles (with MIC values ≤1.0 μg/mL). The improved model (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) showed that the distal nitrogen of the piperazine ring of <b>1</b> (corresponding to P8 in the previous common feature model) was omitted, while an additional hydrophobic region (H2), adjacent to the P7 feature (a positively ionizable feature), accommodated the terminal hydrophobic groups of the C3 side chain.</div><div class="NLM_p">In order to prove the effectiveness of our compounds, the cytotoxicity of the novel pyrroles was then evaluated on RAW264.7 cells as well as THP-1 cell lines. Compounds <b>7j</b>, <b>9c</b>, and <b>9h</b> showed an excellent cytotoxicity profile, with a selectivity index (SI) of 92, 50, and 5.6 against RAW264.7 cells and 155, 37, and 28 against THP-1 cells, respectively. Both <b>7j</b> and <b>9c</b> showed a better cytotoxicity profile than <b>1</b> against the murine and human cells (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_p">Finally, the effect of pyrroles on the efflux pump inhibitory (EPI) activity of the model surrogate organism <i>M. aurum</i> was tested in order to identify compounds able to reverse multidrug resistance in TB (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). An efflux pump activity whole-cell-based assay has been carried out, and as a consequence, the results account for the total activity of the whole population of efflux pumps present in the cells. The efflux pump assay revealed that most of the pyrrole compounds (barring <b>7k</b>) possess at least a low to moderate inhibitory property. However, a weak correlation between inhibition of bacterial growth and efflux pump mechanism is observed. For example, <b>9a</b>–<b>c</b> are very efficient in killing mycobacterial cells but only display moderate modulatory effect on the pumps. On the other hand, <b>11b</b> inhibits efflux inhibition on a par with the control inhibitor verapamil, but it shows almost no effect on the growth of these cells. Interestingly, <b>7c</b>, <b>7h</b>, <b>7i</b>, and <b>7l</b>, bearing a bulky alkyl substituent on the piperazine ring, showed good/excellent inhibitory activity. These findings confer that specific endogenous targets for these compounds are still elusive; however, the results indicate that they may have pleiotropic modes of action and potential to reverse antimicrobial resistance. As TB treatment regimens always comprise of a combination of complementary drugs, this off-target effect of the compounds could have a positive impact on the effectiveness of drug treatment regimens. Within this context it is noteworthy that five compounds (<b>11b</b>, <b>7c</b>, <b>7h</b>, <b>7i</b>, <b>7l</b>) show a much higher efflux pump inhibitory activity than <b>1</b> and <b>2</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>), which are known inhibitors solely of the pump transporter MmpL3. In fact, the less potent mycobacterial growth inhibitors showing higher whole-cell efflux inhibitory properties may also prove to be prospective leads in a multidrug therapy owing to synergistic combinations, should that arise. Thus, unlike <b>1</b> and <b>2</b>, which show poor EPI activity, <b>11b</b> and <b>7b</b> could be used in combination with standard antitubercular drugs such isoniazid or rifampin to reverse multidrug resistance in tuberculosis.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0008.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Graphs showing the accumulation of ethidium bromide (EtBr) within <i>M. aurum</i> cells in the presence of selected compounds and positive (verapamil) and negative (1× PBS) controls. Low to very high inhibition of efflux (as a representation of an increased level of EtBr accumulation) are shown by the numbers 1–4. The experiments were performed in triplicate (<i>n</i> = 3), and the graph is plotted using the average values obtained.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, a library of pyrrole derivatives was successfully synthesized and evaluated for its antitubercular activity against MTB and MDR-TB clinical isolates. The new pyrroles were designed as hybrids of the antimycobacterial agents <b>1</b> and <b>2</b>. Five compounds showed antitubercular activity on MTB at ≤1.0 μg/mL, and two of them (<b>9b</b> and <b>9c</b>) proved to be highly active also against MDR-1 TB strains. SAR studies revealed the key features essential for the antimycobacterial activity. Finally, the potent antitubercular derivative <b>9c</b> showed low eukaryotic cell toxicity, turning out to be an excellent lead candidate for preclinical trials. In general, compound <b>9c</b> showed a better drug profile than <b>1</b> in terms of activity, cytotoxicity, and potency toward MDR-TB clinical isolates. The pharmacokinetics parameters of <b>9b</b> and <b>9c</b> will be evaluated in due course and compared with those of <b>1</b> in order to prove the efficacy of the new compounds and to progress toward preclinical trials.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Computational Details</h3><div class="NLM_p">The structures of all the molecules were sketched using Maestro<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and then subjected to the program LigPrep to generate high-quality, all-atom 3D structures to be used as the input for the next calculations. The OPLS_2005 force field was applied, and possible ionization states were generated for the structures at pH 7 ± 2 using Epik.</div><div class="NLM_p">Conformers were generated by MacroModel<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> with the Systematic Pseudo Monte Carlo (a systematic torsional sampling protocol) search algorithm and OPLS-2005 force field with implicit GB/SA distance-dependent dielectric solvent model (water as the solvent) at a cutoff root-mean-square deviation of 0.5 with 1000 steps. All the conformers were subsequently minimized using Polak–Ribiere conjugate gradient minimization with 5000 iteractions. For each molecule, a conformer set with a maximum energy difference of 25 kcal/mol relative to the global energy minimum conformer was stored.</div><div class="NLM_p last">Both <b>1</b> and <b>2</b> were used to build three-dimensional common feature models comprised of chemical features common to the two compounds. Considering the reduced number of compounds and the fact that their antimycobacterial activity was assayed by different research groups with different tests, we chose to apply a common feature hypothesis generation routine, instead of building a quantitative model. Phase<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> software has been applied to generate the models. Minimum and maximum number of sites for all the features were set to 4 and 5, respectively. Only the positively ionizable group (P) and the hydrophobic region (H) features were used to build a series of hypotheses, while the aromatic ring (R) feature was not further considered by the software because it was not present in the structure of <b>2</b>. The resulting four-feature hypotheses were constituted by two H and two P features.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Biology—Experimental Part</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Bacterial Strains and Growth Conditions</h4><div class="NLM_p last">The bacterial species used in this study were <i>M. smegmatis</i> mc<sup>2</sup>155 (ATCC 700084), <i>M. aurum</i> (ATCC23366), <i>M. bovis</i> BCG Pasteur (ATCC 35734), <i>M. tuberculosis</i> mc<sup>2</sup>7000,<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a><i>M. tuberculosis</i> H37Rv (ATTC27294), and two MDR-TB clinical isolates (MDR1 and MDR2) obtained from Royal Free Hospital NHS Trust, London, UK. The cell lines utilized for cytotoxicity studies were the murine macrophage cell line RAW264.7 (ATCC TIB-71) and the human peripheral blood monocyte-derived cell line THP-1. Mycobacterial species were cultured in either Middlebrook 7H9 broth or Middlebrook 7H10 agar media supplemented with albumin–dextrose–catalase (ADC) or oleic acid–albumin–dextrose–catalase (OADC) enrichments, respectively, purchased from BD Biosciences. All reagents were purchased from Sigma-Aldrich unless stated otherwise.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Bacterial Growth Inhibition Assays</h4><div id="sec5_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Antimycobacterial Activity</h5><div class="NLM_p">HT-SPOTi was used as described previously<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33-35)</a> to assess the minimum inhibitory concentrations of the compounds on <i>M. aurum</i>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><i>M. tuberculosis</i> H37Rv, and the MDR strains of the pathogen. Briefly, the assay was conducted in a semiautomated 96-well plate format. The compounds were dissolved in a suitable solvent to a concentration of 50 mg/mL and serially diluted (2-fold dilutions). Two microliters of each dilution was dispensed into a well of a 96-well plate to which 200 μL of Middlebrook 7H10 agar medium kept at 55 °C supplemented with 0.05% (v/v) glycerol and 10% (v/v) OADC was added. The concentration range of the compounds used was 500–0.5 μg/mL. Wells with no compounds (DMSO only) and with isoniazid were used as experimental controls. To all the plates, a drop (2 μL) of early- to mid-log bacterial culture containing 2 × 10<sup>3</sup> colony forming units (CFUs) was spotted in the middle of each well, and the plates were incubated at 35 or 37 °C, depending on the bacterial species, until distinct spots were observed in the control wells (this took 4 days in the case of <i>M. aurum</i>, 7 days in the case of <i>M. tuberculosis</i> H37Rv, and 9 days for the drug-resistant clinical isolates). The MICs were determined as the lowest concentration of the compound where mycobacterial growth was completely inhibited.</div><div class="NLM_p last">The MIC of the compounds against <i>M. smegmatis</i> mc<sup>2</sup>155, <i>M. bovis</i> BCG, and <i>M. tuberculosis</i> mc<sup>2</sup>7000 were calculated by standard MABA (microplate Alamar Blue assay) as previously described.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Briefly, 200 μL of sterile deionized water was added to all outer-perimeter wells of a sterile 96-well plate (Corning Inc., Corning, NY) to minimize evaporation of the medium in the test wells during incubation. The wells in rows B–G in columns 3–11 received 100 μL of 7H9 medium containing 0.2% casamino acids, 24 μg/mL pantothenate, and 10% OADC (Beckton Dickinson, Sparks, MD). Compounds were added to rows B–G followed by 1:2 serial dilutions across the plate to column 10, and 100 μL of excess medium was discarded from the wells in column 10. The bacterial culture at 0.5 McFarland standard diluted 1:25 (100 μL) was added to the wells in rows B–G in columns 2–11, where the wells in column 11 served as drug-free controls. The plates were sealed with parafilm and were incubated at 37 °C. A freshly prepared 1:1 mixture of Alamar Blue (Celltiter-Blue, Promega Corp, Madison, WI) reagent and 10% Tween 80 (50 μL) was added, and the plates reincubated at 37 °C for 24 h.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Eukaryotic Cell Toxicity and Selectivity Indices</h5><div class="NLM_p last">The cell lines were grown and maintained in RPMI-1640 supplemented with 10% FBS incubated at 37 °C with 5% CO<sub>2</sub> in a humidified incubator. For the experiment, 2 μL of the 50 mg/mL stock solution of each compound was diluted in 200 μL of RPMI-1640 medium in the first row of a 96-well microplate and 2-fold dilutions were performed along the rows, leaving the last one (row H) as a solvent control. Then 100 μL containing 10<sup>5</sup> cells/mL of confluent murine macrophage cells (RAW 264.7) or THP-1 cells in logarithmic growth phase were added to each well. The plates were incubated at 37 °C in a humidified CO<sub>2</sub> incubator (5% CO<sub>2</sub>) for 48 h. Each well was washed twice with 1× PBS, and 170 μL of fresh RPMI-1640 was added to each well, followed by 30 μL of 0.01% Trypan Blue. As THP-1 cells are suspension cultures, the plates were centrifuged between the washing steps. After overnight incubation, the change in color was observed and the fluorescence intensity was measured at 560/590 nm (λ<sub>ex</sub>/λ<sub>em</sub>).</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Assaying Whole-Cell Drug Efflux Pump Inhibition</h5><div class="NLM_p last">The assay was modified from a previously published protocol.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Early log phase cells of <i>M. aurum</i> (OD<sub>600</sub> ∼ 0.8) were taken and the OD<sub>600</sub> was adjusted to 0.4 by diluting the cells with culture medium. The cells were collected by centrifugation and resuspended in an equivalent volume of 1× PBS. The test samples contained (4–6) × 10<sup>7</sup> bacteria/mL in PBS, 0.4% glucose (as a source of energy for efflux pumps activity), 0.5 mg/L ethidium bromide (as a substrate for efflux pumps), and the compounds being tested at 1/4× MIC concentrations. Blank samples contained all of the components mentioned above, except the bacterial suspension, which was replaced with 1× PBS. Verapamil, a known efflux pump inhibitor, was used as the positive control at a concentration of 125 μg/mL. Compounds <b>1</b> and <b>2</b> were also included in the experiment to obtain a comparison between them and the newly synthesized compounds with regard to their efflux inhibitory properties. The experiment was performed in a 96-well plate that was placed in a fluorimeter (FLUOstar OPTIMA, BMG Labtech), and the instrument was programmed with the following parameters: wavelengths of 544 and 590 nm for excitation and detection of fluorescence, gain 2200, a temperature of 37 °C, and a cycle of measurement every minute for a total period of 60 min. The accumulation or efflux of ethidium bromide was monitored for the mentioned period on a real-time basis.</div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry—Materials and Methods</h3><div class="NLM_p"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on JEOL Delta-270 or JEOL ECS-400 spectrometers operating at the frequencies indicated. Chemical shifts (δ) are in ppm, referenced to tetramethylsilane. Coupling constants (<i>J</i>) are reported in hertz and rounded to 0.5 Hz. Splitting patterns are abbreviated as follows: singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), broad (br) or some combination of them. Infrared spectra were obtained using a Durascope diamond ATR system. Mass spectra (HRMS) were recorded at the EPSRC National Mass Spectrometry Service Centre on a Thermo Scientific LTQ Orbitrap XL mass spectrometer using low-resolution ESI or high-resolution nanoESI techniques. The purity of the compounds was assessed by reverse-phase liquid chromatography coupled with a mass spectrometer (Agilent series 1100 LC/MSD) with a UV detector at <i>k</i> = 254 nm and an electrospray ionization source (ESI). HPLC analyses were performed at 0.4 mL/min flow rate and using a binary solvent system of 95:5 methyl alcohol/water. All the solvents were of HPLC grade. Mass spectra were acquired in positive mode scanning over the mass range of 50–1500. The following ion source parameters were used: drying gas flow, 9 mL/min; nebulize pressure, 40 psig; and drying gas temperature, 350 °C. All target compounds possessed a purity of ≥95%, as verified by HPLC analyses. TLC was performed using commercially available precoated plates and visualized with UV light at 254 nm; KMnO<sub>4</sub> was used to reveal the products. Flash column chromatography was carried out using Fluorochem Davisil 40–63 μm, 60 Å. All reactions were conducted under a nitrogen atmosphere in oven-dried glassware unless stated otherwise. THF was distilled under nitrogen from sodium using a benzophenone indicator. Dichloromethane was purchased from Aldrich. Acetonitrile was further dried over 4 Å oven-activated molecular sieves for 1 h prior to use. Petrol refers to the fraction of light petroleum ether boiling between 40 and 65 °C. All other solvents and commercially available reagents were used as received.</div><div class="NLM_p">Pyrroles <b>3a</b>–<b>e</b> were synthesized as described in the literature.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div id="sec6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Synthesis of Alkyl Piperazines <b>6a,</b><b>b</b>. General Procedure</h4><div class="NLM_p">The Boc piperazine <b>4</b> (2 mmol) and the appropriate ketone <b>5</b> (2 mmol) were dissolved in THF (8 mL), and the resulting mixture was stirred for 5 min. The reaction was cooled at 0 °C, and then Na(AcO)<sub>3</sub>BH (2.4 mmol) and AcOH (2 mmol) were carefully added. The resulting mixture was stirred at rt for 16 h. The reaction was quenched with NaOH (1 N, 20 mL) and the product was extracted with AcOEt (3 × 25 mL). The AcOEt extract was dried (MgSO<sub>4</sub>), and the solvent was evaporated to give the crude piperazine derivatives, which were filtered through a pad of silica gel (eluent AcOEt/petroleum ether 1:1). The filtered compounds were then dissolved in DCM (4 mL) and treated with 1 mL of TFA. The resulting mixture was stirred at rt for 12 h. The solvents were removed, and the crude compound was dissolved in AcOEt (10 mL) and washed several times with 1 N NaOH (20 mL). The organic phase was dried (MgSO<sub>4</sub>), and the solvent was evaporated to yield the crude piperazines <b>6a,</b><b>b</b> which were purified by column chromatography using petroleum ether/AcOEt 1:1 as eluent.</div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 1-(Adamantan-2-yl)piperazine (<b>6a</b>)</h5><div class="NLM_p last">Tan oil; <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 3.31 (m, 4H), 2.81 (m, 2H), 2.31 (br s, 2H), 2.01–1.94 (m, 4H), 1.76–1.68 (m, 5H), 1.60–1.53 (m, 4H), 1.42–1.39 (m, 1H), 1.30–1.27 (m, 1H) ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 221 [M + H]<sup>+</sup>.</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 1-(Bicyclo[2.2.1]heptan-2-yl)piperazine (<b>6b</b>)</h5><div class="NLM_p last">Tan oil; <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 2.88–2.82 (m, 5H), 2.28 (br s, 3H), 2.20–2.09 (m, 3H), 1.67–1.60 (m, 2H), 1.41–1.39 (m, 1H), 1.28–1.19 (m, 4H), 0.82–0.79 (m, 1H) ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 181 [M + H]<sup>+</sup>.</div></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Synthesis of Pyrrole Derivatives <b>7a</b>–<b>m</b>. General Procedure</h4><div class="NLM_p">Following the Mannich reaction, to a stirred solution of an appropriate pyrrole <b>3a</b>–<b>e</b> (1.5 mmol) in acetonitrile (5 mL) was added a mixture of the appropriate piperazine <b>6</b> (1.5 mmol) and formaldehyde (1.5 mmol) (40% in water), and 1.3 mL of acetic acid was added dropwise. After the addition was complete, the mixture was stirred at rt for 3 h. The mixture was then treated with a solution of sodium hydroxide (20%, w/v) (20 mL) and extracted with AcOEt (10 mL). The organic extracts were combined, washed with water, and dried. After removal of solvent, the residue was purified by column chromatography, using silica gel and petroleum ether/ethyl acetate (4:1 v/v) as eluent.</div><div id="sec6_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 1-(Adamantan-2-yl)-4-((1-(4-chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methyl)piperazine (<b>7a</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.11 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.41 (d, 2H, <i>J</i> = 8.7 Hz), 7.12 (d, 2H, <i>J</i> = 8.7 Hz), 5.92 (s, 1H), 3.36 (s, 2H), 2.50 (br s, 4H), 2.05–2.02 (m, 6H), 1.98 (s, 3H), 1.95 (s, 3H), 1.85–1.72 (m, 5H), 1.68–1.62 (m, 5H), 1.37–1.34 (m, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 137.7, 133.4, 129.7, 129.3, 127.6, 126.8, 115.2, 108.7, 67.9, 54.4, 53.5, 49.6, 37.9, 37.3, 31.6, 31.4, 29.0, 27.6, 27.4, 22.7, 14.2, 12.9, 11.0 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 439 [M + 1]<sup>+</sup>; HRMS (ESI) calcd for C<sub>27</sub>H<sub>37</sub>ClN<sub>3</sub> (M + H<sup>+</sup>) 438.2671, found 438.2664.</div></div><div id="sec6_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 1-(Adamantan-2-yl)-4-((1-(2-fluorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methyl)piperazine (<b>7b</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.15 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.37–7.36 (m, 1H), 7.22–7.17 (m, 3H), 5.95 (s, 1H), 3.36 (s, 2H), 2.59–2.29 (br s, 4H), 2.08–2.03 (m, 6H), 1.97 (s, 3H), 1.93 (s, 3H), 1.83–1.75 (m, 5H), 1.67–1.62 (m, 5H), 1.36–1.24 (m, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ159.81, 157.31, 130.84, 129.6, 128.06, 127.2, 126.9, 124.5, 124.4, 116.7, 116.5, 115.3, 108.6, 67.9, 54.6, 53.6, 49.6, 47.0, 39.3, 37.3, 36.3, 31.9, 31.4, 29.04, 27.6, 27.5, 22.7, 14.2, 12.4, 10.5 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 422 [M + 1]<sup>+</sup>; HRMS (ESI) calcd for C<sub>27</sub>H<sub>37</sub>FN<sub>3</sub> (M + H<sup>+</sup>) 422.2966, found 422.2889.</div></div><div id="sec6_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 1-(Adamantan-2-yl)-4-((1-(4-isopropylphenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methyl)piperazine (<b>7c</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.2 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.27–7.24 (m, 2H), 7.10–7.04 (m, 2H), 5.91 (s, 1H), 3.46 (s, 2H), 2.97–2.92 (m, 1H), 2.52 (br s, 4H), 2.06–2.03 (m, 6H), 1.95 (s, 3H), 1.93 (s, 3H), 1.83–1.75 (m, 5H), 1.68–1.62 (m, 5H), 1.29 (s, 3H), 1.27 (s, 3H), 1.25 (m, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) 148.2, 136.6, 128.2, 128.1, 127.9, 127.1, 126.9, 108.0, 67.9, 54.5, 53.4, 50.8, 49.5, 37.9, 37.3, 33.8, 31.6, 31.4, 29.0, 27.6, 27.4, 24.0, 22.7, 14.2, 12.9, 11.2, 11.0 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 446 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>30</sub>H<sub>44</sub>N<sub>3</sub> (M + H<sup>+</sup>) 446.3530, found 446.3523.</div></div><div id="sec6_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 1-(Adamantan-2-yl)-4-((1-(3-methylphenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methyl)piperazine (<b>7d</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.17 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.32–7.29 (m, 1H), 7.18–7.16 (m, 1H), 6.99–6.95 (m, 2H), 5.91 (s, 1H), 3.39 (s, 2H), 2.53 (br s, 4H), 2.38 (s, 3H), 2.03 (m, 6H), 1.99 (s, 3H), 1.95 (s, 3H), 1.83–1.75 (m, 5H), 1.68–1.62 (m, 5H), 1.37–1.34 (m, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 139.1, 138.9, 129.0, 128.7, 128.3, 127.7, 125.4, 108.2, 67.9, 54.5, 53.4, 49.5, 41.0, 37.9, 37.3, 31.4, 29.03, 28.5, 27.6, 27.4, 21.3, 12.9, 11.0 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 418 [M + 1]<sup>+</sup>; HRMS (ESI) calcd for C<sub>28</sub>H<sub>40</sub>N<sub>3</sub> (M + H<sup>+</sup>) 418.3217, found 418.3234.</div></div><div id="sec6_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 1-((1-(4-Chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methyl)-4-phenylpiperazine (<b>7e</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.43 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.44 (d, 2H, <i>J</i> = 8 Hz), 7.26 (dd, 2H, <i>J</i> = 8.7, 7.3 Hz), 7.15 (d, 2H, <i>J</i> = 7 Hz), 6.94 (d, 2H, <i>J</i> = 7 Hz), 6.85 (m, 1H), 5.96 (s, 1H), 3.45 (s, 2H), 3.23 (m, 4H), 2.66 (m, 4H), 2.02 (s, 3H), 2.00 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 151.5, 137.6, 133.5, 129.7, 129.3, 129.1, 127.8, 126.8, 119.5, 115.0, 108.6, 54.5, 52.9, 49.2, 12.9, 11.0 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 380 [M + 1]<sup>+</sup>; HRMS (ESI) calcd for C<sub>23</sub>H<sub>27</sub>ClN<sub>3</sub> (M + H<sup>+</sup>) 380.1888, found 380.1884.</div></div><div id="sec6_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 4,4′-((1-(4-Chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrole-3,4-diyl)bis(methylene))bis(1-phenylpiperazine) (<b>7f</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.25 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.30–7.28 (d, 2H, <i>J</i> = 8.2 Hz), 7.08 (dd, 4H, <i>J</i> = 8.5, 7.6 Hz), 7.01 (d, 2H, <i>J</i> = 8.7 Hz), 6.77 (d, 4H, <i>J</i> = 8.2 Hz), 6.66 (m, 2H), 3.34 (s, 4H), 3.03 (m, 8H), 2.47 (m, 8H), 1.85 (s, 6H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 151.5, 137.7, 133.4, 129.8, 129.3, 129.1, 126.5, 119.5, 116.0, 53.0, 52.8, 11.0 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 555 [M + 1]<sup>+</sup>; HRMS (ESI) calcd for C<sub>34</sub>H<sub>41</sub>ClN<sub>5</sub> (M + H<sup>+</sup>) 554.3045, found 554.3032.</div></div><div id="sec6_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 1-((1<i>S</i>,4<i>R</i>)-Bicyclo[2.2.1]heptan-2-yl)-4-((1-(4-chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methyl)piperazine (<b>7g</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.15 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.40 (d, 2H, <i>J</i> = 5 Hz), 7.11 (d, 2H, <i>J</i> = 5 Hz), 5.90 (s, 1H), 3.37 (s, 2H), 2.48 (br m, 5H), 2.24–2.12 (m, 4H), 1.97 (s, 3H), 1.94 (s, 3H), 1.72–1.65 (m, 2H), 1.46 (m, 1H), 1.33–1.22 (m, 5H), 0.88–0.81 (m, 2H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 137.7, 133.4, 129.7, 129.3, 127.6, 126.8, 115.2, 108.7, 67.9, 54.4, 52.8, 52.7, 39.0, 38.1, 36.8, 35.8, 30.6, 21.1, 12.8, 11.0 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 398 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>24</sub>H<sub>33</sub>ClN<sub>3</sub> (M + H<sup>+</sup>) 398.2358, found 398.2352.</div></div><div id="sec6_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 1-((1-(4-Chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methyl)-4-cyclohexylpiperazine (<b>7h</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.15 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.40 (d, 2H, <i>J</i> = 5 Hz), 7.10 (d, 2H, <i>J</i> = 5 Hz), 5.89 (s, 1H), 3.37 (s, 2H), 2.60 (br s, 8H), 2.20 (m, 1H), 1.96 (s, 3H), 1.93 (s, 3H), 1.88–1.86 (m, 2H), 1.77–1.75 (m, 2H), 1.61–1.58 (m, 1H), 1.26–1.11 (m, 5H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 137.6, 133.5, 129.7, 129.6, 129.3, 127.7, 118.7, 108.7, 63.5, 56.2, 54.3, 53.0, 48.8, 29.0, 26.3, 25.9, 12.8, 11.0, 10.5 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 386 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>23</sub>H<sub>33</sub>ClN<sub>3</sub> (M + H<sup>+</sup>) 386.2358, found 386.2356.</div></div><div id="sec6_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 1-(Adamantan-1-yl)-4-((1-(4-chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methyl)piperazine (<b>7i</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.10 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.41 (d, 2H, <i>J</i> = 8.7 Hz), 7.10 (d, 2H, <i>J</i> = 8.7 Hz), 5.89 (s, 1H), 3.38 (s, 2H), 2.67 (br s, 4H), 2.50 (br s, 4H), 2.05 (m, 4H), 1.96 (s, 3H), 1.93 (s, 3H), 1.69–1.59 (m, 11H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 137.7, 133.4, 129.7, 129.8, 129.3, 127.6, 126.8, 115.0, 108.8, 60.4, 56.1, 54.2, 53.5, 44.0, 38.5, 37.0, 31.6, 29.7, 25.3, 22.7, 20.7, 18.8, 14.1, 11.0 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 439 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>27</sub>H<sub>37</sub>ClN<sub>3</sub> (M + H<sup>+</sup>) 438.2671, found 438.2680.</div></div><div id="sec6_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1<i>H</i>-pyrrol-3-yl)methyl)-4-phenylpiperazine (<b>7j</b>)</h5><div class="NLM_p last">White solid; mp 169 °C; <i>R</i><sub><i>f</i></sub> 0.2 (AcOEt 100%); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.33 (d, 2H, <i>J</i> = 8.2 Hz), 7.23 (m, 2H), 7.07 (dd, 4H, <i>J</i> = 16.9, 8.2 Hz), 6.92 (m, 4H), 6.82 (m, 1H), 6.36 (s, 1H), 3.49 (s, 2H), 3.21 (m, 4H), 2.67 (m, 4H), 2.07 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 151.4, 137.8, 133.5, 132.0, 131.7, 131.5, 130.3, 129.8, 129.4, 129.1, 128.8, 128.4, 119.7, 116.9, 116.1, 111.7, 54.5, 52.9, 49.2, 11.3 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 477 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>28</sub>H<sub>28</sub>Cl<sub>2</sub>N<sub>3</sub> (M + H<sup>+</sup>) 476.1655, found 476.1648.</div></div><div id="sec6_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 1-(Adamantan-2-yl)-4-((1,5-bis(4-chlorophenyl)-2-methyl-1<i>H</i>-pyrrol-3-yl)methyl)piperazine (<b>7k</b>)</h5><div class="NLM_p last">Yellow solid; mp 197 °C; <i>R</i><sub><i>f</i></sub> 0.35 (AcOEt/MeOH 4:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.34–7.32 (d, 2H, <i>J</i> = 4 Hz), 7.10–7.04 (m, 4H), 6.93 (d, 2H, <i>J</i> = 4 Hz), 6.36 (s, 1H), 3.44 (s, 2H), 2.54 (br s, 4H), 2.05 (s, 3H), 2.03 (m, 4H), 1.84–1.75 (m, 4H), 1.68–1.63 (m, 4H), 1.38–1.25 (m, 5H), 0.88–0.82 (m, 2H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 137.8, 133.4, 131.9, 131.5, 130.2, 129.8, 129.4, 128.8, 128.3, 117.1, 111.5, 67.9, 54.4, 53.5, 49.6, 37.9, 37.3, 31.6, 31.4, 29.0, 27.6, 27.4, 22.7, 14.2, 11.2 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 534 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>32</sub>H<sub>38</sub>Cl<sub>2</sub>N<sub>3</sub> (M + H<sup>+</sup>) 534.2437, found 534.2425.</div></div><div id="sec6_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 1-(Adamantan-1-yl)-4-((1,5-bis(4-chlorophenyl)-2-methyl-1<i>H</i>-pyrrol-3-yl)methyl)piperazine (<b>7l</b>)</h5><div class="NLM_p last">Yellow solid; mp 148 °C; <i>R</i><sub><i>f</i></sub> 0.34 (AcOEt/MeOH 4:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.34–7.32 (m, 2H), 7.10–7.03 (m, 4H), 5.92 (s, 1H), 6.91 (m, 2H), 6.33 (s, 1H), 3.48 (s, 2H), 2.72–2.70 (br d, 8H), 2.07–2.02 (m, 4H), 2.04 (s, 3H), 1.71–1.56 (m, 11H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 137.8, 133.4, 131.6, 131.5, 130.3, 129.7, 129.4, 128.8, 128.3, 125.1, 116.5, 111.9, 66.6, 54.1, 53.2, 44.0, 38.3, 36.9, 32.2, 29.7, 26.4, 23.5, 18.7, 13.2, 11.3 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 535 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>32</sub>H<sub>38</sub>Cl<sub>2</sub>N<sub>3</sub> (M + H<sup>+</sup>) 534.2437, found 534.2424.</div></div><div id="sec6_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 1-(Bicyclo[2.2.1]heptan-2-yl)-4-((1,5-bis(4-chlorophenyl)-2-methyl-1<i>H</i>-pyrrol-3-yl)methyl)piperazine (<b>7m</b>)</h5><div class="NLM_p last">Pale yellow solid; mp 81 °C; <i>R</i><sub><i>f</i></sub> 0.40 (AcOEt/MeOH 4:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.26 (d, 2H, <i>J</i> = 12 Hz), 7.04 (d, 2H, <i>J</i> = 12 Hz), 6.99 (d, 2H, <i>J</i> = 12 Hz), 6.85 (d, 2H, <i>J</i> = 12 Hz), 6.30 (s, 1H), 3.44 (s, 2H), 2.51 (brs, 6H), 2.19–2.17 (m, 2H), 2.12–2.07 (m, 1H), 2.00 (s, 3H), 1.66–1.62 (m, 2H), 1.43–1.40 (m, 1H), 1.29–1.17 (m, 7H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 137.8, 133.4, 131.9,131.5, 129.7, 128.7, 128.3, 111.8, 67.9, 65.9, 54.2, 52.6, 38.9, 38.0, 36.8, 36.8, 31.6, 30.6, 22.7, 21.0, 14.2, 11.2 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 494 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>29</sub>H<sub>34</sub>Cl<sub>2</sub>N<sub>3</sub> (M + H<sup>+</sup>) 494.2124, found 494.2113.</div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Synthesis of Compounds <b>8a</b>–<b>c</b>. General Procedure</h4><div class="NLM_p">POCl<sub>3</sub> (6 mmol) was added dropwise to a round-bottom flask containing ice-cooled DMF (5 mL) under N<sub>2</sub> atmosphere. After 15 min, a solution of the appropriate pyrrole <b>3a</b>, <b>3b</b>, or <b>3e</b> (1 mmol) was added to the stirring solution. Then the reaction mixture was allowed to stir at 100 °C for 3 h. The reaction was monitored through TLC. After completion, the reaction was quenched with 10% w/v NaOH solution (20 mL). The reaction mixture was then diluted with EtOAc (10 mL) and washed two times with EtOAc (10 mL) and once with brine (20 mL). The organic extracts were collected and then they were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was then purified by flash chromatography (hexanes/AcOEt, 4:1 v/v), affording the desired compounds <b>8a</b>–<b>c</b>.</div><div id="sec6_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 1-(4-Chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrole-3-carbaldehyde (<b>8a</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.67 (hexane/AcOEt 9:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 9.71 (s, 1H), 7.41–7.39 (d, 2H, <i>J</i> = 7.8), 7.10–7.07 (d, 2H, <i>J</i> = 7.8), 6.25 (s, 1H), 2.17 (s, 3H), 1.88 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 185.3, 162.6, 138.7, 135.5, 130.9, 129.6, 129.3, 122.1, 106.15, 12.7, 11.2 ppm; data are in agreement with those previously reported.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec6_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 1-(4-Fluorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrole-3-carbaldehyde (<b>8b</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.71 (hexane/AcOEt 9:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 9.86 (s, 1H), 7.20–7.17 (m, 4H), 6.36 (s, 1H), 2.26 (s, 3H), 1.96 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 187.3, 129.8, 120.4, 117.2, 116.8, 116.6, 105.9, 12.7, 11.2 ppm; data are in agreement with those previously reported.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec6_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 1,5-Bis(4-chlorophenyl)-2-methyl-1<i>H</i>-pyrrole-3-carbaldehyde (<b>8c</b>)</h5><div class="NLM_p last">White solid; mp 110 °C; <i>R</i><sub><i>f</i></sub> 0.6 (hexane/AcOEt 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 9.89 (s, 1H), 7.33 (d, 2H, <i>J</i> = 12 Hz), 7.09 (d, 2H, <i>J</i> = 12 Hz), 7.01 (d, 2H, <i>J</i> = 12 Hz), 6.87 (d, 2H, <i>J</i> = 12 Hz), 6.70 (s, 1H), 2.32 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 185.6, 140.1, 135.6, 134.5, 133.2, 132.0, 130.0, 129.8, 129.5, 129.4, 128.6, 122.9, 108.9, 11.5 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 331 [M + H]<sup>+</sup>.</div></div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Synthesis of Pyrrole Derivatives <b>9a</b>–<b>j</b>. General Procedure</h4><div class="NLM_p">The appropriate aldehyde <b>8a</b>–<b>c</b> (1 mmol) was dissolved in 5 mL of THF in a round-bottom flask. Then AcOH (1 mmol) and the appropriate amine (1 mmol) were added to the stirring solution at room temperature. The mixture was allowed to stir at room temperature for 20 min before NaB(AcO)<sub>3</sub>H (3 mmol) was added. The mixture was allowed to stir at room temperature for 18 h. Then, after completion, the reaction was quenched with 1 M NaOH solution (25 mL). The mixture was then allowed to stir for 30 min. The reaction mixture was then diluted with EtOAc (10 mL) and washed two times with EtOAc (10 mL) and once with brine (20 mL). The organic extracts were collected and then dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was then purified by flash chromatography (hexane/AcOEt, 6:4 v/v, affording the desired compounds <b>9a</b>–<b>j</b>.</div><div id="sec6_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> <i>N</i>-((1-(4-Chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methyl)-2-phenylethan-1-amine (<b>9a</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.29 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.42–7.40 (d, 2H, <i>J</i> = 1.4 Hz), 7.29–7.27 (m, 2H), 7.24–7.22 (m, 3H), 7.12–7.10 (d, 2H, <i>J</i> = 1.4 Hz), 5.90 (s, 1H), 3.63 (s, 2H), 2.95 (m, 2H), 2.86 (m, 2H), 1.99 (s, 3H), 1.94 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 140.3, 137.6, 133.5, 129.6, 129.3, 128.8, 128.5, 128.0, 126.1, 125.5, 118.1, 107.1, 51.0, 45.7, 36.4, 12.8, 10.7 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 339 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>21</sub>H<sub>24</sub>ClN<sub>2</sub> (M + H<sup>+</sup>) 339.1623, found 339.1603.</div></div><div id="sec6_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> <i>N</i>-Benzyl-1-(1-(4-chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methanamine (<b>9b</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.5 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.39 (d, 2H, <i>J</i> = 8.7 Hz), 7.34–7.27 (m, 4H), 7.22–7.20 (m, 1H), 7.10 (d, 2H, <i>J</i> = 8.7 Hz), 5.92 (s, 1H), 3.83 (s, 2H), 3.60 (s, 2H), 1.97 (s, 3H), 1.91 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 140.7, 137.6, 133.5, 129.6, 129.3, 128.3, 128.1, 127.9, 126.8, 125.6, 118.1, 107.1, 53.5, 45.0, 12.8, 10.7 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 325 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>20</sub>H<sub>22</sub>ClN<sub>2</sub> (M + H<sup>+</sup>) 325.1466, found 325.1466.</div></div><div id="sec6_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> <i>N</i>-((1-(4-Chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methyl)cyclohexanamine (<b>9c</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.17 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.40 (d, 2H, <i>J</i> = 8.2 Hz), 7.10 (d, 2H, <i>J</i> = 8.2 Hz), 5.91 (s, 1H), 3.59 (s, 2H), 2.53–2.48 (m, 1H), 1.98 (s, 3H), 1.95 (s, 3H), 1.94–1.90 (m, 2H), 1.74–1.70 (m, 2H), 1.16–1.06 (m, 3H), 0.85–0.81 (m, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 137.6, 133.4, 129.6, 129.3, 128.0, 125.3, 118.6, 107.0, 56.7, 42.8, 33.6, 26.3, 25.1, 12.8, 10.7 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 317 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>19</sub>H<sub>26</sub>ClN<sub>2</sub> (M + H<sup>+</sup>) 317.1779, found 317.1779.</div></div><div id="sec6_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> <i>N</i>-((1-(4-Chlorophenyl)-2,5-dimethyl-<i>1H</i>-pyrrol-3-yl)methyl)adamantan-2-amine (<b>9d</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.51 (AcOEt/hexane 1:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.41 (d, 2H, <i>J</i> = 8.0 Hz), 7.12 (d, 2H, <i>J</i> = 8.0 Hz), 5.94 (s, 1H), 3.57 (s, 2H), 2.81 (m, 1H), 2.04–2.00 (m, 2H), 1.99 (s, 3H), 1.97 (s, 3H), 1.93 (m, 2H), 1.86–1.83 (m, 3H), 1.76–1.70 (m, 5H), 1.50–1.47 (m, 2H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 137.6, 133.4, 129.6, 129.3, 127.9, 125.4, 118.8, 107.2, 61.7, 42.9, 38.1, 37.7, 32.1, 31.5, 28.0, 27.8, 12.9, 10.7 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 369 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>23</sub>H<sub>30</sub>ClN<sub>2</sub> (M + H<sup>+</sup>) 369.2092, found 369.2089.</div></div><div id="sec6_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 1-(1-(4-Chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)-<i>N</i>-(4-methylbenzyl)methanamine (<b>9e</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.37 (AcOEt/MeOH 4:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.41 (d, <i>J</i> = 8.7 Hz, 2H), 7.24 (d, <i>J</i> = 7.9 Hz, 2H), 7.13–7.10 (m, 4H), 5.94 (s, 1H), 3.18 (s, 2H), 3.61 (s, 2H), 2.32 (s, 3H), 1.99 (s, 3H), 1.93 (s, 3H), ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 137.6, 137.4, 136.4, 133.5, 129.6, 129.4, 129.1, 128.2, 128.0, 125.8, 117.9, 107.2, 53.1, 44.9, 21.2, 12.9, 10.8 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 339 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>21</sub>H<sub>24</sub>ClN<sub>2</sub> (M + H<sup>+</sup>) 339.1623, found 339.1624.</div></div><div id="sec6_4_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> <i>N</i>-(4-Chlorobenzyl)-1-(1-(4-chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methanamine (<b>9f</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.12 (AcOEt 100%); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.41 (d, <i>J</i> = 8.7 Hz, 2H), 7.30–7.24 (m, 4H), 7.11 (d, <i>J</i> = 8.2 Hz, 2H), 5.91 (s, 1H), 3.81 (s, 2H), 3.59 (s, 2H), 1.99 (s, 3H), 1.92 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 139.3, 133.7, 129.6, 129.5, 129.4, 128.4, 128.1, 125.7, 117.9, 107.1, 52.7, 45.1, 12.8, 10.8 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 359 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>20</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub> (M + H<sup>+</sup>) 359.1076, found 359.1076.</div></div><div id="sec6_4_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> <i>N</i>-(4-Fluorobenzyl)-1-(1-(4-chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methanamine (<b>9g</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.16 (AcOEt 100%); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.41 (d, <i>J</i> = 8.7 Hz, 2H), 7.31 (dd, <i>J</i> = 8.7 Hz 2H), 7.11 (d, <i>J</i> = 8.2 Hz, 2H), 6.99 (t, <i>J</i> = 8.2 Hz, 2H), 5.91 (s, 1H), 3.81 (s, 2H), 3.59 (s, 2H), 1.99 (s, 3H), 1.92 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 163.1, 160.7, 137.6, 133.6, 129.7, 129.6, 129.4, 128.1, 125.7, 118.0, 115.2, 107.1, 52.8, 45.1, 12.8, 10.8 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 343 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>20</sub>H<sub>21</sub>ClFN<sub>2</sub> (M + H<sup>+</sup>) 343.1372, found 343.1374.</div></div><div id="sec6_4_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> <i>N</i>-Benzyl-1-(1-(4-fluorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methanamine (<b>9h</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.20 (AcOEt/hexane 4:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.36–7.29 (m, 4H), 7.23 (t, <i>J</i> = 7.9 Hz, 1H), 7.15–7.09 (m, 4H), 5.92 (s, 1H), 3.85 (s, 2H), 3.61 (s, 2H), 1.98 (s, 3H), 1.91 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 130.1, 129.9, 128.4, 128.2, 117.9, 116.2, 115.9, 106.8, 53.6, 45.2, 12.9, 10.8 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 309 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>20</sub>H<sub>22</sub>FN<sub>2</sub> (M + H<sup>+</sup>) 309.1762, found 309.1764.</div></div><div id="sec6_4_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> <i>N</i>-Benzyl-1-(1,5-bis(4-chlorophenyl)-2-methyl-1<i>H</i>-pyrrol-3-yl)methanamine (<b>9i</b>)</h5><div class="NLM_p last">White solid; mp 183 °C; <i>R</i><sub><i>f</i></sub> 0.23 (AcOEt/MeOH 9:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.31–7.25 (m, 7H), 7.04 (d, 2H, <i>J</i> = 12 Hz), 6.97 (d, 2H, <i>J</i> = 12 Hz), 6.86 (d, 2H, <i>J</i> = 12 Hz), 6.31 (s, 1H), 3.82 (s, 2H), 3.62 (s, 2H), 1.96 (s, 3H), 1.80 (brs, 1H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 137.3, 133.9, 132.7, 132.0, 130.0, 129.6, 129.5, 128.9, 128.3, 111.4, 110.5, 29.1, 24.6, 11.4 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 421 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>25</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub> (M + H<sup>+</sup>) 421.1233, found 421.1228.</div></div><div id="sec6_4_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> <i>N</i>-((1,5-Bis(4-chlorophenyl)-2-methyl-1<i>H</i>-pyrrol-3-yl)methyl)cyclohexanamine (<b>9j</b>)</h5><div class="NLM_p last">White solid; mp 218 °C; <i>R</i><sub><i>f</i></sub> 0.32 (AcOEt/MeOH 9:1); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.24 (d, 2H, <i>J</i> = 12 Hz), 7.00 (d, 2H, <i>J</i> = 12 Hz), 6.95 (d, 2H, <i>J</i> = 12 Hz), 6.80 (d, 2H, <i>J</i> = 12 Hz), 6.69 (s, 1H), 2.93–2.87 (m, 1H), 2.19 (d, 2H, <i>J</i> = 12 Hz), 2.01 (s, 3H), 1.76–1.63 (m, 3H), 1.21–1.15 (m, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 137.0, 133.9, 132.0, 129.7, 128.9, 128.3, 111.4, 110.5, 55.0, 39.4, 29.1, 28.9, 24.6, 11.4 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 413 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>24</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>2</sub> (M + H<sup>+</sup>) 413.1546, found 413.1548.</div></div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Synthesis of Oximes <b>10a,b</b>. General Procedure<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></h4><div class="NLM_p">The appropriate aldehyde <b>8a,</b><b>b</b> (1 mmol) was dissolved in 5 mL of THF in a round-bottom flask. Then AcOH (1 mmol) and benzylhydroxylamine (1 mmol) were added to the stirring solution at room temperature. The mixture was allowed to stir at room temperature for 18 h. After completion, the reaction was quenched with 1 M NaOH solution (25 mL). The reaction mixture was then diluted with EtOAc (10 mL) and washed two times with EtOAc (10 mL) and once with brine (20 mL). The organic extracts were collected and then dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was then purified by flash chromatography (hexanes-AcOEt, 6:4 v/v), affording the desired compounds <b>10a,</b><b>b</b>.</div><div id="sec6_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 1-(4-Chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrole-3-carbaldehyde <i>O</i>-Benzyl Oxime (<b>10a</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.88 (hexane/Et<sub>2</sub>O 3:2); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 8.15, 7.45–7.41 (m, 4H), 7.37–7.33 (m, 2H), 7.30–7.29 (m, 1H), 7.11 (d, 2H, <i>J</i> = 8.7 Hz), 6.24 (s, 1H), 5.14 (s, 2H), 2.03 (s, 3H), 1.97 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 144.6, 138.0, 136.6, 134.3, 130.8, 130.1, 129.7, 129.6, 128.5, 128.4, 127.8, 112.9, 104.6, 75.9, 12.8, 11.5 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 339 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>20</sub>H<sub>19</sub>ClN<sub>2</sub>O (M + H<sup>+</sup>) 339.1259, found 339.1260.</div></div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Synthesis of Compounds <b>11a,</b><b>b</b>. General Procedure</h4><div class="NLM_p">The appropriate oxime <b>10a,</b><b>b</b> (1 mmol) was dissolved in 5 mL of THF in a round-bottom flask. Then, NaBH<sub>3</sub>(CN) (3 mmol) was added to the solution and the mixture was allowed to stir at room temperature for 18 h. Then, the reaction was quenched with 1 M NaOH solution (25 mL). The reaction mixture was then diluted with EtOAc (10 mL) and washed two times with EtOAc (10 mL) and once with brine (20 mL). The organic extracts were collected and then dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was then purified by flash chromatography (hexanes/AcOEt, 6:4 v/v), affording the desired compounds <b>11a,</b><b>b</b>.</div><div id="sec6_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> <i>O</i>-Benzyl-<i>N</i>-((1-(4-chlorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methyl)hydroxylamine (<b>11a</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.43 (AcOEt/hexane 2:3); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.42–7.25 (m, 7H), 7.10 (d, 2H, <i>J</i> = 8.7 Hz), 5.90 (s, 1H), 5.48 (brs, 1H), 4.74 (s, 2H), 3.91 (s, 2H), 1.97 (s, 3H), 1.93 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 138.2, 137.5, 133.6, 129.6, 129.4, 128.6, 128.4, 128.2, 127.3, 126.9, 114.3, 107.6, 76.1, 48.5, 12.8, 10.7 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 339 [M – H<sup>+</sup>]; HRMS (ESI) calcd for C<sub>20</sub>H<sub>20</sub>ClN<sub>2</sub>O (M – H<sup>+</sup>) 339.1264, found 339.1259.</div></div><div id="sec6_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> <i>O</i>-Benzyl-<i>N</i>-((1-(4-fluorophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methyl)hydroxylamine (<b>11b</b>)</h5><div class="NLM_p last">Tan oil; <i>R</i><sub><i>f</i></sub> 0.45 (AcOEt/hexane 2:3); <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) δ 7.39–7.28 (m, 5H), 7.12 (m, 4H), 5.90 (s, 1H), 4.75 (s, 2H), 3.92 (s, 2H), 1.96 (s, 3H), 1.92 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz CDCl<sub>3</sub>) δ 138.2, 134.9, 130.0, 129.9, 128.6, 128.4, 128.3, 127.8, 127.1, 116.2, 115.9, 114.0, 107.3, 76.1, 48.5, 12.8, 10.7 ppm; LRMS <i>m</i>/<i>z</i> (ES+) <i>m</i>/<i>z</i> 323 [M – H<sup>+</sup>]; HRMS (ESI) calcd for C<sub>20</sub>H<sub>20</sub>FN<sub>2</sub>O (M – H<sup>+</sup>) 323.1560, found 323.1554.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00031">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66123" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66123" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00031" class="ext-link">10.1021/acs.jmedchem.6b00031</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Copies of <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra for compounds <b>7g</b>, <b>7j</b>, <b>9a</b>, <b>9b</b>, and <b>9c</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00031/suppl_file/jm6b00031_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all the new compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00031/suppl_file/jm6b00031_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00031/suppl_file/jm6b00031_si_001.pdf">jm6b00031_si_001.pdf (0.99 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00031/suppl_file/jm6b00031_si_002.csv">jm6b00031_si_002.csv (2.84 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00031" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75675" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75675" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Manetti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Biotecnologie, Chimica e Farmacia, Università
di Siena, Via Aldo Moro
2, I-53100 Siena, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#12747370607b687b7d3c7f737c7766667b52677c7b617b3c7b66"><span class="__cf_email__" data-cfemail="93f5f2f1e1fae9fafcbdfef2fdf6e7e7fad3e6fdfae0fabdfae7">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniele Castagnolo</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Science, King’s
College London, 150 Stamford
Street, London SE1 9NH, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Applied Sciences, Northumbria University
Newcastle, Ellison Place, NE1 8ST, Newcastle upon Tyne, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7c181d1215191019521f1d0f081d1b121310133c171f10521d1f520917"><span class="__cf_email__" data-cfemail="a5c1c4cbccc0c9c08bc6c4d6d1c4c2cbcac9cae5cec6c98bc4c68bd0ce">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sanjib Bhakta</span> - <span class="hlFld-Affiliation affiliation">Mycobacteria
Research Laboratory, Department of Biological Sciences, Institute
of Structural and Molecular Biology, Birkbeck, University of London, Malet Street, London WC1E
7HX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolò Scalacci</span> - <span class="hlFld-Affiliation affiliation">Department
of Applied Sciences, Northumbria University
Newcastle, Ellison Place, NE1 8ST, Newcastle upon Tyne, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Science, King’s
College London, 150 Stamford
Street, London SE1 9NH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arundhati Maitra</span> - <span class="hlFld-Affiliation affiliation">Mycobacteria
Research Laboratory, Department of Biological Sciences, Institute
of Structural and Molecular Biology, Birkbeck, University of London, Malet Street, London WC1E
7HX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alistair K. Brown</span> - <span class="hlFld-Affiliation affiliation">School of
Medicine, Pharmacy and Health, Durham University, Queen’s Campus, Stockton-on-Tees, TS17 6BH, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Applied Sciences, Northumbria University
Newcastle, Ellison Place, NE1 8ST, Newcastle upon Tyne, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Saiprasad Dasugari</span> - <span class="hlFld-Affiliation affiliation">Department
of Applied Sciences, Northumbria University
Newcastle, Ellison Place, NE1 8ST, Newcastle upon Tyne, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dimitrios Evangelopoulos</span> - <span class="hlFld-Affiliation affiliation">Centre
for Clinical Microbiology, University College
London, London, NW3 2PF U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy D. McHugh</span> - <span class="hlFld-Affiliation affiliation">Centre
for Clinical Microbiology, University College
London, London, NW3 2PF U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Parisa N. Mortazavi</span> - <span class="hlFld-Affiliation affiliation">Mycobacteria
Research Laboratory, Department of Biological Sciences, Institute
of Structural and Molecular Biology, Birkbeck, University of London, Malet Street, London WC1E
7HX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander Twist</span> - <span class="hlFld-Affiliation affiliation">Department
of Applied Sciences, Northumbria University
Newcastle, Ellison Place, NE1 8ST, Newcastle upon Tyne, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Petricci</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Biotecnologie, Chimica e Farmacia, Università
di Siena, Via Aldo Moro
2, I-53100 Siena, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written and enhanced through contributions of all authors. All authors have given approval to the final version of the manuscript. S.B., F.M. and D.C. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6233-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are thankful for funding from the Medical Research Council (grant G0801956 to SB), Wellcome Trust/Birkbeck Anniversary Scholarship (to A.M.), Birkbeck Translational Research Award, Royal Society of Chemistry (Research Fund 2015 to D.C.), and Northumbria University Ph.D. Studentship. S.B. is a Cipla Distinguished Fellow in Pharmaceutical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We gratefully acknowledge the EPSRC UK National Mass Spectrometry Facility for providing the mass spectrometry data. Prof. A. Tafi is also acknowledged for helpful discussion on the computational details.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i67" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i67"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i68" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i68"> Abbreviations Used</h2><tr><td class="NLM_term">MTB</td><td class="NLM_def"><p class="first last"><i>Mycobacterium tuberculosis</i></p></td></tr><tr><td class="NLM_term">MDR-TB</td><td class="NLM_def"><p class="first last">multidrug-resistant tuberculosis</p></td></tr><tr><td class="NLM_term">XDR-TB</td><td class="NLM_def"><p class="first last">extensively drug resistant tuberculosis</p></td></tr><tr><td class="NLM_term">TDR-TB</td><td class="NLM_def"><p class="first last">totally drug resistant tuberculosis</p></td></tr><tr><td class="NLM_term">MmpL</td><td class="NLM_def"><p class="first last">mycobacterial membrane protein large</p></td></tr><tr><td class="NLM_term">RND</td><td class="NLM_def"><p class="first last">resistance-nodulation-cell division</p></td></tr><tr><td class="NLM_term">BCG</td><td class="NLM_def"><p class="first last">bacille Calmette–Guerin</p></td></tr><tr><td class="NLM_term">GIC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% growth inhibitory concentration</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">EPI</td><td class="NLM_def"><p class="first last">efflux pump inhibitory</p></td></tr><tr><td class="NLM_term">ADC</td><td class="NLM_def"><p class="first last">albumin–dextrose–catalase</p></td></tr><tr><td class="NLM_term">OADC</td><td class="NLM_def"><p class="first last">oleic acid–albumin–dextrose–catalase</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony forming unit</p></td></tr><tr><td class="NLM_term">MABA</td><td class="NLM_def"><p class="first last">microplate Alamar Blue assay</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">OD<sub>600</sub></td><td class="NLM_def"><p class="first last">optical density at 600 nm</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">WHO</span><span class="NLM_x">. Global Tuberculosis Report 2015. </span><a href="http://www.who.int/tb/publications/global_report/en/" class="extLink">http://www.who.int/tb/publications/global_report/en/</a> (accessed Feb 8,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WHO.+Global+Tuberculosis+Report+2015.+http%3A%2F%2Fwww.who.int%2Ftb%2Fpublications%2Fglobal_report%2Fen%2F+%28accessed+Feb+8%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Caminero, J. A.</span><span> </span><span class="NLM_article-title">Treatment of multidrug-resistant tuberculosis: evidence and controversies</span> <span class="citation_source-journal">Int. J. Tuberc. Lung Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=16898365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BD28vnsVOhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=829-837&author=J.+A.+Caminero&title=Treatment+of+multidrug-resistant+tuberculosis%3A+evidence+and+controversies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of multidrug-resistant tuberculosis: evidence and controversies</span></div><div class="casAuthors">Caminero J A</div><div class="citationInfo"><span class="NLM_cas:title">The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">829-37</span>
        ISSN:<span class="NLM_cas:issn">1027-3719</span>.
    </div><div class="casAbstract">In the last decade, multidrug-resistant tuberculosis (MDR-TB, defined as resistance to at least isoniazid and rifampicin) has become an epidemiological issue of first priority at the global level.  Case management needs to be simplified and standardised, as in many countries MDR-TB cases cannot receive individualised attention from specialist physicians.  However, before any decision can be made on standardisation, a careful analysis must first be made of the evidence and controversies behind the various published recommendations.  Unfortunately, the controversies outweigh the evidence.  The difficulties lie not only in the absence of controlled trials to validate specific recommendations, but also in the very different and even contradictory results found in the literature.  It is therefore essential to analyse these discrepancies before developing rational, uniform recommendations.  The analysis should encompass the most essential and controversial issues regarding the management of MDR-TB patients: 1) confirmation of diagnosis in a suspected MDR-TB patient, and determination of the value of drug susceptibility testing; 2) the number of anti-tuberculosis drugs required to treat MDR-TB; 3) the most rational use of effective drugs against tuberculosis; 4) the advisable length of parenteral drug administration or of the initial phase of treatment; 5) the contribution of surgery to the management of MDR-TB patients; and 6) the optimal regimen for treating MDR-TB: standardised vs. individualised regimens.  The evidence and controversies regarding each of the above questions are analysed with the aim of facilitating decision making in the treatment of these complex patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrbnqXnY7ZfQWRJ3OJdH_qfW6udTcc2eYnQ7rXIt-aL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vnsVOhsw%253D%253D&md5=5d9cd0116afe1bb905ca343503192821</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaminero%26aufirst%3DJ.%2BA.%26atitle%3DTreatment%2520of%2520multidrug-resistant%2520tuberculosis%253A%2520evidence%2520and%2520controversies%26jtitle%3DInt.%2520J.%2520Tuberc.%2520Lung%2520Dis.%26date%3D2006%26volume%3D10%26spage%3D829%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Chan, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strand, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goble, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iseman, M. D.</span><span> </span><span class="NLM_article-title">Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">1103</span><span class="NLM_x">–</span> <span class="NLM_lpage">1109</span><span class="refDoi"> DOI: 10.1164/rccm.200308-1159OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1164%2Frccm.200308-1159OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=14742301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BD2c3jtlKhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2004&pages=1103-1109&author=E.+D.+Chanauthor=V.+Laurelauthor=M.+J.+Strandauthor=J.+F.+Chanauthor=M.+L.+Huynhauthor=M.+Gobleauthor=M.+D.+Iseman&title=Treatment+and+outcome+analysis+of+205+patients+with+multidrug-resistant+tuberculosis&doi=10.1164%2Frccm.200308-1159OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis</span></div><div class="casAuthors">Chan Edward D; Laurel Valerie; Strand Matthew J; Chan Julanie F; Huynh Mai-Lan N; Goble Marian; Iseman Michael D</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1103-9</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">Multidrug-resistant tuberculosis, a disease caused by Mycobacterium tuberculosis strains that are resistant at least to rifampin and isoniazid, entails extended treatment, expensive and toxic regimens, and higher rates of treatment failure and death.  We retrospectively analyzed the outcomes in 205 patients treated at our center for multidrug-resistant tuberculosis, with strains resistant to a median of six drugs, and compared the results with those of our previous series.  Logistic regression and survival analysis were used to evaluate short- and long-term outcomes, respectively.  Initial favorable response, defined as at least three consecutive negative sputum cultures over a period of at least 3 months, was 85% compared with 65% in the prior cohort.  The current cohort had greater long-term success rates, 75% versus 56%, and lower tuberculosis death rates, 12% versus 22%, than the earlier one.  Surgical resection and fluoroquinolone therapy were associated with improved microbiological and clinical outcomes in the 205 patients studied after adjusting for other variables.  The improvement was statistically significant for surgery and among older patients for fluoroquinolone therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTADxmZBcvS7DMsgLhIoICsfW6udTcc2eYnQ7rXIt-aL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3jtlKhsA%253D%253D&md5=8fde1fde3ab75993c8faa6c526306aec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1164%2Frccm.200308-1159OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200308-1159OC%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DE.%2BD.%26aulast%3DLaurel%26aufirst%3DV.%26aulast%3DStrand%26aufirst%3DM.%2BJ.%26aulast%3DChan%26aufirst%3DJ.%2BF.%26aulast%3DHuynh%26aufirst%3DM.%2BL.%26aulast%3DGoble%26aufirst%3DM.%26aulast%3DIseman%26aufirst%3DM.%2BD.%26atitle%3DTreatment%2520and%2520outcome%2520analysis%2520of%2520205%2520patients%2520with%2520multidrug-resistant%2520tuberculosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2004%26volume%3D169%26spage%3D1103%26epage%3D1109%26doi%3D10.1164%2Frccm.200308-1159OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Eker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliori, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotgiu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muetterlein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Centis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruesch-Gerdes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C.</span><span> </span><span class="NLM_article-title">Multidrug- and extensively drug-resistant tuberculosis, Germany</span> <span class="citation_source-journal">Emerging Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1700</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span><span class="refDoi"> DOI: 10.3201/eid1411.080729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.3201%2Feid1411.080729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=18976552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BD1cjhtlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1700-1706&author=B.+Ekerauthor=J.+Ortmannauthor=G.+B.+Miglioriauthor=G.+Sotgiuauthor=R.+Muetterleinauthor=R.+Centisauthor=H.+Hoffmannauthor=D.+Kirstenauthor=T.+Schabergauthor=S.+Ruesch-Gerdesauthor=C.+Lange&title=Multidrug-+and+extensively+drug-resistant+tuberculosis%2C+Germany&doi=10.3201%2Feid1411.080729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug- and extensively drug-resistant tuberculosis, Germany</span></div><div class="casAuthors">Eker Barbara; Ortmann Johannes; Migliori Giovanni B; Sotgiu Giovanni; Muetterlein Ralf; Centis Rosella; Hoffmann Harald; Kirsten Detlef; Schaberg Tom; Ruesch-Gerdes Sabine; Lange Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Emerging infectious diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1700-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We evaluated risk factors and treatment outcomes associated with multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) in Germany in 2004-2006.  In 177 (4%) of 4,557 culture-positive TB cases, Mycobacterium tuberculosis isolates were identified as MDR TB; an additional 7 (0.15%) met criteria for XDR TB.  Of these 184 patients, 148 (80%) were born in countries of the former Soviet Union.  In patients with XDR TB, hospitalization was longer (mean +/- SD 202 +/- 130 vs. 123 +/- 81 days; p = 0.015) and resistance to all first-line drugs was more frequent (36% vs. 86%; p = 0.013) than in patients with MDR TB.  Seventy-four (40%) of these 184 patients received treatment with linezolid.  Treatment success rates ranged from 59% for the entire cohort (59% for MDR TB and 57% for XDR TB) to 87% for those with a definitive outcome (n = 125; 89% for MDR TB and 80% for XDR TB).  Extensive drug susceptibility testing and availability of second- and third-line drugs under inpatient management conditions permit relatively high treatment success rates in MDR- and XDR TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLoYYbyenxnWBAiYWy6n3SfW6udTcc2eaNFQB0aaHU07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjhtlGitA%253D%253D&md5=4b7a295b71561ea764630adeba04ef0a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3201%2Feid1411.080729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid1411.080729%26sid%3Dliteratum%253Aachs%26aulast%3DEker%26aufirst%3DB.%26aulast%3DOrtmann%26aufirst%3DJ.%26aulast%3DMigliori%26aufirst%3DG.%2BB.%26aulast%3DSotgiu%26aufirst%3DG.%26aulast%3DMuetterlein%26aufirst%3DR.%26aulast%3DCentis%26aufirst%3DR.%26aulast%3DHoffmann%26aufirst%3DH.%26aulast%3DKirsten%26aufirst%3DD.%26aulast%3DSchaberg%26aufirst%3DT.%26aulast%3DRuesch-Gerdes%26aufirst%3DS.%26aulast%3DLange%26aufirst%3DC.%26atitle%3DMultidrug-%2520and%2520extensively%2520drug-resistant%2520tuberculosis%252C%2520Germany%26jtitle%3DEmerging%2520Infect.%2520Dis.%26date%3D2008%26volume%3D14%26spage%3D1700%26epage%3D1706%26doi%3D10.3201%2Feid1411.080729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mitnick, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seung, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwood, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzmaurice, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcantara Viru, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleton, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayona, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonilla, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalco, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurtado, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jazayeri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llaro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestanza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloutsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becerra, M. C.</span><span> </span><span class="NLM_article-title">Comprehensive treatment of extensively drug-resistant tuberculosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span><span class="refDoi"> DOI: 10.1056/NEJMoa0800106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1056%2FNEJMoa0800106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=18687637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt12iu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2008&pages=563-574&author=C.+D.+Mitnickauthor=S.+S.+Shinauthor=K.+J.+Seungauthor=M.+L.+Richauthor=S.+S.+Atwoodauthor=J.+J.+Furinauthor=G.+M.+Fitzmauriceauthor=F.+A.+Alcantara+Viruauthor=S.+C.+Appletonauthor=J.+N.+Bayonaauthor=C.+A.+Bonillaauthor=K.+Chalcoauthor=S.+Choiauthor=M.+F.+Frankeauthor=H.+S.+Fraserauthor=D.+Guerraauthor=R.+M.+Hurtadoauthor=D.+Jazayeriauthor=K.+Josephauthor=K.+Llaroauthor=L.+Mestanzaauthor=J.+S.+Mukherjeeauthor=M.+Mu%C3%B1ozauthor=E.+Palaciosauthor=E.+Sanchezauthor=A.+Sloutskyauthor=M.+C.+Becerra&title=Comprehensive+treatment+of+extensively+drug-resistant+tuberculosis&doi=10.1056%2FNEJMoa0800106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive treatment of extensively drug-resistant tuberculosis</span></div><div class="casAuthors">Mitnick, Carole D.; Shin, Sonya S.; Seung, Kwonjune J.; Rich, Michael L.; Atwood, Sidney S.; Furing, Jennifer J.; Fitzmaurice, Garrett M.; Alcantara Viru, Felix A.; Appleton, Sasha C.; Bayona, Jaime N.; Bonilla, Cesar A.; Chalco, Katiuska; Choi, Sharon; Franke, Molly F.; Fraser, Hamish S. F.; Guerra, Dalia; Hurtado, Rocio M.; Jazayeri, Darius; Joseph, Keith; Llaro, Karim; Mestanza, Lorena; Mukherjee, Joia S.; Munoz, Maribel; Palacios, Eda; Sanchez, Epifanio; Sloutsky, Alexander; Becerra, Mercedes C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">563-574</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Extensively drug-resistant tuberculosis has been reported in 45 countries, including countries with limited resources and a high burden of tuberculosis.  We describe the management of extensively drug-resistant tuberculosis and treatment outcomes among patients who were referred for individualized outpatient therapy in Peru.  A total of 810 patients were referred for free individualized therapy, including drug treatment, resective surgery, adverse-event management, and nutritional and psychosocial support.  We tested isolates from 651 patients for extensively drug-resistant tuberculosis and developed regimens that included five or more drugs to which the infecting isolate was not resistant.  Of the 651 patients tested, 48 (7.4%) had extensively drug-resistant tuberculosis; the remaining 603 patients had multidrug-resistant tuberculosis.  The patients with extensively drug-resistant tuberculosis had undergone more treatment than the other patients (mean [± SD] no. of regimens, 4.2±1.9 vs. 3.2±1.6; P < 0.001) and had isolates that were resistant to more drugs (no. of drugs, 8.4±1.1 vs. 5.3±1.5; P < 0.001).  None of the patients with extensively drug-resistant tuberculosis were coinfected with the human immunodeficiency virus (HIV).  Patients with extensively drug-resistant tuberculosis received daily, supervised therapy with an av. of 5.3±1.3 drugs, including cycloserine, an injectable drug, and a fluoroquinolone.  Twenty-nine of these patients (60.4%) completed treatment or were cured, as compared with 400 patients (66.3%) with multidrug-resistant tuberculosis (P = 0.36).  Extensively drug-resistant tuberculosis can be cured in HIV-neg. patients through outpatient treatment, even in those who have received multiple prior courses of therapy for tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfpygpC_IPPLVg90H21EOLACvtfcHk0lhuDDNFhVwudg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt12iu7g%253D&md5=8b0a958dd5181c9acdbcb9f0d708bf43</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0800106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0800106%26sid%3Dliteratum%253Aachs%26aulast%3DMitnick%26aufirst%3DC.%2BD.%26aulast%3DShin%26aufirst%3DS.%2BS.%26aulast%3DSeung%26aufirst%3DK.%2BJ.%26aulast%3DRich%26aufirst%3DM.%2BL.%26aulast%3DAtwood%26aufirst%3DS.%2BS.%26aulast%3DFurin%26aufirst%3DJ.%2BJ.%26aulast%3DFitzmaurice%26aufirst%3DG.%2BM.%26aulast%3DAlcantara%2BViru%26aufirst%3DF.%2BA.%26aulast%3DAppleton%26aufirst%3DS.%2BC.%26aulast%3DBayona%26aufirst%3DJ.%2BN.%26aulast%3DBonilla%26aufirst%3DC.%2BA.%26aulast%3DChalco%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DFranke%26aufirst%3DM.%2BF.%26aulast%3DFraser%26aufirst%3DH.%2BS.%26aulast%3DGuerra%26aufirst%3DD.%26aulast%3DHurtado%26aufirst%3DR.%2BM.%26aulast%3DJazayeri%26aufirst%3DD.%26aulast%3DJoseph%26aufirst%3DK.%26aulast%3DLlaro%26aufirst%3DK.%26aulast%3DMestanza%26aufirst%3DL.%26aulast%3DMukherjee%26aufirst%3DJ.%2BS.%26aulast%3DMu%25C3%25B1oz%26aufirst%3DM.%26aulast%3DPalacios%26aufirst%3DE.%26aulast%3DSanchez%26aufirst%3DE.%26aulast%3DSloutsky%26aufirst%3DA.%26aulast%3DBecerra%26aufirst%3DM.%2BC.%26atitle%3DComprehensive%2520treatment%2520of%2520extensively%2520drug-resistant%2520tuberculosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D359%26spage%3D563%26epage%3D574%26doi%3D10.1056%2FNEJMoa0800106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Migliori, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loddenkemper, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raviglione, M. C.</span><span> </span><span class="NLM_article-title">125 years after Robert Koch’s discovery of the tubercle bacillus: the new XDR-TB threat. Is ″science″ enough to tackle the epidemic?</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span><span class="refDoi"> DOI: 10.1183/09031936.00001307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1183%2F09031936.00001307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=17329486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ivFOgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=423-427&author=G.+B.+Miglioriauthor=R.+Loddenkemperauthor=F.+Blasiauthor=M.+C.+Raviglione&title=125+years+after+Robert+Koch%E2%80%99s+discovery+of+the+tubercle+bacillus%3A+the+new+XDR-TB+threat.+Is+%E2%80%B3science%E2%80%B3+enough+to+tackle+the+epidemic%3F&doi=10.1183%2F09031936.00001307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic?</span></div><div class="casAuthors">Migliori G B; Loddenkemper R; Blasi F; Raviglione M C</div><div class="citationInfo"><span class="NLM_cas:title">The European respiratory journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">423-7</span>
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkJlxHGuTx0ZagfuraLLzSfW6udTcc2eaNFQB0aaHU07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ivFOgtQ%253D%253D&md5=543c313805077a2c539bdb4c7cbc153e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1183%2F09031936.00001307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00001307%26sid%3Dliteratum%253Aachs%26aulast%3DMigliori%26aufirst%3DG.%2BB.%26aulast%3DLoddenkemper%26aufirst%3DR.%26aulast%3DBlasi%26aufirst%3DF.%26aulast%3DRaviglione%26aufirst%3DM.%2BC.%26atitle%3D125%2520years%2520after%2520Robert%2520Koch%25E2%2580%2599s%2520discovery%2520of%2520the%2520tubercle%2520bacillus%253A%2520the%2520new%2520XDR-TB%2520threat.%2520Is%2520%25E2%2580%25B3science%25E2%2580%25B3%2520enough%2520to%2520tackle%2520the%2520epidemic%253F%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2007%26volume%3D29%26spage%3D423%26epage%3D427%26doi%3D10.1183%2F09031936.00001307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Velayati, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farnia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masjedi, M. R.</span><span> </span><span class="NLM_article-title">The totally drug resistant tuberculosis (TDR-TB)</span> <span class="citation_source-journal">Int. J. Clin. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=23641309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BC3sngsF2htQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=307-309&author=A.+A.+Velayatiauthor=P.+Farniaauthor=M.+R.+Masjedi&title=The+totally+drug+resistant+tuberculosis+%28TDR-TB%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The totally drug resistant tuberculosis (TDR-TB)</span></div><div class="casAuthors">Velayati Ali Akbar; Farnia Parissa; Masjedi Mohammad Reza</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-9</span>
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSj--hoFhw8vIxhnOQkIHOxfW6udTcc2eaKjzmUqagrIrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sngsF2htQ%253D%253D&md5=792fd0a06fd4e326f0ca4acc944600b4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVelayati%26aufirst%3DA.%2BA.%26aulast%3DFarnia%26aufirst%3DP.%26aulast%3DMasjedi%26aufirst%3DM.%2BR.%26atitle%3DThe%2520totally%2520drug%2520resistant%2520tuberculosis%2520%2528TDR-TB%2529%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2013%26volume%3D6%26spage%3D307%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Biava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porretta, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deidda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompei, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molicotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward <i>Mycobacterium tuberculosis</i> and Low Cytotoxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4946</span><span class="NLM_x">–</span> <span class="NLM_lpage">4952</span><span class="refDoi"> DOI: 10.1021/jm0602662</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0602662" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4946-4952&author=M.+Biavaauthor=G.+C.+Porrettaauthor=G.+Poceauthor=S.+Supinoauthor=D.+Deiddaauthor=R.+Pompeiauthor=P.+Molicottiauthor=F.+Manettiauthor=M.+Botta&title=Antimycobacterial+agents.+Novel+diarylpyrrole+derivatives+of+BM212+endowed+with+high+activity+toward+Mycobacterium+tuberculosis+and+Low+Cytotoxicity&doi=10.1021%2Fjm0602662"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm0602662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0602662%26sid%3Dliteratum%253Aachs%26aulast%3DBiava%26aufirst%3DM.%26aulast%3DPorretta%26aufirst%3DG.%2BC.%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DSupino%26aufirst%3DS.%26aulast%3DDeidda%26aufirst%3DD.%26aulast%3DPompei%26aufirst%3DR.%26aulast%3DMolicotti%26aufirst%3DP.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DAntimycobacterial%2520agents.%2520Novel%2520diarylpyrrole%2520derivatives%2520of%2520BM212%2520endowed%2520with%2520high%2520activity%2520toward%2520Mycobacterium%2520tuberculosis%2520and%2520Low%2520Cytotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4946%26epage%3D4952%26doi%3D10.1021%2Fjm0602662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Alfonso, S.</span><span> </span><span class="NLM_article-title">BM212-derived MmpL3 inhibitors enabling new possibilities for the treatment of TB and studies of mycobacterial iron assimilation as new potential target for drug discovery</span>. Ph.D. Thesis, <span class="NLM_publisher-name">Sapienza Università di Roma</span>, September 10,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://hdl.handle.net/10805/2145" class="extLink">http://hdl.handle.net/10805/2145</a>, accessed April 27, 2015.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Alfonso&title=BM212-derived+MmpL3+inhibitors+enabling+new+possibilities+for+the+treatment+of+TB+and+studies+of+mycobacterial+iron+assimilation+as+new+potential+target+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlfonso%26aufirst%3DS.%26atitle%3DBM212-derived%2520MmpL3%2520inhibitors%2520enabling%2520new%2520possibilities%2520for%2520the%2520treatment%2520of%2520TB%2520and%2520studies%2520of%2520mycobacterial%2520iron%2520assimilation%2520as%2520new%2520potential%2520target%2520for%2520drug%2520discovery%26pub%3DSapienza%2520Universit%25C3%25A0%2520di%2520Roma%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Biava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porretta, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battilocchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Logu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.1002/cmdc.201000526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1002%2Fcmdc.201000526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=21341373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslKhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=593-599&author=M.+Biavaauthor=G.+C.+Porrettaauthor=G.+Poceauthor=C.+Battilocchioauthor=S.+Alfonsoauthor=A.+de+Loguauthor=F.+Manettiauthor=M.+Botta&title=Developing+pyrrole-derived+antimycobacterial+agents%3A+a+rational+lead+optimization+approach&doi=10.1002%2Fcmdc.201000526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Developing Pyrrole-Derived Antimycobacterial Agents: a Rational Lead Optimization Approach</span></div><div class="casAuthors">Biava, Mariangela; Porretta, Giulio Cesare; Poce, Giovanna; Battilocchio, Claudio; Alfonso, Salvatore; de Logu, Alessandro; Manetti, Fabrizio; Botta, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">593-599</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Tuberculosis (TB) represents a never-ending challenge toward which research efforts are needed.  Drug resistance is the key problem that scientists in the field need to fight.  The development of new drugs endowed with novel modes of action against different biol. targets is of extreme importance; these new agents should also exhibit lower toxicity compared with the anti-TB drugs currently available.  Furthermore, new drugs should be inexpensive since most of the TB-infected population lives in developing nations.  In the last few years, numerous researchers have focused their attention on TB, leading to the discovery of some interesting compds.  Among these, the pyrrole-derived compds. we developed can be considered very promising antimycobacterial agents.  Aided by mol. modeling studies, we synthesized numerous compds. characterized by the same 1,5-diarylpyrrole scaffold and elucidated very interesting antitubercular/antimycobacterial properties.  Some compds. identified are extremely promising and represent a step towards the design of novel lead structures in the fight against TB.  Our efforts to this end are reviewed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmIVID45JnRLVg90H21EOLACvtfcHk0lgn40O4IMyj_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslKhtbY%253D&md5=16918d5f02707b05907dd6faa732a764</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000526%26sid%3Dliteratum%253Aachs%26aulast%3DBiava%26aufirst%3DM.%26aulast%3DPorretta%26aufirst%3DG.%2BC.%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DBattilocchio%26aufirst%3DC.%26aulast%3DAlfonso%26aufirst%3DS.%26aulast%3Dde%2BLogu%26aufirst%3DA.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DDeveloping%2520pyrrole-derived%2520antimycobacterial%2520agents%253A%2520a%2520rational%2520lead%2520optimization%2520approach%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D593%26epage%3D599%26doi%3D10.1002%2Fcmdc.201000526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Poce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocozza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porretta, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rullas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Logu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rosa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasca, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rossi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wae, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biava, M.</span><span> </span><span class="NLM_article-title">Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e56980</span><span class="refDoi"> DOI: 10.1371/journal.pone.0056980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1371%2Fjournal.pone.0056980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=23437287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjs12ntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e56980&author=G.+Poceauthor=R.+H.+Batesauthor=S.+Alfonsoauthor=M.+Cocozzaauthor=G.+C.+Porrettaauthor=L.+Ballellauthor=J.+Rullasauthor=F.+Ortegaauthor=A.+De+Loguauthor=E.+Agusauthor=V.+La+Rosaauthor=M.+R.+Pascaauthor=E.+De+Rossiauthor=B.+Waeauthor=S.+G.+Franzblauauthor=F.+Manettiauthor=M.+Bottaauthor=M.+Biava&title=Improved+BM212+MmpL3+inhibitor+analogue+shows+efficacy+in+acute+murine+model+of+tuberculosis+infection&doi=10.1371%2Fjournal.pone.0056980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection</span></div><div class="casAuthors">Poce, Giovanna; Bates, Robert H.; Alfonso, Salvatore; Cocozza, Martina; Porretta, Giulio Cesare; Ballell, Lluis; Rullas, Joaquin; Ortega, Fatima; De Logu, Alessandro; Agus, Emanuela; La Rosa, Valentina; Pasca, Maria Rosalia; De Rossi, Edda; Wae, Baojie; Franzblau, Scott G.; Manetti, Fabrizio; Botta, Maurizio; Biava, Mariangela</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e56980</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">1,5-Di-Ph pyrroles were previously identified as a class of compds. endowed with high in vitro efficacy against M. tuberculosis.  To improve the phys. chem. properties and drug-like parameters of this class of compds., a medicinal chem. effort was undertaken.  By selecting the optimal substitution patterns for the Ph rings at N1 and C5 and by replacing the thiomorpholine moiety with a morpholine one, a new series of compds. was produced.  The replacement of the sulfur with oxygen gave compds. with lower lipophilicity and improved in vitro microsomal stability.  Moreover, since the parent compd. of this family has been shown to target MmpL3, mycobacterial mutants resistant to two compds. have been isolated and characterized by sequencing the mmpL3 gene; all the mutants showed point mutations in this gene.  The best compd. identified to date was progressed to dose-response studies in an acute murine TB infection model.  The resulting ED99 of 49 mg/Kg is within the range of commonly employed tuberculosis drugs, demonstrating the potential of this chem. series.  The in vitro and in vivo target validation evidence presented here adds further wt. to MmpL3 as a druggable target of interest for anti-tubercular drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyyLtc66FRAbVg90H21EOLACvtfcHk0lj_4s_sFPKZig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjs12ntr0%253D&md5=9dd29b729e6bdc9b94409bc1147e28e0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0056980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0056980%26sid%3Dliteratum%253Aachs%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DAlfonso%26aufirst%3DS.%26aulast%3DCocozza%26aufirst%3DM.%26aulast%3DPorretta%26aufirst%3DG.%2BC.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DOrtega%26aufirst%3DF.%26aulast%3DDe%2BLogu%26aufirst%3DA.%26aulast%3DAgus%26aufirst%3DE.%26aulast%3DLa%2BRosa%26aufirst%3DV.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DWae%26aufirst%3DB.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DBiava%26aufirst%3DM.%26atitle%3DImproved%2520BM212%2520MmpL3%2520inhibitor%2520analogue%2520shows%2520efficacy%2520in%2520acute%2520murine%2520model%2520of%2520tuberculosis%2520infection%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De56980%26doi%3D10.1371%2Fjournal.pone.0056980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onajole, O. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunosewoyo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipparaju, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammerman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishai, W. R.</span><span> </span><span class="NLM_article-title">Indoleamides are active against drug-resistant Mycobacterium tuberculosis</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2907</span><span class="refDoi"> DOI: 10.1038/ncomms3907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1038%2Fncomms3907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=24352433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslKgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2907&author=S.+Lunauthor=H.+Guoauthor=O.+K.+Onajoleauthor=M.+Pieroniauthor=H.+Gunosewoyoauthor=G.+Chenauthor=S.+K.+Tipparajuauthor=N.+C.+Ammermanauthor=A.+P.+Kozikowskiauthor=W.+R.+Bishai&title=Indoleamides+are+active+against+drug-resistant+Mycobacterium+tuberculosis&doi=10.1038%2Fncomms3907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamides are active against drug-resistant Mycobacterium tuberculosis</span></div><div class="casAuthors">Lun Shichun; Guo Haidan; Onajole Oluseye K; Gunosewoyo Hendra; Chen Gang; Kozikowski Alan P; Pieroni Marco; Tipparaju Suresh K; Ammerman Nicole C; Bishai William R</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2907</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Responsible for nearly two million deaths each year, the infectious disease tuberculosis remains a serious global health challenge.  The emergence of multidrug- and extensively drug-resistant strains of Mycobacterium tuberculosis confounds control efforts, and new drugs with novel molecular targets are desperately needed.  Here we describe lead compounds, the indoleamides, with potent activity against both drug-susceptible and drug-resistant strains of M. tuberculosis by targeting the mycolic acid transporter MmpL3.  We identify a single mutation in mmpL3, which confers high resistance to the indoleamide class while remaining susceptible to currently used first- and second-line tuberculosis drugs, indicating a lack of cross-resistance.  Importantly, an indoleamide derivative exhibits dose-dependent antimycobacterial activity when orally administered to M. tuberculosis-infected mice.  The bioavailability of the indoleamides, combined with their ability to kill tubercle bacilli, indicates great potential for translational developments of this structure class for the treatment of drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR4ame_FVdejL7NkxioyDXTfW6udTcc2ea55mKLhldvNbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslKgtw%253D%253D&md5=29323f5b10dff540b38973491545d1c5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fncomms3907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3907%26sid%3Dliteratum%253Aachs%26aulast%3DLun%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DOnajole%26aufirst%3DO.%2BK.%26aulast%3DPieroni%26aufirst%3DM.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DTipparaju%26aufirst%3DS.%2BK.%26aulast%3DAmmerman%26aufirst%3DN.%2BC.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DBishai%26aufirst%3DW.%2BR.%26atitle%3DIndoleamides%2520are%2520active%2520against%2520drug-resistant%2520Mycobacterium%2520tuberculosis%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D2907%26doi%3D10.1038%2Fncomms3907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">La Rosa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canseco, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buroni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasca, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porretta, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battilocchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javid, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorrentino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioerger, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchettini, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Logu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rossi, E.</span><span> </span><span class="NLM_article-title">MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span><span class="refDoi"> DOI: 10.1128/AAC.05270-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1128%2FAAC.05270-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=22024828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Gqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=324-331&author=V.+La+Rosaauthor=G.+Poceauthor=J.+O.+Cansecoauthor=S.+Buroniauthor=M.+R.+Pascaauthor=M.+Biavaauthor=R.+M.+Rajuauthor=G.+C.+Porrettaauthor=S.+Alfonsoauthor=C.+Battilocchioauthor=B.+Javidauthor=F.+Sorrentinoauthor=T.+R.+Ioergerauthor=J.+C.+Sacchettiniauthor=F.+Manettiauthor=M.+Bottaauthor=A.+De+Loguauthor=E.+J.+Rubinauthor=E.+De+Rossi&title=MmpL3+is+the+cellular+target+of+the+antitubercular+pyrrole+derivative+BM212&doi=10.1128%2FAAC.05270-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212</span></div><div class="casAuthors">La Rosa, Valentina; Poce, Giovanna; Canseco, Julio Ortiz; Buroni, Silvia; Pasca, Maria Rosalia; Biava, Mariangela; Raju, Ravikiran M.; Porretta, Giulio Cesare; Alfonso, Salvatore; Battilocchio, Claudio; Javid, Babak; Sorrentino, Flavia; Ioerger, Thomas R.; Sacchettini, James C.; Manetti, Fabrizio; Botta, Maurizio; De Logu, Alessandro; Rubin, Eric J.; De Rossi, Edda</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">324-331</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The 1,5-diarylpyrrole deriv. BM212 was previously shown to be active against multidrug-resistant clin. isolates and Mycobacterium tuberculosis residing within macrophages as well as against Mycobacterium avium and other atypical mycobacteria.  To det. its mechanism of action, the cellular target was identified.  Spontaneous Mycobacterium smegmatis, Mycobacterium bovis BCG, and M. tuberculosis H37Rv mutants that were resistant to BM212 were isolated.  By the screening of genomic libraries and by whole-genome sequencing, it was found that all the characterized mutants showed mutations in the mmpL3 gene, allowing the conclusion that resistance to BM212 maps to the MmpL3 protein, a member of the MmpL (mycobacterial membrane protein, large) family.  Susceptibility was unaffected by the efflux pump inhibitors reserpine, carbonylcyanide m-chlorophenylhydrazone, and verapamil.  Uptake/efflux expts. with [14C]BM212 demonstrated that resistance is not driven by the efflux of BM212.  Together, these data strongly suggest that the MmpL3 protein is the cellular target of BM212.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBpqZddgKhTLVg90H21EOLACvtfcHk0lj_4s_sFPKZig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Gqtw%253D%253D&md5=f73b43cff2112c31ae27878eeb740d76</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FAAC.05270-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.05270-11%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BRosa%26aufirst%3DV.%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DCanseco%26aufirst%3DJ.%2BO.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DBiava%26aufirst%3DM.%26aulast%3DRaju%26aufirst%3DR.%2BM.%26aulast%3DPorretta%26aufirst%3DG.%2BC.%26aulast%3DAlfonso%26aufirst%3DS.%26aulast%3DBattilocchio%26aufirst%3DC.%26aulast%3DJavid%26aufirst%3DB.%26aulast%3DSorrentino%26aufirst%3DF.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DDe%2BLogu%26aufirst%3DA.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26atitle%3DMmpL3%2520is%2520the%2520cellular%2520target%2520of%2520the%2520antitubercular%2520pyrrole%2520derivative%2520BM212%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D324%26epage%3D331%26doi%3D10.1128%2FAAC.05270-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Protopopova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanrahan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikonenko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gearhart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacy, C. A.</span><span> </span><span class="NLM_article-title">Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">968</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span><span class="refDoi"> DOI: 10.1093/jac/dki319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1093%2Fjac%2Fdki319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=16172107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCjtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2005&pages=968-974&author=M.+Protopopovaauthor=C.+Hanrahanauthor=B.+Nikonenkoauthor=R.+Samalaauthor=P.+Chenauthor=J.+Gearhartauthor=L.+Einckauthor=C.+A.+Nacy&title=Identification+of+a+new+antitubercular+drug+candidate%2C+SQ109%2C+from+a+combinatorial+library+of+1%2C2-ethylenediamines&doi=10.1093%2Fjac%2Fdki319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines</span></div><div class="casAuthors">Protopopova, Marina; Hanrahan, Colleen; Nikonenko, Boris; Samala, Rowena; Chen, Ping; Gearhart, Jackie; Einck, Leo; Nacy, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">968-974</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: The aim of this study was to identify a candidate drug for clin. development from a previously synthesized combinatorial library based on the 1,2-ethylenediamine structure of ethambutol.  Methods: Sixty-nine of the most potent hits against Mycobacterium tuberculosis from the original studies were subjected to a sequential set of tests in vitro and in vivo-detn. of MIC for M. tuberculosis H37Rv, cytotoxicity, intracellular antimycobacterial activity, permeability evaluation and in vivo efficacy testing.  Results: Twenty-seven compds. with MICs of ≤15.6 μM were tested on Vero cells to det. in vitro cytotoxicity (IC50) and to establish a selectivity index (SI) (SI = IC50/MIC).  Ten compds. with acceptable SI were tested for activity against intracellular bacteria; all were equiv. (within 1%) or superior to ethambutol and several demonstrated bactericidal activity.  Five of the most potent compds. were tested for in vivo efficacy in a murine model of chronic tuberculosis infection.  Conclusion: Compd. SQ109 with an MIC of 0.7-1.56 μM (H37Rv, Erdman and drug-resistant strains of M. tuberculosis), an SI of 16.7 and 99% inhibition activity against intracellular bacteria, demonstrated potency in vivo and limited toxicity in vitro and in vivo, and was selected for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqvmYc-WY3LrVg90H21EOLACvtfcHk0ljo9mxq6Ubm7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCjtLjI&md5=2f3d82748de8a565112541b2aa4e5437</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdki319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdki319%26sid%3Dliteratum%253Aachs%26aulast%3DProtopopova%26aufirst%3DM.%26aulast%3DHanrahan%26aufirst%3DC.%26aulast%3DNikonenko%26aufirst%3DB.%26aulast%3DSamala%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DGearhart%26aufirst%3DJ.%26aulast%3DEinck%26aufirst%3DL.%26aulast%3DNacy%26aufirst%3DC.%2BA.%26atitle%3DIdentification%2520of%2520a%2520new%2520antitubercular%2520drug%2520candidate%252C%2520SQ109%252C%2520from%2520a%2520combinatorial%2520library%2520of%25201%252C2-ethylenediamines%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2005%26volume%3D56%26spage%3D968%26epage%3D974%26doi%3D10.1093%2Fjac%2Fdki319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Nikonenko, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protopopova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacy, C. A.</span><span> </span><span class="NLM_article-title">Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1563</span><span class="NLM_x">–</span> <span class="NLM_lpage">1565</span><span class="refDoi"> DOI: 10.1128/AAC.01326-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1128%2FAAC.01326-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=17242141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlOisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=1563-1565&author=B.+V.+Nikonenkoauthor=M.+Protopopovaauthor=R.+Samalaauthor=L.+Einckauthor=C.+A.+Nacy&title=Drug+therapy+of+experimental+tuberculosis+%28TB%29%3A+improved+outcome+by+combining+SQ109%2C+a+new+diamine+antibiotic%2C+with+existing+TB+drugs&doi=10.1128%2FAAC.01326-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs</span></div><div class="casAuthors">Nikonenko, Boris V.; Protopopova, Marina; Samala, Rowena; Einck, Leo; Nacy, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1563-1565</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Substitution of the new diamine antibiotic SQ109 for ethambutol in a mouse model of chronic tuberculosis (TB) improved efficacy of combination drug therapy with first-line TB drugs rifampin and isoniazid, with or without pyrazinamide: at 8 wk, lung bacteria were 1.5 log10 lower in SQ109-contg. regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrywULJFY6Xv7Vg90H21EOLACvtfcHk0ljo9mxq6Ubm7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlOisr4%253D&md5=179cfc6a3256417b542fd64decba25c3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FAAC.01326-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01326-06%26sid%3Dliteratum%253Aachs%26aulast%3DNikonenko%26aufirst%3DB.%2BV.%26aulast%3DProtopopova%26aufirst%3DM.%26aulast%3DSamala%26aufirst%3DR.%26aulast%3DEinck%26aufirst%3DL.%26aulast%3DNacy%26aufirst%3DC.%2BA.%26atitle%3DDrug%2520therapy%2520of%2520experimental%2520tuberculosis%2520%2528TB%2529%253A%2520improved%2520outcome%2520by%2520combining%2520SQ109%252C%2520a%2520new%2520diamine%2520antibiotic%252C%2520with%2520existing%2520TB%2520drugs%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D1563%26epage%3D1565%26doi%3D10.1128%2FAAC.01326-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanrahan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coward, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikonenko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protopopova, M.</span><span> </span><span class="NLM_article-title">Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1038%2Fsj.bjp.0705984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=15644871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVelsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2005&pages=80-87&author=L.+Jiaauthor=J.+E.+Tomaszewskiauthor=C.+Hanrahanauthor=L.+Cowardauthor=P.+Nokerauthor=G.+Gormanauthor=B.+Nikonenkoauthor=M.+Protopopova&title=Pharmacodynamics+and+pharmacokinetics+of+SQ109%2C+a+new+diamine-based+antitubercular+drug&doi=10.1038%2Fsj.bjp.0705984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug</span></div><div class="casAuthors">Jia, Lee; Tomaszewski, Joseph E.; Hanrahan, Colleen; Coward, Lori; Noker, Patricia; Gorman, Gregory; Nikonenko, Boris; Protopopova, Marina</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-87</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SQ109 is a novel [1,2]-diamine-based ethambutol (EMB) analog developed from high-throughput combinatorial screening.  The present study aimed at characterizing its pharmacodynamics and pharmacokinetics.  The antimicrobial activity of SQ109 was confirmed in vitro (Mycobacterium tuberculosis-infected murine macrophages) and in vivo (M. tuberculosis-infected C57BL/6 mice) and compared to isoniazid (INH) and EMB.  SQ109 showed potency and efficacy in inhibiting intracellular M. tuberculosis that was similar to INH, but superior to EMB.  In vivo oral administration of SQ109 (0.1-25 mg kg-1 day-1) to the mice for 28 days resulted in dose-dependent redns. of mycobacterial load in both spleen and lung comparable to that of EMB administered at 100 mg kg-1 day-1, but was less potent than INH at 25 mg kg-1 day-1.  Monitoring of SQ109 levels in mouse tissues on days 1, 14 and 28 following 28-day oral administration (10 mg kg-1 day-1) revealed that lungs and spleen contained the highest concn. of SQ109, at least 10 times above its MIC.  Pharmacokinetic profiles of SQ109 in mice following a single administration showed its Cmax as 1038 (i.v.) and 135 ng ml-1 (p.o.), with an oral Tmax of 0.31 h.  The elimination t1/2 of SQ109 was 3.5 (i.v.) and 5.2 h (p.o.).  The oral bioavailability was 4%.  However, SQ109 displayed a large vol. of distribution into various tissues.  The highest concn. of SQ109 was present in lung (>MIC), which was at least 120-fold (p.o.) and 180-fold (i.v.) higher than that in plasma.  The next ranked tissues were spleen and kidney.  SQ109 levels in most tissues after a single administration were significantly higher than that in blood.  High tissue concns. of SQ109 persisted for the observation period (10 h).This study demonstrated that SQ109 displays promising in vitro and in vivo antitubercular activity with favorable targeted tissue distribution properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr465Y-yxoiw7Vg90H21EOLACvtfcHk0ljo9mxq6Ubm7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVelsA%253D%253D&md5=224a4ee49bae4c58ef8a0463848c5c12</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705984%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DL.%26aulast%3DTomaszewski%26aufirst%3DJ.%2BE.%26aulast%3DHanrahan%26aufirst%3DC.%26aulast%3DCoward%26aufirst%3DL.%26aulast%3DNoker%26aufirst%3DP.%26aulast%3DGorman%26aufirst%3DG.%26aulast%3DNikonenko%26aufirst%3DB.%26aulast%3DProtopopova%26aufirst%3DM.%26atitle%3DPharmacodynamics%2520and%2520pharmacokinetics%2520of%2520SQ109%252C%2520a%2520new%2520diamine-based%2520antitubercular%2520drug%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D144%26spage%3D80%26epage%3D87%26doi%3D10.1038%2Fsj.bjp.0705984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Heinrich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Bois, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narunsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horwith, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phipps, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacy, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aarnoutse, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeree, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelscher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diacon, A. H.</span><span> </span><span class="NLM_article-title">Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1558</span><span class="NLM_x">–</span> <span class="NLM_lpage">1566</span><span class="refDoi"> DOI: 10.1093/jac/dku553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1093%2Fjac%2Fdku553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=25630641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSru7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=1558-1566&author=N.+Heinrichauthor=R.+Dawsonauthor=J.+du+Boisauthor=K.+Narunskyauthor=G.+Horwithauthor=A.+J.+Phippsauthor=C.+A.+Nacyauthor=R.+E.+Aarnoutseauthor=M.+J.+Boereeauthor=S.+H.+Gillespieauthor=A.+Venterauthor=S.+Henneauthor=A.+Rachowauthor=P.+P.+Phillipsauthor=M.+Hoelscherauthor=A.+H.+Diacon&title=Early+phase+evaluation+of+SQ109+alone+and+in+combination+with+rifampicin+in+pulmonary+TB+patients&doi=10.1093%2Fjac%2Fdku553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients</span></div><div class="casAuthors">Heinrich, Norbert; Dawson, Rodney; du Bois, Jeannine; Narunsky, Kim; Horwith, Gary; Phipps, Andrew J.; Nacy, Carol A.; Aarnoutse, Rob E.; Boeree, Martin J.; Gillespie, Stephen H.; Venter, Amour; Henne, Sonja; Rachow, Andrea; Phillips, Patrick P. J.; Hoelscher, Michael; Diacon, Andreas H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1558-1566</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: SQ109, an asym. diamine, is a novel anti-TB drug candidate.  This first study in patients was done to det. safety, tolerability, pharmacokinetics and bacteriol. effect of different doses of SQ109 alone and in combination with rifampicin when administered over 14 days.  Patients and methods: Smear-pos. pulmonary TB patients were randomized into six groups of 15 to receive once-daily oral treatment with 75, 150 or 300 mg of SQ109, rifampicin (10 mg/kg body wt.), rifampicin plus 150 mg of SQ109, or rifampicin plus 300 mg of SQ109 for 14 days.  Patients were hospitalized for supervised treatment, regular clin., biochem. and electrocardiog. safety assessments, pharmacokinetic profiling and daily overnight sputum collection.  Results: SQ109 was safe and generally well tolerated.  Mild to moderate dose-dependent gastrointestinal complaints were the most frequent adverse events.  No relevant QT prolongation was noted.  Maximum SQ109 plasma concns. were lower than MICs.  Exposure to SQ109 (AUC0-24) increased by drug accumulation upon repeated administration in the SQ109 monotherapy groups.  Co-administration of SQ109 150 mg with rifampicin resulted in decreasing SQ109 exposures from day 1 to day 14.  A higher (300 mg) dose of SQ109 largely outweighed the evolving inductive effect of rifampicin.  The daily fall in log cfu/mL of sputum (95% CI) was 0.093 (0.126-0.059) with rifampicin, 0.133 (0.166-0.100) with rifampicin plus 150 mg of SQ109 and 0.089 (0.121-0.057) with rifampicin plus 300 mg of SQ109.  Treatments with SQ109 alone showed no significant activity.  Conclusions: SQ109 alone or with rifampicin was safe over 14 days.  Upon co-administration with rifampicin, 300 mg of SQ109 yielded a higher exposure than the 150 mg dose.  SQ109 did not appear to be active alone or to enhance the activity of rifampicin during the 14 days of treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5XuvH1u_XnLVg90H21EOLACvtfcHk0liWp2Ybu7t0qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSru7vO&md5=74383f8c0b9e897881ab69eb12b8e08f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdku553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdku553%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DN.%26aulast%3DDawson%26aufirst%3DR.%26aulast%3Ddu%2BBois%26aufirst%3DJ.%26aulast%3DNarunsky%26aufirst%3DK.%26aulast%3DHorwith%26aufirst%3DG.%26aulast%3DPhipps%26aufirst%3DA.%2BJ.%26aulast%3DNacy%26aufirst%3DC.%2BA.%26aulast%3DAarnoutse%26aufirst%3DR.%2BE.%26aulast%3DBoeree%26aufirst%3DM.%2BJ.%26aulast%3DGillespie%26aufirst%3DS.%2BH.%26aulast%3DVenter%26aufirst%3DA.%26aulast%3DHenne%26aufirst%3DS.%26aulast%3DRachow%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DP.%2BP.%26aulast%3DHoelscher%26aufirst%3DM.%26aulast%3DDiacon%26aufirst%3DA.%2BH.%26atitle%3DEarly%2520phase%2520evaluation%2520of%2520SQ109%2520alone%2520and%2520in%2520combination%2520with%2520rifampicin%2520in%2520pulmonary%2520TB%2520patients%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2015%26volume%3D70%26spage%3D1558%26epage%3D1566%26doi%3D10.1093%2Fjac%2Fdku553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnolo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passalacqua, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saddi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deidda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Logu, A.</span><span> </span><span class="NLM_article-title">Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of mycobacterium tuberculosis</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span><span class="refDoi"> DOI: 10.1002/cmdc.200600026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1002%2Fcmdc.200600026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=16892466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=973-989&author=F.+Manettiauthor=M.+Magnaniauthor=D.+Castagnoloauthor=L.+Passalacquaauthor=M.+Bottaauthor=F.+Corelliauthor=M.+Saddiauthor=D.+Deiddaauthor=A.+De+Logu&title=Ligand-based+virtual+screening%2C+parallel+solution-phase+and+microwave-assisted+synthesis+as+tools+to+identify+and+synthesize+new+inhibitors+of+mycobacterium+tuberculosis&doi=10.1002%2Fcmdc.200600026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of Mycobacterium tuberculosis</span></div><div class="casAuthors">Manetti, Fabrizio; Magnani, Matteo; Castagnolo, Daniele; Passalacqua, Laura; Botta, Maurizio; Corelli, Federico; Saddi, Manuela; Deidda, Delia; De Logu, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">973-989</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In an attempt to identify new inhibitors of the growth of Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis, a procedure for the generation, design, and screening of a ligand-based virtual library was applied.  This used both an in silico protocol centered on a recursive partitioning (RP) model described herein, and a pharmacophoric model for antitubercular agents previously generated by our research group.  Two candidates emerged from databases of com. available compds., both characterized by a min. inhibitory concn. (MIC) of 25 μg mL-1.  Based on these compds., two series of derivs. were synthesized by both parallel soln.-phase and microwave-assisted synthesis, leading to enhanced antimycobacterial activity.  During both the design and synthesis, attention was focused on the efficient allocation of available resources with the aim of reducing the overall costs assocd. with calcn. and synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqUbmJeLZ0_LVg90H21EOLACvtfcHk0liWp2Ybu7t0qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVCmu7Y%253D&md5=9e44838cf10c39cb7a1d318749e482ab</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600026%26sid%3Dliteratum%253Aachs%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DMagnani%26aufirst%3DM.%26aulast%3DCastagnolo%26aufirst%3DD.%26aulast%3DPassalacqua%26aufirst%3DL.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DCorelli%26aufirst%3DF.%26aulast%3DSaddi%26aufirst%3DM.%26aulast%3DDeidda%26aufirst%3DD.%26aulast%3DDe%2BLogu%26aufirst%3DA.%26atitle%3DLigand-based%2520virtual%2520screening%252C%2520parallel%2520solution-phase%2520and%2520microwave-assisted%2520synthesis%2520as%2520tools%2520to%2520identify%2520and%2520synthesize%2520new%2520inhibitors%2520of%2520mycobacterium%2520tuberculosis%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D973%26epage%3D989%26doi%3D10.1002%2Fcmdc.200600026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Badiola, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triccas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, M. H.</span><span> </span><span class="NLM_article-title">Efficient synthesis and anti-tubercular activity of a series of spirocycles: an exercise in open science</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e111782</span><span class="refDoi"> DOI: 10.1371/journal.pone.0111782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1371%2Fjournal.pone.0111782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=25493550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyjs7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e111782&author=K.+A.+Badiolaauthor=D.+H.+Quanauthor=J.+A.+Triccasauthor=M.+H.+Todd&title=Efficient+synthesis+and+anti-tubercular+activity+of+a+series+of+spirocycles%3A+an+exercise+in+open+science&doi=10.1371%2Fjournal.pone.0111782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis and anti-tubercular activity of a series of spirocycles: an exercise in open science</span></div><div class="casAuthors">Badiola, Katrina A.; Quan, Diana H.; Triccas, James A.; Todd, Matthew H.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e111782/1-e111782/20, 20 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">An efficient synthesis of a series of spirocyclic pyrans I [R = benzodioxan-6-yl, benzodioxol-5-yl, 4-hydroxy-3-methoxyphenyl, etc.] and II [R1 = C6H5, 4-BrC6H4, 2-BrC6H4] via oxa-Pictet-Spengler reaction is developed.  The oxa-Pictet-Spengler reaction of 4-benzylpiperidone and 2-thiopheneethanol gives N-benzylated intermediate III, which on further debenzylation produces secondary amine IV.  Secondary amine IV upon reductive amination with aldehydes/ketones yielded spirocyclic pyrans I and upon acylation with acyl chlorides yielded spirocyclic pyrans II in moderate to good yields.  The synthesized spirocyclic pyrans I and II were tested against the virulent M. tuberculosis strain (H37Rv), of which compds. I [R = benzodioxan-6-yl, benzodioxol-5-yl, 4-chlorophenyl, 1-(4-fluorophenyl)-2,5-dimethylpyrrol-3-yl] and III showd excellent anti-tubercular activity.  The toxicity of spirocyclic pyrans I displaying anti-H37Rv activity was assessed using the human monocytic cell line THP1, results showed that spirocyclic pyrans I [R = benzodioxan-6-yl, benzodioxol-5-yl, 4-chlorophenyl] and III displayed THP1 toxicty at relatively high concns.(>50 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7oCV08HTMArVg90H21EOLACvtfcHk0ljhg6YpHe-sCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyjs7nE&md5=ffff8fe33d16469205ea56402be70da2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0111782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0111782%26sid%3Dliteratum%253Aachs%26aulast%3DBadiola%26aufirst%3DK.%2BA.%26aulast%3DQuan%26aufirst%3DD.%2BH.%26aulast%3DTriccas%26aufirst%3DJ.%2BA.%26aulast%3DTodd%26aufirst%3DM.%2BH.%26atitle%3DEfficient%2520synthesis%2520and%2520anti-tubercular%2520activity%2520of%2520a%2520series%2520of%2520spirocycles%253A%2520an%2520exercise%2520in%2520open%2520science%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De111782%26doi%3D10.1371%2Fjournal.pone.0111782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span> <span class="citation_source-book">Phase</span>, version 3.3, <span class="NLM_publisher-name">Schrodinger LLC</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Phase%2C+version+3.3%2C+Schrodinger+LLC%2C+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPhase%26pub%3DSchrodinger%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wermuth, C. G.; Aldous, D.; Raboisson, P.; Rognan, D.</span>, Eds.  <span class="citation_source-book">The Practice of Medicinal Chemistry</span>, <span class="NLM_edition">4</span>th ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">385</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=385&author=C.+G.+Wermuth&author=D.+Aldous&author=P.+Raboisson&author=D.+Rognan&title=The+Practice+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26btitle%3DThe%2520Practice%2520of%2520Medicinal%2520Chemistry%26pub%3DAcademic%2520Press%26date%3D2015%26spage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insight by examining carbo- and hetero-aromatic and – aliphatic ring types</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1016/j.drudis.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchieauthor=S.+J.+Macdonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insight+by+examining+carbo-+and+hetero-aromatic+and+%E2%80%93+aliphatic+ring+types&doi=10.1016%2Fj.drudis.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insight%2520by%2520examining%2520carbo-%2520and%2520hetero-aromatic%2520and%2520%25E2%2580%2593%2520aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.drudis.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Castagnolo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Logu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meleddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chisu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8587</span><span class="NLM_x">–</span> <span class="NLM_lpage">8591</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.08.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1016%2Fj.bmc.2008.08.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=18752962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFantLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8587-8591&author=D.+Castagnoloauthor=A.+De+Loguauthor=M.+Radiauthor=B.+Bechiauthor=F.+Manettiauthor=M.+Magnaniauthor=S.+Supinoauthor=R.+Meledduauthor=L.+Chisuauthor=M.+Botta&title=Synthesis%2C+biological+evaluation+and+SAR+study+of+novel+pyrazole+analogues+as+inhibitors+of+Mycobacterium+tuberculosis&doi=10.1016%2Fj.bmc.2008.08.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis</span></div><div class="casAuthors">Castagnolo, Daniele; De Logu, Alessandro; Radi, Marco; Bechi, Beatrice; Manetti, Fabrizio; Magnani, Matteo; Supino, Sibilla; Meleddu, Rita; Chisu, Lorenza; Botta, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8587-8591</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">As a continuation of the previous work that turned toward the identification of antimycobacterial compds. with innovative structures, two series of pyrazole derivs. were synthesized by parallel soln.-phase synthesis and were assayed as inhibitors of Mycobacterium tuberculosis (MTB), which is the causative agent of tuberculosis.  One of these compds. showed high activity against MTB (MIC = 4 μg/mL).  The newly synthesized pyrazoles were also computationally investigated to analyze their fit properties to the pharmacophoric model for antitubercular compds. previously built by us and to refine structure-activity relationship anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjG2KfIIt_W7Vg90H21EOLACvtfcHk0ljhg6YpHe-sCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFantLrK&md5=57ff11988bedd828072c4940e1272982</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.08.016%26sid%3Dliteratum%253Aachs%26aulast%3DCastagnolo%26aufirst%3DD.%26aulast%3DDe%2BLogu%26aufirst%3DA.%26aulast%3DRadi%26aufirst%3DM.%26aulast%3DBechi%26aufirst%3DB.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DMagnani%26aufirst%3DM.%26aulast%3DSupino%26aufirst%3DS.%26aulast%3DMeleddu%26aufirst%3DR.%26aulast%3DChisu%26aufirst%3DL.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520SAR%2520study%2520of%2520novel%2520pyrazole%2520analogues%2520as%2520inhibitors%2520of%2520Mycobacterium%2520tuberculosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8587%26epage%3D8591%26doi%3D10.1016%2Fj.bmc.2008.08.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Castagnolo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Logu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meleddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saddi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Synthesis biological evaluation and SAR study of novel pyrazole analogues as inhibitors of <i>Mycobacterium tuberculosis</i>: Part 2. Synthesis of rigid pyrazolones</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5716</span><span class="NLM_x">–</span> <span class="NLM_lpage">5721</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.05.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1016%2Fj.bmc.2009.05.058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=5716-5721&author=D.+Castagnoloauthor=F.+Manettiauthor=M.+Radiauthor=B.+Bechiauthor=M.+Paganoauthor=A.+De+Loguauthor=R.+Meledduauthor=M.+Saddiauthor=M.+Botta&title=Synthesis+biological+evaluation+and+SAR+study+of+novel+pyrazole+analogues+as+inhibitors+of+Mycobacterium+tuberculosis%3A+Part+2.+Synthesis+of+rigid+pyrazolones&doi=10.1016%2Fj.bmc.2009.05.058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.05.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.05.058%26sid%3Dliteratum%253Aachs%26aulast%3DCastagnolo%26aufirst%3DD.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DRadi%26aufirst%3DM.%26aulast%3DBechi%26aufirst%3DB.%26aulast%3DPagano%26aufirst%3DM.%26aulast%3DDe%2BLogu%26aufirst%3DA.%26aulast%3DMeleddu%26aufirst%3DR.%26aulast%3DSaddi%26aufirst%3DM.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DSynthesis%2520biological%2520evaluation%2520and%2520SAR%2520study%2520of%2520novel%2520pyrazole%2520analogues%2520as%2520inhibitors%2520of%2520Mycobacterium%2520tuberculosis%253A%2520Part%25202.%2520Synthesis%2520of%2520rigid%2520pyrazolones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D5716%26epage%3D5721%26doi%3D10.1016%2Fj.bmc.2009.05.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Phelan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNerney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T. G.</span><span> </span><span class="NLM_article-title">The draft genome of <i>Mycobacterium Aurum</i>, a potential model organism for investigating drugs against <i>Mycobacterium tuberculosis</i> and <i>Mycobacterium leprae</i></span> <span class="citation_source-journal">Int. J. Mycobacteriology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/j.ijmyco.2015.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1016%2Fj.ijmyco.2015.05.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=207-216&author=J.+Phelanauthor=A.+Maitraauthor=R.+McNerneyauthor=M.+Nairauthor=A.+Guptaauthor=F.+Collauthor=A.+Painauthor=S.+Bhaktaauthor=T.+G.+Clark&title=The+draft+genome+of+Mycobacterium+Aurum%2C+a+potential+model+organism+for+investigating+drugs+against+Mycobacterium+tuberculosis+and+Mycobacterium+leprae&doi=10.1016%2Fj.ijmyco.2015.05.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ijmyco.2015.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijmyco.2015.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DPhelan%26aufirst%3DJ.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DMcNerney%26aufirst%3DR.%26aulast%3DNair%26aufirst%3DM.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DColl%26aufirst%3DF.%26aulast%3DPain%26aufirst%3DA.%26aulast%3DBhakta%26aufirst%3DS.%26aulast%3DClark%26aufirst%3DT.%2BG.%26atitle%3DThe%2520draft%2520genome%2520of%2520Mycobacterium%2520Aurum%252C%2520a%2520potential%2520model%2520organism%2520for%2520investigating%2520drugs%2520against%2520Mycobacterium%2520tuberculosis%2520and%2520Mycobacterium%2520leprae%26jtitle%3DInt.%2520J.%2520Mycobacteriology%26date%3D2015%26volume%3D4%26spage%3D207%26epage%3D216%26doi%3D10.1016%2Fj.ijmyco.2015.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Naik, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohanty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padhi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonawane, A.</span><span> </span><span class="NLM_article-title">Evaluation of antibacterial and cytotoxic activity of <i>Artemisia nilagirica</i> and <i>Murraya koenigii</i> leaf extracts against mycobacteria and macrophages</span> <span class="citation_source-journal">BMC Complementary Altern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="refDoi"> DOI: 10.1186/1472-6882-14-87</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1186%2F1472-6882-14-87" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=24597853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BC2crgvFalsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=87&author=S.+K.+Naikauthor=S.+Mohantyauthor=A.+Padhiauthor=R.+Patiauthor=A.+Sonawane&title=Evaluation+of+antibacterial+and+cytotoxic+activity+of+Artemisia+nilagirica+and+Murraya+koenigii+leaf+extracts+against+mycobacteria+and+macrophages&doi=10.1186%2F1472-6882-14-87"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of antibacterial and cytotoxic activity of Artemisia nilagirica and Murraya koenigii leaf extracts against mycobacteria and macrophages</span></div><div class="casAuthors">Naik Sumanta Kumar; Mohanty Soumitra; Padhi Avinash; Pati Rashmirekha; Sonawane Avinash</div><div class="citationInfo"><span class="NLM_cas:title">BMC complementary and alternative medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Artemisia nilagirica (Asteraceae) and Murraya koenigii (Rutaceae) are widely distributed in eastern region of India.  Leaves of Artemisia nilagirica plant are used to treat cold and cough by the local tribal population in east India.  Murraya koenigii is an edible plant previously reported to have an antibacterial activity.  Pathogenic strains of mycobacteria are resistant to most of the conventional antibiotics.  Therefore, it is imperative to identify novel antimycobacterial molecules to treat mycobacterial infection.  METHODS:  In this study, ethanol, petroleum ether and water extracts of Artemisia nilagirica and Murraya koenigii were tested for antibacterial activity against Mycobacterium smegmatis and Mycobacterium bovis BCG in synergy with first line anti-tuberculosis (TB) drugs, and for cytotoxic activities on mouse macrophage RAW264.7 cells.  Antibacterial activity was determined by colony forming unit (CFU) assay.  Intracellular survival assay was performed by infecting RAW264.7 cells with M. smegmatis before and after treatment with plant extracts.  Cytotoxity was checked by MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide] assay.  Genotoxicity was studied by DAPI staining and COMET assay using mouse macrophage RAW264.7 cell line.  Cell apoptosis was checked by Annexin-V/FITC dual staining method.  Reactive oxygen species and nitric oxide production was checked by DCFH staining and Griess reagent, respectively.  RESULTS:  Ethanol extracts of A. nilagirica (IC50 300 μg/ml) and M. koenigii (IC50 400 μg/ml) were found to be more effective against Mycobacterium smegmatis as compared to petroleum ether and water extracts.  M. koenigii extract showed maximum activity against M. bovis BCG in combination with a first line anti-TB drug rifampicin.  M. koenigii leaf extract also exerted more cytototoxic (IC50 20 μg/ml), genotoxic and apoptosis in mouse macrophage RAW 264.7 cell line.  Treatment of mouse macrophages with A. nilagirica extract increased intracellular killing of M. smegmatis by inducing production of reactive oxygen species and nitric oxide.  CONCLUSIONS:  Ethanol extracts of A. nilagirica and M. koenigii were found to be more effective against mycobacteria.  As compared to A. nilagirica, M. koenigii ethanol extract exhibited significant synergistic antibacterial activity against M. smegmatis and M. bovis BCG in combination with anti-tuberculosis drug rifampicin, and also showed increased cytotoxicity, DNA damage and apoptosis in mouse macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbDFbEMLxp1DEC-75aqa5AfW6udTcc2eYlLCbFeXO82Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crgvFalsA%253D%253D&md5=dd86e217eb45d9d4fd404bbeee763184</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2F1472-6882-14-87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6882-14-87%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DS.%2BK.%26aulast%3DMohanty%26aufirst%3DS.%26aulast%3DPadhi%26aufirst%3DA.%26aulast%3DPati%26aufirst%3DR.%26aulast%3DSonawane%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520antibacterial%2520and%2520cytotoxic%2520activity%2520of%2520Artemisia%2520nilagirica%2520and%2520Murraya%2520koenigii%2520leaf%2520extracts%2520against%2520mycobacteria%2520and%2520macrophages%26jtitle%3DBMC%2520Complementary%2520Altern.%2520Med.%26date%3D2014%26volume%3D14%26spage%3D87%26doi%3D10.1186%2F1472-6882-14-87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span> </span><span class="NLM_article-title">An integrated surrogate model for screening of drugs against <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1391</span><span class="refDoi"> DOI: 10.1093/jac/dks056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1093%2Fjac%2Fdks056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=22398649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2qs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=1380-1391&author=A.+Guptaauthor=S.+Bhakta&title=An+integrated+surrogate+model+for+screening+of+drugs+against+Mycobacterium+tuberculosis&doi=10.1093%2Fjac%2Fdks056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">An integrated surrogate model for screening of drugs against Mycobacterium tuberculosis</span></div><div class="casAuthors">Gupta, Antima; Bhakta, Sanjib</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1380-1391</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The intracellularly surviving and slow-growing pathogen, Mycobacterium tuberculosis, adapts the host cell environment for its active and dormant life cycle.  It is evident that the lack of appropriate high-throughput screening of inhibitors within host cells is an impediment for the early stages of anti-tubercular drug discovery.  The authors developed an integrated surrogate model that enhances the screening of large inhibitor libraries.  Different mycobacterial species were compared for their growth, drug susceptibility and intracellular uptake.  A 6-well plate solid agar-based spot culture growth inhibition (SPOTi) assay was developed into a higher throughput format.  The uptake and intracellular survival of Mycobacterium aurum within mouse macrophage cells (RAW 264.7) were optimized using 24/96-well plate formats.  Fast-growing, non-pathogenic M. aurum was found to have an antibiotic-susceptibility profile similar to that of M. tuberculosis.  The sensitivity to an acidic pH environment and the ability to multiply inside RAW 264.7 macrophages provided addnl. advantages for employing M. aurum in intracellular drug screening methods.  A selection of anti-tubercular drugs inhibited the growth and viability of M. aurum inside the macrophages at different levels.  Thus, the authors present a rapid, convenient, high-throughput surrogate model that provides a comprehensive evaluation platform for new chem. scaffolds against different physiol. stages of mycobacteria within the primary cell environment of the host.  The results using anti-tubercular drugs validate this model for screening libraries of existing and novel chem. entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprxqZBGNLxD7Vg90H21EOLACvtfcHk0lhN3PTEDKMqbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2qs7w%253D&md5=18f51e99ee3ca84a8bde1c0e6ffe5631</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks056%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DBhakta%26aufirst%3DS.%26atitle%3DAn%2520integrated%2520surrogate%2520model%2520for%2520screening%2520of%2520drugs%2520against%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D1380%26epage%3D1391%26doi%3D10.1093%2Fjac%2Fdks056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span> <span class="citation_source-book">Maestro</span>, version 9.2; <span class="NLM_publisher-name">Schrodinger LLC</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+9.2%3B+Schrodinger+LLC%2C+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%26pub%3DSchrodinger%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span> <span class="citation_source-book">MacroModel</span>, version 9.9; <span class="NLM_publisher-name">Schrodinger LLC</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MacroModel%2C+version+9.9%3B+Schrodinger+LLC%2C+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMacroModel%26pub%3DSchrodinger%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Sambandamurthy, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalapathy, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcelli, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, W. R.,  Jr.</span><span> </span><span class="NLM_article-title"><i>Mycobacterium tuberculosis</i> DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis</span> <span class="citation_source-journal">Vaccine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">6309</span><span class="NLM_x">–</span> <span class="NLM_lpage">6320</span><span class="refDoi"> DOI: 10.1016/j.vaccine.2006.05.097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1016%2Fj.vaccine.2006.05.097" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=6309-6320&author=V.+K.+Sambandamurthyauthor=S.+C.+Derrickauthor=T.+Hsuauthor=B.+Chenauthor=M.+H.+Larsenauthor=K.+V.+Jalapathyauthor=M.+Chenauthor=J.+Kimauthor=S.+A.+Porcelliauthor=J.+Chanauthor=S.+L.+Morrisauthor=W.+R.+Jacobs&title=Mycobacterium+tuberculosis+DeltaRD1+DeltapanCD%3A+a+safe+and+limited+replicating+mutant+strain+that+protects+immunocompetent+and+immunocompromised+mice+against+experimental+tuberculosis&doi=10.1016%2Fj.vaccine.2006.05.097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2006.05.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2006.05.097%26sid%3Dliteratum%253Aachs%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DDerrick%26aufirst%3DS.%2BC.%26aulast%3DHsu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DLarsen%26aufirst%3DM.%2BH.%26aulast%3DJalapathy%26aufirst%3DK.%2BV.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DPorcelli%26aufirst%3DS.%2BA.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DMorris%26aufirst%3DS.%2BL.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26atitle%3DMycobacterium%2520tuberculosis%2520DeltaRD1%2520DeltapanCD%253A%2520a%2520safe%2520and%2520limited%2520replicating%2520mutant%2520strain%2520that%2520protects%2520immunocompetent%2520and%2520immunocompromised%2520mice%2520against%2520experimental%2520tuberculosis%26jtitle%3DVaccine%26date%3D2006%26volume%3D24%26spage%3D6309%26epage%3D6320%26doi%3D10.1016%2Fj.vaccine.2006.05.097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Larsen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambandamurthy, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackner, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aye, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letvin, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frothingham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, W. R.,  Jr.</span><span> </span><span class="NLM_article-title">Efficacy and safety of live attenuated persistent and rapidly cleared <i>Mycobacterium tuberculosis</i> vaccine candidates in non-human primates</span> <span class="citation_source-journal">Vaccine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4709</span><span class="NLM_x">–</span> <span class="NLM_lpage">4717</span><span class="refDoi"> DOI: 10.1016/j.vaccine.2009.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1016%2Fj.vaccine.2009.05.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=4709-4717&author=M.+H.+Larsenauthor=K.+Biermannauthor=B.+Chenauthor=T.+Hsuauthor=V.+K.+Sambandamurthyauthor=A.+A.+Lacknerauthor=P.+P.+Ayeauthor=P.+Didierauthor=D.+Huangauthor=L.+Shaoauthor=H.+Weiauthor=N.+L.+Letvinauthor=R.+Frothinghamauthor=B.+F.+Haynesauthor=Z.+W.+Chenauthor=W.+R.+Jacobs&title=Efficacy+and+safety+of+live+attenuated+persistent+and+rapidly+cleared+Mycobacterium+tuberculosis+vaccine+candidates+in+non-human+primates&doi=10.1016%2Fj.vaccine.2009.05.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2009.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2009.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DM.%2BH.%26aulast%3DBiermann%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DHsu%26aufirst%3DT.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DLackner%26aufirst%3DA.%2BA.%26aulast%3DAye%26aufirst%3DP.%2BP.%26aulast%3DDidier%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLetvin%26aufirst%3DN.%2BL.%26aulast%3DFrothingham%26aufirst%3DR.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26aulast%3DChen%26aufirst%3DZ.%2BW.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520live%2520attenuated%2520persistent%2520and%2520rapidly%2520cleared%2520Mycobacterium%2520tuberculosis%2520vaccine%2520candidates%2520in%2520non-human%2520primates%26jtitle%3DVaccine%26date%3D2009%26volume%3D27%26spage%3D4709%26epage%3D4717%26doi%3D10.1016%2Fj.vaccine.2009.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Sambandamurthy, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, W. R.,  Jr.</span><span> </span><span class="NLM_article-title">A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1171</span><span class="NLM_x">–</span> <span class="NLM_lpage">1174</span><span class="refDoi"> DOI: 10.1038/nm765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1038%2Fnm765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=12219086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVGrt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1171-1174&author=V.+K.+Sambandamurthyauthor=X.+Wangauthor=B.+Chenauthor=R.+G.+Russellauthor=S.+Derrickauthor=F.+M.+Collinsauthor=S.+L.+Morrisauthor=W.+R.+Jacobs&title=A+pantothenate+auxotroph+of+Mycobacterium+tuberculosis+is+highly+attenuated+and+protects+mice+against+tuberculosis&doi=10.1038%2Fnm765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis</span></div><div class="casAuthors">Sambandamurthy, Vasan K.; Wang, Xiaojuan; Chen, Bing; Russell, Robert G.; Derrick, Steven; Collins, Frank M.; Morris, Sheldon L.; Jacobs, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1171-1174</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">With the advent of HIV and the widespread emergence of drug-resistant strains of Mycobacterium tuberculosis, newer control strategies in the form of a better vaccine could decrease the global incidence of tuberculosis.  A desirable trait in an effective live attenuated vaccine strain is an ability to persist within the host in a limited fashion in order to produce important protective antigens in vivo.  Attenuated M. tuberculosis vaccine candidates have been constructed by deleting genes required for growth in mice.  These candidate vaccines did not elicit adequate protective immunity in animal models, due to their inability to persist sufficiently long within the host tissues.  Here we report that an auxotrophic mutant of M. tuberculosis defective in the de novo biosynthesis of pantothenic acid (vitamin B5) is highly attenuated in immunocompromised SCID mice and in immunocompetent BALB/c mice.  SCID mice infected with the pantothenate auxotroph survived significantly longer (250 days) than mice infected with either bacille Calmette-Guerin (BCG) vaccine or virulent M. tuberculosis (77 and 35 days, resp.).  S.c. immunization with this auxotroph conferred protection in C57BL/6J mice against an aerosol challenge with virulent M. tuberculosis, which was comparable with that afforded by BCG vaccination.  Our findings highlight the importance of de novo pantothenate biosynthesis in limiting the intracellular survival and pathogenesis of M. tuberculosis without reducing its immunogenicity in vaccinated mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOxuoVg9k--rVg90H21EOLACvtfcHk0lh6eCIC5RqsfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVGrt7c%253D&md5=2f6a03e8699952251f88064484ad48f5</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnm765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm765%26sid%3Dliteratum%253Aachs%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DRussell%26aufirst%3DR.%2BG.%26aulast%3DDerrick%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DF.%2BM.%26aulast%3DMorris%26aufirst%3DS.%2BL.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26atitle%3DA%2520pantothenate%2520auxotroph%2520of%2520Mycobacterium%2520tuberculosis%2520is%2520highly%2520attenuated%2520and%2520protects%2520mice%2520against%2520tuberculosis%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D1171%26epage%3D1174%26doi%3D10.1038%2Fnm765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Evangelopoulos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span> </span><span class="NLM_article-title">Rapid methods for testing inhibitors of mycobacterial growth</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">642</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1007/978-1-60327-279-7_15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1007%2F978-1-60327-279-7_15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=20401596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFWntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=642&publication_year=2010&pages=193-201&author=D.+Evangelopoulosauthor=S.+Bhakta&title=Rapid+methods+for+testing+inhibitors+of+mycobacterial+growth&doi=10.1007%2F978-1-60327-279-7_15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid methods for testing inhibitors of mycobacterial growth</span></div><div class="casAuthors">Evangelopoulos, Dimitrios; Bhakta, Sanjib</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">642</span>
        (<span class="NLM_cas:issue">Antibiotic Resistance Protocols</span>),
    <span class="NLM_cas:pages">193-201</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Considering the increased concerns with controlling infectious epidemics such as tuberculosis, a global concerted effort (WHO) is now dead-lined to tackle the emergence of extensive drug resistance through identifying a novel line of therapeutics which will on the one hand shorten the course of treatment and on the other is also expected to be effective against the emerging resistant strains.  Major problems with the preclin. drug screening against the uniquely slow-growing pathogen Mycobacterium tuberculosis are either found expensive, time-consuming, or require a highly complex lab. setup.  A rapid and convenient, although relatively inexpensive, method requiring very little consumption of inhibitors within a simple microbiol. setup for antimycobacterial screening is thus timely.  The spot-culture growth inhibition assay aims to test the biol. activity of a no. of newly discovered natural products and thousands of novel chems. synthesized on the basis of basic structural and mol. biol. studies.  Many different classes of novel chem. entities are now independently prepd. around the world by distinguished chemists on the chem. behavior of the group of mols.  To serve the purpose of antimycobacterials screening, we aim to describe a method in this chapter performed in a six-well plate format.  This method can also be extended accurately to a 96-well plate format according to the necessity of the project.  In addn. to evaluating a range of prospective drug candidates, this method would also contribute to elucidate substrates for many putative endogenous pathways through comparing the chem. inhibition with the corresponding genetic modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEpGGZLtvhnLVg90H21EOLACvtfcHk0lh6eCIC5RqsfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFWntb4%253D&md5=2469ab085e062cadb8324837611954a7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2F978-1-60327-279-7_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-60327-279-7_15%26sid%3Dliteratum%253Aachs%26aulast%3DEvangelopoulos%26aufirst%3DD.%26aulast%3DBhakta%26aufirst%3DS.%26atitle%3DRapid%2520methods%2520for%2520testing%2520inhibitors%2520of%2520mycobacterial%2520growth%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2010%26volume%3D642%26spage%3D193%26epage%3D201%26doi%3D10.1007%2F978-1-60327-279-7_15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Guzman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evangelopoulos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwaigwisya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span> </span><span class="NLM_article-title">Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay</span> <span class="citation_source-journal">BMJ. Open</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e002672</span><span class="refDoi"> DOI: 10.1136/bmjopen-2013-002672</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1136%2Fbmjopen-2013-002672" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=e002672&author=J.+D.+Guzmanauthor=D.+Evangelopoulosauthor=A.+Guptaauthor=K.+Birchallauthor=S.+Mwaigwisyaauthor=B.+Saxtyauthor=T.+D.+McHughauthor=S.+Gibbonsauthor=J.+Malkinsonauthor=S.+Bhakta&title=Antitubercular+specific+activity+of+ibuprofen+and+the+other+2-arylpropanoic+acids+using+the+HT-SPOTi+whole-cell+phenotypic+assay&doi=10.1136%2Fbmjopen-2013-002672"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1136%2Fbmjopen-2013-002672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmjopen-2013-002672%26sid%3Dliteratum%253Aachs%26aulast%3DGuzman%26aufirst%3DJ.%2BD.%26aulast%3DEvangelopoulos%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DBirchall%26aufirst%3DK.%26aulast%3DMwaigwisya%26aufirst%3DS.%26aulast%3DSaxty%26aufirst%3DB.%26aulast%3DMcHugh%26aufirst%3DT.%2BD.%26aulast%3DGibbons%26aufirst%3DS.%26aulast%3DMalkinson%26aufirst%3DJ.%26aulast%3DBhakta%26aufirst%3DS.%26atitle%3DAntitubercular%2520specific%2520activity%2520of%2520ibuprofen%2520and%2520the%2520other%25202-arylpropanoic%2520acids%2520using%2520the%2520HT-SPOTi%2520whole-cell%2520phenotypic%2520assay%26jtitle%3DBMJ.%2520Open%26date%3D2013%26volume%3D3%26spage%3De002672%26doi%3D10.1136%2Fbmjopen-2013-002672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Danquah, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span> </span><span class="NLM_article-title">HT-SPOTi: a rapid, drug susceptibility test (DST), to evaluate antibiotic resistance profiles and novel chemicals for anti-infective drug discovery</span> <span class="citation_source-journal">Curr. Protoc. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">17.8.1</span><span class="NLM_x">–</span> <span class="NLM_lpage">17.8.12</span><span class="refDoi"> DOI: 10.1002/9780471729259.mc1708s40</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1002%2F9780471729259.mc1708s40" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2016&pages=17.8.1-17.8.12&author=C.+A.+Danquahauthor=A.+Maitraauthor=S.+Gibbonsauthor=J.+Faullauthor=S.+Bhakta&title=HT-SPOTi%3A+a+rapid%2C+drug+susceptibility+test+%28DST%29%2C+to+evaluate+antibiotic+resistance+profiles+and+novel+chemicals+for+anti-infective+drug+discovery&doi=10.1002%2F9780471729259.mc1708s40"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2F9780471729259.mc1708s40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780471729259.mc1708s40%26sid%3Dliteratum%253Aachs%26aulast%3DDanquah%26aufirst%3DC.%2BA.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DGibbons%26aufirst%3DS.%26aulast%3DFaull%26aufirst%3DJ.%26aulast%3DBhakta%26aufirst%3DS.%26atitle%3DHT-SPOTi%253A%2520a%2520rapid%252C%2520drug%2520susceptibility%2520test%2520%2528DST%2529%252C%2520to%2520evaluate%2520antibiotic%2520resistance%2520profiles%2520and%2520novel%2520chemicals%2520for%2520anti-infective%2520drug%2520discovery%26jtitle%3DCurr.%2520Protoc.%2520Microbiol.%26date%3D2016%26volume%3D40%26spage%3D17.8.1%26epage%3D17.8.12%26doi%3D10.1002%2F9780471729259.mc1708s40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Rodrigues, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viveiros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampaio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vavra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, W. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaral, L.</span><span> </span><span class="NLM_article-title">Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in <i>Mycobacterium avium</i> and <i>Mycobacterium smegmatis</i></span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1076</span><span class="NLM_x">–</span> <span class="NLM_lpage">1082</span><span class="refDoi"> DOI: 10.1093/jac/dkn070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1093%2Fjac%2Fdkn070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=18310137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksF2ltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2008&pages=1076-1082&author=L.+Rodriguesauthor=D.+Wagnerauthor=M.+Viveirosauthor=D.+Sampaioauthor=I.+Coutoauthor=M.+Vavraauthor=W.+V.+Kernauthor=L.+Amaral&title=Thioridazine+and+chlorpromazine+inhibition+of+ethidium+bromide+efflux+in+Mycobacterium+avium+and+Mycobacterium+smegmatis&doi=10.1093%2Fjac%2Fdkn070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis</span></div><div class="casAuthors">Rodrigues, Liliana; Wagner, Dirk; Viveiros, Miguel; Sampaio, Daniela; Couto, Isabel; Vavra, Martina; Kern, Winfried V.; Amaral, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1076-1082</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Therapy of AIDS patients infected with Mycobacterium avium is problematic due to its intrinsic resistance to antibiotics.  We have characterized the efflux pump activity of M. avium wild-type strain through an automated fluorometric method and correlated it with intrinsic resistance to antibiotics.  M. avium ATCC 25291T and Mycobacterium smegmatis Mc2155 were evaluated for accumulation and efflux of ethidium bromide in the presence or absence of the efflux pump inhibitors (EPIs) thioridazine, chlorpromazine, verapamil and the proton uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP).  For this purpose, a new automated fluorometric method was used that sep. assesses accumulation and extrusion of ethidium bromide.  The automated fluorometric method described in this paper allowed the detection and quantification of ethidium bromide transport across M. avium and M. smegmatis cell walls.  Accumulation of ethidium bromide was found to be temp.-dependent and significantly increased by EPIs thioridazine, chlorpromazine, verapamil and CCCP in a concn.-dependent manner.  Efflux of ethidium bromide under optimum conditions of temp. and glucose is inhibited by the above agents.  At half their intrinsic MICs, both thioridazine and chlorpromazine, similarly to verapamil and CCCP, significantly increased the susceptibility of M. avium to erythromycin, suggesting an effect upon an efflux pump with ethidium bromide and erythromycin as substrates.  A similar effect was obsd. for M. smegmatis with verapamil only.  Conclusions: M. avium and M. smegmatis intrinsic resistance is affected by EPIs such as thioridazine or chlorpromazine, an effect that might be important in research and development of new, more effective antimycobacterial therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq68k1124KkJ7Vg90H21EOLACvtfcHk0li6RkIOsLUz1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksF2ltr8%253D&md5=d5515d376e9e1eb60099948762e6918e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkn070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkn070%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DL.%26aulast%3DWagner%26aufirst%3DD.%26aulast%3DViveiros%26aufirst%3DM.%26aulast%3DSampaio%26aufirst%3DD.%26aulast%3DCouto%26aufirst%3DI.%26aulast%3DVavra%26aufirst%3DM.%26aulast%3DKern%26aufirst%3DW.%2BV.%26aulast%3DAmaral%26aufirst%3DL.%26atitle%3DThioridazine%2520and%2520chlorpromazine%2520inhibition%2520of%2520ethidium%2520bromide%2520efflux%2520in%2520Mycobacterium%2520avium%2520and%2520Mycobacterium%2520smegmatis%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2008%26volume%3D61%26spage%3D1076%26epage%3D1082%26doi%3D10.1093%2Fjac%2Fdkn070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 30 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Vadim Makarov, Elena Salina, Robert C. Reynolds, Phyo Phyo Kyaw Zin, <span class="NLM_string-name hlFld-ContribAuthor">Sean Ekins</span>. </span><span class="cited-content_cbyCitation_article-title">Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 8917-8955. <a href="https://doi.org/10.1021/acs.jmedchem.9b02075" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02075%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecule%252BProperty%252BAnalyses%252Bof%252BActive%252BCompounds%252Bfor%252BMycobacterium%252Btuberculosis%26aulast%3DMakarov%26aufirst%3DVadim%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D13122019%26date%3D20042020%26date%3D07042020%26volume%3D63%26issue%3D17%26spage%3D8917%26epage%3D8955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Meir Touitou, Fabrizio Manetti, Camila Maringolo Ribeiro, Fernando Rogerio Pavan, Nicolò Scalacci, Katarina Zrebna, Neelu Begum, Dorothy Semenya, Antima Gupta, Sanjib Bhakta, Timothy D. McHugh, Hanoch Senderowitz, Melina Kyriazi, <span class="NLM_string-name hlFld-ContribAuthor">Daniele Castagnolo</span>. </span><span class="cited-content_cbyCitation_article-title">Improving the Potency of N-Aryl-2,5-dimethylpyrroles against Multidrug-Resistant and Intracellular Mycobacteria. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 638-644. <a href="https://doi.org/10.1021/acsmedchemlett.9b00515" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00515%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImproving%252Bthe%252BPotency%252Bof%252BN-Aryl-2%25252C5-dimethylpyrroles%252Bagainst%252BMultidrug-Resistant%252Band%252BIntracellular%252BMycobacteria%26aulast%3DTouitou%26aufirst%3DMeir%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07112019%26date%3D10122019%26date%3D23122019%26date%3D10122019%26volume%3D11%26issue%3D5%26spage%3D638%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Valentina
Noemi Madia, Antonella Messore, Luca Pescatori, Francesco Saccoliti, Valeria Tudino, Alessandro De Leo, Luigi Scipione, Lucia Fiore, Eric Rhoden, Fabrizio Manetti, M. Steven Oberste, Roberto Di Santo, <span class="NLM_string-name hlFld-ContribAuthor">Roberta Costi</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro Antiviral Activity of New Oxazoline Derivatives as Potent Poliovirus Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 798-810. <a href="https://doi.org/10.1021/acs.jmedchem.8b01482" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01482%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIn%252BVitro%252BAntiviral%252BActivity%252Bof%252BNew%252BOxazoline%252BDerivatives%252Bas%252BPotent%252BPoliovirus%252BInhibitors%26aulast%3DMadia%26aufirst%3DValentina%2BNoemi%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D24092018%26date%3D18122018%26date%3D04122018%26volume%3D62%26issue%3D2%26spage%3D798%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicoló  Scalacci</span>, <span class="hlFld-ContribAuthor ">Gary W.  Black</span>, <span class="hlFld-ContribAuthor ">Giulio  Mattedi</span>, <span class="hlFld-ContribAuthor ">Nicola L.  Brown</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Turner</span>, and <span class="hlFld-ContribAuthor ">Daniele  Castagnolo</span>  . </span><span class="cited-content_cbyCitation_article-title">Unveiling the Biocatalytic Aromatizing Activity of Monoamine Oxidases MAO-N and 6-HDNO: Development of Chemoenzymatic Cascades for the Synthesis of Pyrroles. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2017,</strong> <em>7 </em>
                                    (2)
                                     , 1295-1300. <a href="https://doi.org/10.1021/acscatal.6b03081" title="DOI URL">https://doi.org/10.1021/acscatal.6b03081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.6b03081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.6b03081%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DUnveiling%252Bthe%252BBiocatalytic%252BAromatizing%252BActivity%252Bof%252BMonoamine%252BOxidases%252BMAO-N%252Band%252B6-HDNO%25253A%252BDevelopment%252Bof%252BChemoenzymatic%252BCascades%252Bfor%252Bthe%252BSynthesis%252Bof%252BPyrroles%26aulast%3DScalacci%26aufirst%3DNicol%25C3%25B3%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D28102016%26date%3D22122016%26date%3D17012017%26date%3D03022017%26date%3D27122016%26volume%3D7%26issue%3D2%26spage%3D1295%26epage%3D1300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parvinder  Kaur</span>, <span class="hlFld-ContribAuthor ">Vijay  Potluri</span>, <span class="hlFld-ContribAuthor ">Vijay Kamal  Ahuja</span>, <span class="hlFld-ContribAuthor ">C.N.  Naveenkumar</span>, <span class="hlFld-ContribAuthor ">Ramya Vadageri  Krishnamurthy</span>, <span class="hlFld-ContribAuthor ">Shruthi Thimmalapura  Gangadharaiah</span>, <span class="hlFld-ContribAuthor ">Prasad  Shivarudraiah</span>, <span class="hlFld-ContribAuthor ">Sumesh  Eswaran</span>, <span class="hlFld-ContribAuthor ">Christy Rosaline  Nirmal</span>, <span class="hlFld-ContribAuthor ">Balasubramanian  Mahizhaveni</span>, <span class="hlFld-ContribAuthor ">Azger  Dusthackeer</span>, <span class="hlFld-ContribAuthor ">Rajesh  Mondal</span>, <span class="hlFld-ContribAuthor ">Sarah M.  Batt</span>, <span class="hlFld-ContribAuthor ">Emily J.  Richardson</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Loman</span>, <span class="hlFld-ContribAuthor ">Gurdyal Singh  Besra</span>, <span class="hlFld-ContribAuthor ">Radha Krishan  Shandil</span>, <span class="hlFld-ContribAuthor ">Shridhar  Narayanan</span>. </span><span class="cited-content_cbyCitation_article-title">A multi-targeting pre-clinical candidate against drug-resistant tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Tuberculosis</span><span> <strong>2021,</strong> <em>129 </em>, 102104. <a href="https://doi.org/10.1016/j.tube.2021.102104" title="DOI URL">https://doi.org/10.1016/j.tube.2021.102104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tube.2021.102104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tube.2021.102104%26sid%3Dliteratum%253Aachs%26jtitle%3DTuberculosis%26atitle%3DA%252Bmulti-targeting%252Bpre-clinical%252Bcandidate%252Bagainst%252Bdrug-resistant%252Btuberculosis%26aulast%3DKaur%26aufirst%3DParvinder%26date%3D2021%26volume%3D129%26spage%3D102104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Klaudia T.  Angula</span>, <span class="hlFld-ContribAuthor ">Lesetja J.  Legoabe</span>, <span class="hlFld-ContribAuthor ">Richard M.  Beteck</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010–2020 Review. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (5)
                                     , 461. <a href="https://doi.org/10.3390/ph14050461" title="DOI URL">https://doi.org/10.3390/ph14050461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14050461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14050461%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DChemical%252BClasses%252BPresenting%252BNovel%252BAntituberculosis%252BAgents%252BCurrently%252Bin%252BDifferent%252BPhases%252Bof%252BDrug%252BDevelopment%25253A%252BA%252B2010%2525E2%252580%2525932020%252BReview%26aulast%3DAngula%26aufirst%3DKlaudia%2BT.%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D5%26spage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Laws</span>, <span class="hlFld-ContribAuthor ">Peiqin  Jin</span>, <span class="hlFld-ContribAuthor ">Khondaker Miraz  Rahman</span>. </span><span class="cited-content_cbyCitation_article-title">Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance. </span><span class="cited-content_cbyCitation_journal-name">Trends in Microbiology</span><span> <strong>2021,</strong> <em>7 </em><a href="https://doi.org/10.1016/j.tim.2021.05.001" title="DOI URL">https://doi.org/10.1016/j.tim.2021.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tim.2021.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tim.2021.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Microbiology%26atitle%3DEfflux%252Bpumps%252Bin%252BMycobacterium%252Btuberculosis%252Band%252Btheir%252Binhibition%252Bto%252Btackle%252Bantimicrobial%252Bresistance%26aulast%3DLaws%26aufirst%3DMark%26date%3D2021%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seong-Heun  Kim</span>, <span class="hlFld-ContribAuthor ">Dorothy  Semenya</span>, <span class="hlFld-ContribAuthor ">Daniele  Castagnolo</span>. </span><span class="cited-content_cbyCitation_article-title">Antimicrobial drugs bearing guanidine moieties: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113293. <a href="https://doi.org/10.1016/j.ejmech.2021.113293" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113293%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntimicrobial%252Bdrugs%252Bbearing%252Bguanidine%252Bmoieties%25253A%252BA%252Breview%26aulast%3DKim%26aufirst%3DSeong-Heun%26date%3D2021%26volume%3D216%26spage%3D113293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikhil Baliram  Gaikwad</span>, <span class="hlFld-ContribAuthor ">Pathan  Afroz</span>, <span class="hlFld-ContribAuthor ">Mohammad Naiyaz  Ahmad</span>, <span class="hlFld-ContribAuthor ">Grace  Kaul</span>, <span class="hlFld-ContribAuthor ">Manjulika  Shukla</span>, <span class="hlFld-ContribAuthor ">Srinivas  Nanduri</span>, <span class="hlFld-ContribAuthor ">Arunava  Dasgupta</span>, <span class="hlFld-ContribAuthor ">Sidharth  Chopra</span>, <span class="hlFld-ContribAuthor ">Venkata Madhavi  Yaddanapudi</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, in vitro and in silico evaluation of new 3-phenyl-4,5-dihydroisoxazole-5-carboxamides active against drug-resistant mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1227 </em>, 129545. <a href="https://doi.org/10.1016/j.molstruc.2020.129545" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.129545</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.129545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.129545%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bin%252Bvitro%252Band%252Bin%252Bsilico%252Bevaluation%252Bof%252Bnew%252B3-phenyl-4%25252C5-dihydroisoxazole-5-carboxamides%252Bactive%252Bagainst%252Bdrug-resistant%252Bmycobacterium%252Btuberculosis%26aulast%3DGaikwad%26aufirst%3DNikhil%2BBaliram%26date%3D2021%26volume%3D1227%26spage%3D129545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pankaj S.  Girase</span>, <span class="hlFld-ContribAuthor ">Sanjeev  Dhawan</span>, <span class="hlFld-ContribAuthor ">Vishal  Kumar</span>, <span class="hlFld-ContribAuthor ">Suraj R.  Shinde</span>, <span class="hlFld-ContribAuthor ">Mahesh B.  Palkar</span>, <span class="hlFld-ContribAuthor ">Rajshekhar  Karpoormath</span>. </span><span class="cited-content_cbyCitation_article-title">An appraisal of anti-mycobacterial activity with structure-activity relationship of piperazine and its analogues: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112967. <a href="https://doi.org/10.1016/j.ejmech.2020.112967" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112967</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112967%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Bappraisal%252Bof%252Banti-mycobacterial%252Bactivity%252Bwith%252Bstructure-activity%252Brelationship%252Bof%252Bpiperazine%252Band%252Bits%252Banalogues%25253A%252BA%252Breview%26aulast%3DGirase%26aufirst%3DPankaj%2BS.%26date%3D2021%26volume%3D210%26spage%3D112967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel  Ryabchuk</span>, <span class="hlFld-ContribAuthor ">Thomas  Leischner</span>, <span class="hlFld-ContribAuthor ">Carsten  Kreyenschulte</span>, <span class="hlFld-ContribAuthor ">Anke  Spannenberg</span>, <span class="hlFld-ContribAuthor ">Kathrin  Junge</span>, <span class="hlFld-ContribAuthor ">Matthias  Beller</span>. </span><span class="cited-content_cbyCitation_article-title">Cascade Synthesis of Pyrroles from Nitroarenes with Benign Reductants Using a Heterogeneous Cobalt Catalyst. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (42)
                                     , 18838-18844. <a href="https://doi.org/10.1002/ange.202007613" title="DOI URL">https://doi.org/10.1002/ange.202007613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202007613%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DCascade%252BSynthesis%252Bof%252BPyrroles%252Bfrom%252BNitroarenes%252Bwith%252BBenign%252BReductants%252BUsing%252Ba%252BHeterogeneous%252BCobalt%252BCatalyst%26aulast%3DRyabchuk%26aufirst%3DPavel%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D42%26spage%3D18838%26epage%3D18844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel  Ryabchuk</span>, <span class="hlFld-ContribAuthor ">Thomas  Leischner</span>, <span class="hlFld-ContribAuthor ">Carsten  Kreyenschulte</span>, <span class="hlFld-ContribAuthor ">Anke  Spannenberg</span>, <span class="hlFld-ContribAuthor ">Kathrin  Junge</span>, <span class="hlFld-ContribAuthor ">Matthias  Beller</span>. </span><span class="cited-content_cbyCitation_article-title">Cascade Synthesis of Pyrroles from Nitroarenes with Benign Reductants Using a Heterogeneous Cobalt Catalyst. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (42)
                                     , 18679-18685. <a href="https://doi.org/10.1002/anie.202007613" title="DOI URL">https://doi.org/10.1002/anie.202007613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202007613%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DCascade%252BSynthesis%252Bof%252BPyrroles%252Bfrom%252BNitroarenes%252Bwith%252BBenign%252BReductants%252BUsing%252Ba%252BHeterogeneous%252BCobalt%252BCatalyst%26aulast%3DRyabchuk%26aufirst%3DPavel%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D42%26spage%3D18679%26epage%3D18685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Galyna P  Volynets</span>, <span class="hlFld-ContribAuthor ">Michail A  Tukalo</span>, <span class="hlFld-ContribAuthor ">Volodymyr G  Bdzhola</span>, <span class="hlFld-ContribAuthor ">Nataliia M  Derkach</span>, <span class="hlFld-ContribAuthor ">Mykola I  Gumeniuk</span>, <span class="hlFld-ContribAuthor ">Sergiy S  Tarnavskiy</span>, <span class="hlFld-ContribAuthor ">Sergiy M  Yarmoluk</span>. </span><span class="cited-content_cbyCitation_article-title">Novel isoniazid derivative as promising antituberculosis agent. </span><span class="cited-content_cbyCitation_journal-name">Future Microbiology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , 869-879. <a href="https://doi.org/10.2217/fmb-2019-0085" title="DOI URL">https://doi.org/10.2217/fmb-2019-0085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fmb-2019-0085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffmb-2019-0085%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Microbiology%26atitle%3DNovel%252Bisoniazid%252Bderivative%252Bas%252Bpromising%252Bantituberculosis%252Bagent%26aulast%3DVolynets%26aufirst%3DGalyna%2BP%26date%3D2020%26volume%3D15%26issue%3D10%26spage%3D869%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neha  Agre</span>, <span class="hlFld-ContribAuthor ">Nilesh  Tawari</span>, <span class="hlFld-ContribAuthor ">Arundhati  Maitra</span>, <span class="hlFld-ContribAuthor ">Antima  Gupta</span>, <span class="hlFld-ContribAuthor ">Tulika  Munshi</span>, <span class="hlFld-ContribAuthor ">Mariam  Degani</span>, <span class="hlFld-ContribAuthor ">Sanjib  Bhakta</span>. </span><span class="cited-content_cbyCitation_article-title">3-(5-Nitrofuran-2-yl)prop-2-en-1-one Derivatives, with Potent Antituberculosis Activity, Inhibit A Novel Therapeutic Target, Arylamine N-acetyltransferase, in Mycobacteria. </span><span class="cited-content_cbyCitation_journal-name">Antibiotics</span><span> <strong>2020,</strong> <em>9 </em>
                                    (7)
                                     , 368. <a href="https://doi.org/10.3390/antibiotics9070368" title="DOI URL">https://doi.org/10.3390/antibiotics9070368</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antibiotics9070368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantibiotics9070368%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotics%26atitle%3D3-%2525285-Nitrofuran-2-yl%252529prop-2-en-1-one%252BDerivatives%25252C%252Bwith%252BPotent%252BAntituberculosis%252BActivity%25252C%252BInhibit%252BA%252BNovel%252BTherapeutic%252BTarget%25252C%252BArylamine%252BN-acetyltransferase%25252C%252Bin%252BMycobacteria%26aulast%3DAgre%26aufirst%3DNeha%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D7%26spage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neha  Agre</span>, <span class="hlFld-ContribAuthor ">Mihir  Khambete</span>, <span class="hlFld-ContribAuthor ">Arundhati  Maitra</span>, <span class="hlFld-ContribAuthor ">Antima  Gupta</span>, <span class="hlFld-ContribAuthor ">Tulika  Munshi</span>, <span class="hlFld-ContribAuthor ">Sanjib  Bhakta</span>, <span class="hlFld-ContribAuthor ">Mariam  Degani</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of 5‐(5‐nitrothiophen‐2‐yl)‐4,5‐dihydro‐1H‐pyrazoles as selective, multitargeted antimycobacterial agents. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>95 </em>
                                    (1)
                                     , 192-199. <a href="https://doi.org/10.1111/cbdd.13624" title="DOI URL">https://doi.org/10.1111/cbdd.13624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13624%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DExploration%252Bof%252B5%2525E2%252580%252590%2525285%2525E2%252580%252590nitrothiophen%2525E2%252580%2525902%2525E2%252580%252590yl%252529%2525E2%252580%2525904%25252C5%2525E2%252580%252590dihydro%2525E2%252580%2525901H%2525E2%252580%252590pyrazoles%252Bas%252Bselective%25252C%252Bmultitargeted%252Bantimycobacterial%252Bagents%26aulast%3DAgre%26aufirst%3DNeha%26date%3D2020%26date%3D2019%26volume%3D95%26issue%3D1%26spage%3D192%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yogesh B.  Sutar</span>, <span class="hlFld-ContribAuthor ">Jaishree K.  Mali</span>, <span class="hlFld-ContribAuthor ">Vikas N.  Telvekar</span>, <span class="hlFld-ContribAuthor ">Raju S.  Rajmani</span>, <span class="hlFld-ContribAuthor ">Amit  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Transferrin conjugates of antitubercular drug isoniazid: Synthesis and in vitro efficacy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111713. <a href="https://doi.org/10.1016/j.ejmech.2019.111713" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111713%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTransferrin%252Bconjugates%252Bof%252Bantitubercular%252Bdrug%252Bisoniazid%25253A%252BSynthesis%252Band%252Bin%2525C2%2525A0vitro%252Befficacy%26aulast%3DSutar%26aufirst%3DYogesh%2BB.%26date%3D2019%26volume%3D183%26spage%3D111713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Domiziana  Masci</span>, <span class="hlFld-ContribAuthor ">Charlotte  Hind</span>, <span class="hlFld-ContribAuthor ">Mohammad K.  Islam</span>, <span class="hlFld-ContribAuthor ">Anita  Toscani</span>, <span class="hlFld-ContribAuthor ">Melanie  Clifford</span>, <span class="hlFld-ContribAuthor ">Antonio  Coluccia</span>, <span class="hlFld-ContribAuthor ">Irene  Conforti</span>, <span class="hlFld-ContribAuthor ">Meir  Touitou</span>, <span class="hlFld-ContribAuthor ">Siham  Memdouh</span>, <span class="hlFld-ContribAuthor ">Xumin  Wei</span>, <span class="hlFld-ContribAuthor ">Giuseppe  La Regina</span>, <span class="hlFld-ContribAuthor ">Romano  Silvestri</span>, <span class="hlFld-ContribAuthor ">J. Mark  Sutton</span>, <span class="hlFld-ContribAuthor ">Daniele  Castagnolo</span>. </span><span class="cited-content_cbyCitation_article-title">Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 500-514. <a href="https://doi.org/10.1016/j.ejmech.2019.05.087" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.087%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSwitching%252Bon%252Bthe%252Bactivity%252Bof%252B1%25252C5-diaryl-pyrrole%252Bderivatives%252Bagainst%252Bdrug-resistant%252BESKAPE%252Bbacteria%25253A%252BStructure-activity%252Brelationships%252Band%252Bmode%252Bof%252Baction%252Bstudies%26aulast%3DMasci%26aufirst%3DDomiziana%26date%3D2019%26volume%3D178%26spage%3D500%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Luo</span>, <span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Danjun  Fang</span>, <span class="hlFld-ContribAuthor ">Junyu  Zhou</span>, <span class="hlFld-ContribAuthor ">Huayou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Application of the Cu(
              i
              )/TEMPO/O
              2
              catalytic system for aerobic oxidative dehydrogenative aromatization of pyrrolidines. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2019,</strong> <em>21 </em>
                                    (17)
                                     , 4609-4613. <a href="https://doi.org/10.1039/C9GC01932D" title="DOI URL">https://doi.org/10.1039/C9GC01932D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9GC01932D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9GC01932D%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DApplication%252Bof%252Bthe%252BCu%252528%252Bi%252B%252529%25252FTEMPO%25252FO%252B2%252Bcatalytic%252Bsystem%252Bfor%252Baerobic%252Boxidative%252Bdehydrogenative%252Baromatization%252Bof%252Bpyrrolidines%26aulast%3DLuo%26aufirst%3DZheng%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D17%26spage%3D4609%26epage%3D4613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">RamaKrishna  Munnaluri</span>, <span class="hlFld-ContribAuthor ">Saikiran  Reddy Peddi</span>, <span class="hlFld-ContribAuthor ">Sree  Kanth Sivan</span>, <span class="hlFld-ContribAuthor ">Vijjulatha  Manga</span>. </span><span class="cited-content_cbyCitation_article-title">Computational studies on N-phenyl pyrrole derivatives as MmpL3 inhibitors in Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2019,</strong> <em>78 </em>, 81-94. <a href="https://doi.org/10.1016/j.compbiolchem.2018.11.007" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2018.11.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2018.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2018.11.007%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DComputational%252Bstudies%252Bon%252BN-phenyl%252Bpyrrole%252Bderivatives%252Bas%252BMmpL3%252Binhibitors%252Bin%252BMycobacterium%252Btuberculosis%26aulast%3DMunnaluri%26aufirst%3DRamaKrishna%26date%3D2019%26volume%3D78%26spage%3D81%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alistair  Brown</span>, <span class="hlFld-ContribAuthor ">Ahmed  Aljohani</span>, <span class="hlFld-ContribAuthor ">Jason  Gill</span>, <span class="hlFld-ContribAuthor ">Patrick  Steel</span>, <span class="hlFld-ContribAuthor ">Jonathan  Sellars</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Benzoxa-[2,1,3]-diazole Substituted Amino Acid Hydrazides as Potential Anti-Tubercular Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (4)
                                     , 811. <a href="https://doi.org/10.3390/molecules24040811" title="DOI URL">https://doi.org/10.3390/molecules24040811</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24040811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24040811%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DIdentification%252Bof%252BNovel%252BBenzoxa-%25255B2%25252C1%25252C3%25255D-diazole%252BSubstituted%252BAmino%252BAcid%252BHydrazides%252Bas%252BPotential%252BAnti-Tubercular%252BAgents%26aulast%3DBrown%26aufirst%3DAlistair%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D4%26spage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Macchindra S.  Tambe</span>, <span class="hlFld-ContribAuthor ">Amit  Choudhari</span>, <span class="hlFld-ContribAuthor ">Dhiman  Sarkar</span>, <span class="hlFld-ContribAuthor ">Jaiprakash  Sangshetti</span>, <span class="hlFld-ContribAuthor ">Rajesh  Patil</span>, <span class="hlFld-ContribAuthor ">Somnath S.  Gholap</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Screening of Novel 1,3,4‐Oxadiazoles as Antitubercular Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (47)
                                     , 13304-13310. <a href="https://doi.org/10.1002/slct.201802227" title="DOI URL">https://doi.org/10.1002/slct.201802227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201802227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201802227%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BScreening%252Bof%252BNovel%252B1%25252C3%25252C4%2525E2%252580%252590Oxadiazoles%252Bas%252BAntitubercular%252BAgents%26aulast%3DTambe%26aufirst%3DMacchindra%2BS.%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D47%26spage%3D13304%26epage%3D13310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiao  Yang</span>, <span class="hlFld-ContribAuthor ">Pan  Zhou</span>, <span class="hlFld-ContribAuthor ">Biao  Hu</span>, <span class="hlFld-ContribAuthor ">Siyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiaohe  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Xu</span>, <span class="hlFld-ContribAuthor ">Rui  Yang</span>, <span class="hlFld-ContribAuthor ">Fuchao  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">TBAI/K
              2
              S
              2
              O
              8
              ‐Promoted Multicomponent Domino Reaction of Aryl Methyl Ketones, Enaminones, and Indoles: A Facile Access to Multisubstituted 3‐Indolyl‐pyrroles. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (42)
                                     , 11938-11942. <a href="https://doi.org/10.1002/slct.201803317" title="DOI URL">https://doi.org/10.1002/slct.201803317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201803317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201803317%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DTBAI%25252FK%252B2%252BS%252B2%252BO%252B8%252B%2525E2%252580%252590Promoted%252BMulticomponent%252BDomino%252BReaction%252Bof%252BAryl%252BMethyl%252BKetones%25252C%252BEnaminones%25252C%252Band%252BIndoles%25253A%252BA%252BFacile%252BAccess%252Bto%252BMultisubstituted%252B3%2525E2%252580%252590Indolyl%2525E2%252580%252590pyrroles%26aulast%3DYang%26aufirst%3DJiao%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D42%26spage%3D11938%26epage%3D11942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pingxian  Liu</span>, <span class="hlFld-ContribAuthor ">Yang  Yang</span>, <span class="hlFld-ContribAuthor ">Yuan  Ju</span>, <span class="hlFld-ContribAuthor ">Yunxiang  Tang</span>, <span class="hlFld-ContribAuthor ">Zitai  Sang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>, <span class="hlFld-ContribAuthor ">Tao  Yang</span>, <span class="hlFld-ContribAuthor ">Qi  An</span>, <span class="hlFld-ContribAuthor ">Tianyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Youfu  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>80 </em>, 422-432. <a href="https://doi.org/10.1016/j.bioorg.2018.06.004" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpyrrole%252Bderivatives%252Bas%252Bpotential%252BClpP1P2%252Binhibitor%252Bagainst%252BMycobacterium%252Btuberculosis%26aulast%3DLiu%26aufirst%3DPingxian%26date%3D2018%26volume%3D80%26spage%3D422%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">André  Campaniço</span>, <span class="hlFld-ContribAuthor ">Rui  Moreira</span>, <span class="hlFld-ContribAuthor ">Francisca  Lopes</span>. </span><span class="cited-content_cbyCitation_article-title">Drug discovery in tuberculosis. New drug targets and antimycobacterial agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>150 </em>, 525-545. <a href="https://doi.org/10.1016/j.ejmech.2018.03.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDrug%252Bdiscovery%252Bin%252Btuberculosis.%252BNew%252Bdrug%252Btargets%252Band%252Bantimycobacterial%252Bagents%26aulast%3DCampani%25C3%25A7o%26aufirst%3DAndr%25C3%25A9%26date%3D2018%26volume%3D150%26spage%3D525%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul B.  Ghuge</span>, <span class="hlFld-ContribAuthor ">Atul N.  Khadse</span>. </span><span class="cited-content_cbyCitation_article-title">Vicinal Diaryl Pyrroles: Synthesis and Biological Aspects. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 47-82. <a href="https://doi.org/10.1016/B978-0-08-102237-5.00003-1" title="DOI URL">https://doi.org/10.1016/B978-0-08-102237-5.00003-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102237-5.00003-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102237-5.00003-1%26sid%3Dliteratum%253Aachs%26atitle%3DVicinal%252BDiaryl%252BPyrroles%25253A%252BSynthesis%252Band%252BBiological%252BAspects%26aulast%3DGhuge%26aufirst%3DRahul%2BB.%26date%3D2018%26spage%3D47%26epage%3D82%26pub%3DElsevier%26atitle%3DVicinal%252BDiaryl%252BSubstituted%252BHeterocycles%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilherme  Fernandes</span>, <span class="hlFld-ContribAuthor ">Chung  Man Chin</span>, <span class="hlFld-ContribAuthor ">Jean  Dos Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2017,</strong> <em>10 </em>
                                    (4)
                                     , 51. <a href="https://doi.org/10.3390/ph10020051" title="DOI URL">https://doi.org/10.3390/ph10020051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph10020051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph10020051%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DAdvances%252Bin%252BDrug%252BDiscovery%252Bof%252BNew%252BAntitubercular%252BMultidrug-Resistant%252BCompounds%26aulast%3DFernandes%26aufirst%3DGuilherme%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D4%26spage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ravindra D.  Wavhale</span>, <span class="hlFld-ContribAuthor ">Elvis A.F.  Martis</span>, <span class="hlFld-ContribAuthor ">Premlata K.  Ambre</span>, <span class="hlFld-ContribAuthor ">Baojie  Wan</span>, <span class="hlFld-ContribAuthor ">Scott G.  Franzblau</span>, <span class="hlFld-ContribAuthor ">Krishna R.  Iyer</span>, <span class="hlFld-ContribAuthor ">Kavita  Raikuvar</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Macegoniuk</span>, <span class="hlFld-ContribAuthor ">Łukasz  Berlicki</span>, <span class="hlFld-ContribAuthor ">Santosh R.  Nandan</span>, <span class="hlFld-ContribAuthor ">Evans C.  Coutinho</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new leads against Mycobacterium tuberculosis using scaffold hopping and shape based similarity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (17)
                                     , 4835-4844. <a href="https://doi.org/10.1016/j.bmc.2017.07.034" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.07.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.07.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnew%252Bleads%252Bagainst%252BMycobacterium%252Btuberculosis%252Busing%252Bscaffold%252Bhopping%252Band%252Bshape%252Bbased%252Bsimilarity%26aulast%3DWavhale%26aufirst%3DRavindra%2BD.%26date%3D2017%26volume%3D25%26issue%3D17%26spage%3D4835%26epage%3D4844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arundhati  Maitra</span>, <span class="hlFld-ContribAuthor ">Tengku Karmila  Kamil</span>, <span class="hlFld-ContribAuthor ">Monisha  Shaik</span>, <span class="hlFld-ContribAuthor ">Cynthia Amaning  Danquah</span>, <span class="hlFld-ContribAuthor ">Alina  Chrzastek</span>, <span class="hlFld-ContribAuthor ">Sanjib  Bhakta</span>. </span><span class="cited-content_cbyCitation_article-title">Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): A report from Euroscicon's international TB Summit 2016. </span><span class="cited-content_cbyCitation_journal-name">Virulence</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 1005-1024. <a href="https://doi.org/10.1080/21505594.2016.1256536" title="DOI URL">https://doi.org/10.1080/21505594.2016.1256536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/21505594.2016.1256536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F21505594.2016.1256536%26sid%3Dliteratum%253Aachs%26jtitle%3DVirulence%26atitle%3DEarly%252Bdiagnosis%252Band%252Beffective%252Btreatment%252Bregimens%252Bare%252Bthe%252Bkeys%252Bto%252Btackle%252Bantimicrobial%252Bresistance%252Bin%252Btuberculosis%252B%252528TB%252529%25253A%252BA%252Breport%252Bfrom%252BEuroscicon%252527s%252Binternational%252BTB%252BSummit%252B2016%26aulast%3DMaitra%26aufirst%3DArundhati%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D6%26spage%3D1005%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng-Cheng  Diao</span>, <span class="hlFld-ContribAuthor ">Qiu  Li</span>, <span class="hlFld-ContribAuthor ">Meng-Jin  Hu</span>, <span class="hlFld-ContribAuthor ">Yu-Feng  Ma</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  You</span>, <span class="hlFld-ContribAuthor ">Kwon Ho  Hong</span>, <span class="hlFld-ContribAuthor ">Pei-Liang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>134 </em>, 110-118. <a href="https://doi.org/10.1016/j.ejmech.2017.04.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bindole-pyrimidine%252Bhybrids%252Bbearing%252Bmorpholine%252Band%252Bthiomorpholine%252Bmoieties%26aulast%3DDiao%26aufirst%3DPeng-Cheng%26date%3D2017%26volume%3D134%26spage%3D110%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolò  Scalacci</span>, <span class="hlFld-ContribAuthor ">Alistair K.  Brown</span>, <span class="hlFld-ContribAuthor ">Fernando R.  Pavan</span>, <span class="hlFld-ContribAuthor ">Camila M.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Manetti</span>, <span class="hlFld-ContribAuthor ">Sanjib  Bhakta</span>, <span class="hlFld-ContribAuthor ">Arundhati  Maitra</span>, <span class="hlFld-ContribAuthor ">Darren L.  Smith</span>, <span class="hlFld-ContribAuthor ">Elena  Petricci</span>, <span class="hlFld-ContribAuthor ">Daniele  Castagnolo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR evaluation of novel thioridazine derivatives active against drug-resistant tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>127 </em>, 147-158. <a href="https://doi.org/10.1016/j.ejmech.2016.12.042" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.12.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.12.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.12.042%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BSAR%252Bevaluation%252Bof%252Bnovel%252Bthioridazine%252Bderivatives%252Bactive%252Bagainst%252Bdrug-resistant%252Btuberculosis%26aulast%3DScalacci%26aufirst%3DNicol%25C3%25B2%26date%3D2017%26volume%3D127%26spage%3D147%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Graphical representation (left) of <b>1</b> and <b>2</b>, a rough comparison of the topological distribution of their chemical features (middle upper panel), and superposition of their three-dimensional conformers as generated by the common feature hypothesis generation routine (middle lower panel; <b>1</b>, blue; <b>2</b>, red). The flexible structure of <b>2</b> is well-superposable to the skeleton of <b>1</b>. The general structures <b>A</b> and <b>B</b> of the hybrid compounds are also shown (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Graphical representation of the four-feature superposition model common to <b>1</b> (thin lines) and <b>2</b> (thick lines). The two protonatable chemical features (P7 and P8) are in blue, while the two hydrophobic regions (H4 and H6) are in green. The conformer of <b>1</b> represented in the picture is 0.013 kJ/mol  from the lowest energy conformation, while the energy difference between the lowest energy conformation of <b>2</b> and the conformer reported in the picture is 4.660 kJ/mol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0007.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Graphical representation of the four-feature improved model matched by the most active hybrid pyrrole <b>9c</b>. Changes occurred within the region of space occupied by the C3 side chain: the positively ionized P8 feature previously accommodating the N4 nitrogen atom of the piperazine was omitted, while an additional hydrophobic region was added that corresponded to the terminal bulky substituent of the C3 side chain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrroles <b>3a</b>–<b>e</b> and Piperazines <b>6a,</b><b>b</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrroles <b>9</b>–<b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/medium/jm-2016-00031m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0008.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Graphs showing the accumulation of ethidium bromide (EtBr) within <i>M. aurum</i> cells in the presence of selected compounds and positive (verapamil) and negative (1× PBS) controls. Low to very high inhibition of efflux (as a representation of an increased level of EtBr accumulation) are shown by the numbers 1–4. The experiments were performed in triplicate (<i>n</i> = 3), and the graph is plotted using the average values obtained.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00031/20160318/images/large/jm-2016-00031m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00031&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">WHO</span><span class="NLM_x">. Global Tuberculosis Report 2015. </span><a href="http://www.who.int/tb/publications/global_report/en/" class="extLink">http://www.who.int/tb/publications/global_report/en/</a> (accessed Feb 8,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WHO.+Global+Tuberculosis+Report+2015.+http%3A%2F%2Fwww.who.int%2Ftb%2Fpublications%2Fglobal_report%2Fen%2F+%28accessed+Feb+8%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Caminero, J. A.</span><span> </span><span class="NLM_article-title">Treatment of multidrug-resistant tuberculosis: evidence and controversies</span> <span class="citation_source-journal">Int. J. Tuberc. Lung Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=16898365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BD28vnsVOhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=829-837&author=J.+A.+Caminero&title=Treatment+of+multidrug-resistant+tuberculosis%3A+evidence+and+controversies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of multidrug-resistant tuberculosis: evidence and controversies</span></div><div class="casAuthors">Caminero J A</div><div class="citationInfo"><span class="NLM_cas:title">The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">829-37</span>
        ISSN:<span class="NLM_cas:issn">1027-3719</span>.
    </div><div class="casAbstract">In the last decade, multidrug-resistant tuberculosis (MDR-TB, defined as resistance to at least isoniazid and rifampicin) has become an epidemiological issue of first priority at the global level.  Case management needs to be simplified and standardised, as in many countries MDR-TB cases cannot receive individualised attention from specialist physicians.  However, before any decision can be made on standardisation, a careful analysis must first be made of the evidence and controversies behind the various published recommendations.  Unfortunately, the controversies outweigh the evidence.  The difficulties lie not only in the absence of controlled trials to validate specific recommendations, but also in the very different and even contradictory results found in the literature.  It is therefore essential to analyse these discrepancies before developing rational, uniform recommendations.  The analysis should encompass the most essential and controversial issues regarding the management of MDR-TB patients: 1) confirmation of diagnosis in a suspected MDR-TB patient, and determination of the value of drug susceptibility testing; 2) the number of anti-tuberculosis drugs required to treat MDR-TB; 3) the most rational use of effective drugs against tuberculosis; 4) the advisable length of parenteral drug administration or of the initial phase of treatment; 5) the contribution of surgery to the management of MDR-TB patients; and 6) the optimal regimen for treating MDR-TB: standardised vs. individualised regimens.  The evidence and controversies regarding each of the above questions are analysed with the aim of facilitating decision making in the treatment of these complex patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrbnqXnY7ZfQWRJ3OJdH_qfW6udTcc2eaRSWUlhk3fO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vnsVOhsw%253D%253D&md5=5d9cd0116afe1bb905ca343503192821</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaminero%26aufirst%3DJ.%2BA.%26atitle%3DTreatment%2520of%2520multidrug-resistant%2520tuberculosis%253A%2520evidence%2520and%2520controversies%26jtitle%3DInt.%2520J.%2520Tuberc.%2520Lung%2520Dis.%26date%3D2006%26volume%3D10%26spage%3D829%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Chan, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strand, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goble, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iseman, M. D.</span><span> </span><span class="NLM_article-title">Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">1103</span><span class="NLM_x">–</span> <span class="NLM_lpage">1109</span><span class="refDoi"> DOI: 10.1164/rccm.200308-1159OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1164%2Frccm.200308-1159OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=14742301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BD2c3jtlKhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2004&pages=1103-1109&author=E.+D.+Chanauthor=V.+Laurelauthor=M.+J.+Strandauthor=J.+F.+Chanauthor=M.+L.+Huynhauthor=M.+Gobleauthor=M.+D.+Iseman&title=Treatment+and+outcome+analysis+of+205+patients+with+multidrug-resistant+tuberculosis&doi=10.1164%2Frccm.200308-1159OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis</span></div><div class="casAuthors">Chan Edward D; Laurel Valerie; Strand Matthew J; Chan Julanie F; Huynh Mai-Lan N; Goble Marian; Iseman Michael D</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1103-9</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">Multidrug-resistant tuberculosis, a disease caused by Mycobacterium tuberculosis strains that are resistant at least to rifampin and isoniazid, entails extended treatment, expensive and toxic regimens, and higher rates of treatment failure and death.  We retrospectively analyzed the outcomes in 205 patients treated at our center for multidrug-resistant tuberculosis, with strains resistant to a median of six drugs, and compared the results with those of our previous series.  Logistic regression and survival analysis were used to evaluate short- and long-term outcomes, respectively.  Initial favorable response, defined as at least three consecutive negative sputum cultures over a period of at least 3 months, was 85% compared with 65% in the prior cohort.  The current cohort had greater long-term success rates, 75% versus 56%, and lower tuberculosis death rates, 12% versus 22%, than the earlier one.  Surgical resection and fluoroquinolone therapy were associated with improved microbiological and clinical outcomes in the 205 patients studied after adjusting for other variables.  The improvement was statistically significant for surgery and among older patients for fluoroquinolone therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTADxmZBcvS7DMsgLhIoICsfW6udTcc2eYJ5r-buy6L-Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3jtlKhsA%253D%253D&md5=8fde1fde3ab75993c8faa6c526306aec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1164%2Frccm.200308-1159OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200308-1159OC%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DE.%2BD.%26aulast%3DLaurel%26aufirst%3DV.%26aulast%3DStrand%26aufirst%3DM.%2BJ.%26aulast%3DChan%26aufirst%3DJ.%2BF.%26aulast%3DHuynh%26aufirst%3DM.%2BL.%26aulast%3DGoble%26aufirst%3DM.%26aulast%3DIseman%26aufirst%3DM.%2BD.%26atitle%3DTreatment%2520and%2520outcome%2520analysis%2520of%2520205%2520patients%2520with%2520multidrug-resistant%2520tuberculosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2004%26volume%3D169%26spage%3D1103%26epage%3D1109%26doi%3D10.1164%2Frccm.200308-1159OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Eker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliori, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotgiu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muetterlein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Centis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruesch-Gerdes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C.</span><span> </span><span class="NLM_article-title">Multidrug- and extensively drug-resistant tuberculosis, Germany</span> <span class="citation_source-journal">Emerging Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1700</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span><span class="refDoi"> DOI: 10.3201/eid1411.080729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.3201%2Feid1411.080729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=18976552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BD1cjhtlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1700-1706&author=B.+Ekerauthor=J.+Ortmannauthor=G.+B.+Miglioriauthor=G.+Sotgiuauthor=R.+Muetterleinauthor=R.+Centisauthor=H.+Hoffmannauthor=D.+Kirstenauthor=T.+Schabergauthor=S.+Ruesch-Gerdesauthor=C.+Lange&title=Multidrug-+and+extensively+drug-resistant+tuberculosis%2C+Germany&doi=10.3201%2Feid1411.080729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug- and extensively drug-resistant tuberculosis, Germany</span></div><div class="casAuthors">Eker Barbara; Ortmann Johannes; Migliori Giovanni B; Sotgiu Giovanni; Muetterlein Ralf; Centis Rosella; Hoffmann Harald; Kirsten Detlef; Schaberg Tom; Ruesch-Gerdes Sabine; Lange Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Emerging infectious diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1700-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We evaluated risk factors and treatment outcomes associated with multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) in Germany in 2004-2006.  In 177 (4%) of 4,557 culture-positive TB cases, Mycobacterium tuberculosis isolates were identified as MDR TB; an additional 7 (0.15%) met criteria for XDR TB.  Of these 184 patients, 148 (80%) were born in countries of the former Soviet Union.  In patients with XDR TB, hospitalization was longer (mean +/- SD 202 +/- 130 vs. 123 +/- 81 days; p = 0.015) and resistance to all first-line drugs was more frequent (36% vs. 86%; p = 0.013) than in patients with MDR TB.  Seventy-four (40%) of these 184 patients received treatment with linezolid.  Treatment success rates ranged from 59% for the entire cohort (59% for MDR TB and 57% for XDR TB) to 87% for those with a definitive outcome (n = 125; 89% for MDR TB and 80% for XDR TB).  Extensive drug susceptibility testing and availability of second- and third-line drugs under inpatient management conditions permit relatively high treatment success rates in MDR- and XDR TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLoYYbyenxnWBAiYWy6n3SfW6udTcc2eYJ5r-buy6L-Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjhtlGitA%253D%253D&md5=4b7a295b71561ea764630adeba04ef0a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3201%2Feid1411.080729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid1411.080729%26sid%3Dliteratum%253Aachs%26aulast%3DEker%26aufirst%3DB.%26aulast%3DOrtmann%26aufirst%3DJ.%26aulast%3DMigliori%26aufirst%3DG.%2BB.%26aulast%3DSotgiu%26aufirst%3DG.%26aulast%3DMuetterlein%26aufirst%3DR.%26aulast%3DCentis%26aufirst%3DR.%26aulast%3DHoffmann%26aufirst%3DH.%26aulast%3DKirsten%26aufirst%3DD.%26aulast%3DSchaberg%26aufirst%3DT.%26aulast%3DRuesch-Gerdes%26aufirst%3DS.%26aulast%3DLange%26aufirst%3DC.%26atitle%3DMultidrug-%2520and%2520extensively%2520drug-resistant%2520tuberculosis%252C%2520Germany%26jtitle%3DEmerging%2520Infect.%2520Dis.%26date%3D2008%26volume%3D14%26spage%3D1700%26epage%3D1706%26doi%3D10.3201%2Feid1411.080729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mitnick, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seung, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwood, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzmaurice, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcantara Viru, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleton, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayona, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonilla, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalco, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurtado, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jazayeri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llaro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestanza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloutsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becerra, M. C.</span><span> </span><span class="NLM_article-title">Comprehensive treatment of extensively drug-resistant tuberculosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span><span class="refDoi"> DOI: 10.1056/NEJMoa0800106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1056%2FNEJMoa0800106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=18687637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt12iu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2008&pages=563-574&author=C.+D.+Mitnickauthor=S.+S.+Shinauthor=K.+J.+Seungauthor=M.+L.+Richauthor=S.+S.+Atwoodauthor=J.+J.+Furinauthor=G.+M.+Fitzmauriceauthor=F.+A.+Alcantara+Viruauthor=S.+C.+Appletonauthor=J.+N.+Bayonaauthor=C.+A.+Bonillaauthor=K.+Chalcoauthor=S.+Choiauthor=M.+F.+Frankeauthor=H.+S.+Fraserauthor=D.+Guerraauthor=R.+M.+Hurtadoauthor=D.+Jazayeriauthor=K.+Josephauthor=K.+Llaroauthor=L.+Mestanzaauthor=J.+S.+Mukherjeeauthor=M.+Mu%C3%B1ozauthor=E.+Palaciosauthor=E.+Sanchezauthor=A.+Sloutskyauthor=M.+C.+Becerra&title=Comprehensive+treatment+of+extensively+drug-resistant+tuberculosis&doi=10.1056%2FNEJMoa0800106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive treatment of extensively drug-resistant tuberculosis</span></div><div class="casAuthors">Mitnick, Carole D.; Shin, Sonya S.; Seung, Kwonjune J.; Rich, Michael L.; Atwood, Sidney S.; Furing, Jennifer J.; Fitzmaurice, Garrett M.; Alcantara Viru, Felix A.; Appleton, Sasha C.; Bayona, Jaime N.; Bonilla, Cesar A.; Chalco, Katiuska; Choi, Sharon; Franke, Molly F.; Fraser, Hamish S. F.; Guerra, Dalia; Hurtado, Rocio M.; Jazayeri, Darius; Joseph, Keith; Llaro, Karim; Mestanza, Lorena; Mukherjee, Joia S.; Munoz, Maribel; Palacios, Eda; Sanchez, Epifanio; Sloutsky, Alexander; Becerra, Mercedes C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">563-574</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Extensively drug-resistant tuberculosis has been reported in 45 countries, including countries with limited resources and a high burden of tuberculosis.  We describe the management of extensively drug-resistant tuberculosis and treatment outcomes among patients who were referred for individualized outpatient therapy in Peru.  A total of 810 patients were referred for free individualized therapy, including drug treatment, resective surgery, adverse-event management, and nutritional and psychosocial support.  We tested isolates from 651 patients for extensively drug-resistant tuberculosis and developed regimens that included five or more drugs to which the infecting isolate was not resistant.  Of the 651 patients tested, 48 (7.4%) had extensively drug-resistant tuberculosis; the remaining 603 patients had multidrug-resistant tuberculosis.  The patients with extensively drug-resistant tuberculosis had undergone more treatment than the other patients (mean [± SD] no. of regimens, 4.2±1.9 vs. 3.2±1.6; P < 0.001) and had isolates that were resistant to more drugs (no. of drugs, 8.4±1.1 vs. 5.3±1.5; P < 0.001).  None of the patients with extensively drug-resistant tuberculosis were coinfected with the human immunodeficiency virus (HIV).  Patients with extensively drug-resistant tuberculosis received daily, supervised therapy with an av. of 5.3±1.3 drugs, including cycloserine, an injectable drug, and a fluoroquinolone.  Twenty-nine of these patients (60.4%) completed treatment or were cured, as compared with 400 patients (66.3%) with multidrug-resistant tuberculosis (P = 0.36).  Extensively drug-resistant tuberculosis can be cured in HIV-neg. patients through outpatient treatment, even in those who have received multiple prior courses of therapy for tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfpygpC_IPPLVg90H21EOLACvtfcHk0lh4s-1CrOmNXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt12iu7g%253D&md5=8b0a958dd5181c9acdbcb9f0d708bf43</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0800106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0800106%26sid%3Dliteratum%253Aachs%26aulast%3DMitnick%26aufirst%3DC.%2BD.%26aulast%3DShin%26aufirst%3DS.%2BS.%26aulast%3DSeung%26aufirst%3DK.%2BJ.%26aulast%3DRich%26aufirst%3DM.%2BL.%26aulast%3DAtwood%26aufirst%3DS.%2BS.%26aulast%3DFurin%26aufirst%3DJ.%2BJ.%26aulast%3DFitzmaurice%26aufirst%3DG.%2BM.%26aulast%3DAlcantara%2BViru%26aufirst%3DF.%2BA.%26aulast%3DAppleton%26aufirst%3DS.%2BC.%26aulast%3DBayona%26aufirst%3DJ.%2BN.%26aulast%3DBonilla%26aufirst%3DC.%2BA.%26aulast%3DChalco%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DFranke%26aufirst%3DM.%2BF.%26aulast%3DFraser%26aufirst%3DH.%2BS.%26aulast%3DGuerra%26aufirst%3DD.%26aulast%3DHurtado%26aufirst%3DR.%2BM.%26aulast%3DJazayeri%26aufirst%3DD.%26aulast%3DJoseph%26aufirst%3DK.%26aulast%3DLlaro%26aufirst%3DK.%26aulast%3DMestanza%26aufirst%3DL.%26aulast%3DMukherjee%26aufirst%3DJ.%2BS.%26aulast%3DMu%25C3%25B1oz%26aufirst%3DM.%26aulast%3DPalacios%26aufirst%3DE.%26aulast%3DSanchez%26aufirst%3DE.%26aulast%3DSloutsky%26aufirst%3DA.%26aulast%3DBecerra%26aufirst%3DM.%2BC.%26atitle%3DComprehensive%2520treatment%2520of%2520extensively%2520drug-resistant%2520tuberculosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D359%26spage%3D563%26epage%3D574%26doi%3D10.1056%2FNEJMoa0800106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Migliori, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loddenkemper, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raviglione, M. C.</span><span> </span><span class="NLM_article-title">125 years after Robert Koch’s discovery of the tubercle bacillus: the new XDR-TB threat. Is ″science″ enough to tackle the epidemic?</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span><span class="refDoi"> DOI: 10.1183/09031936.00001307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1183%2F09031936.00001307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=17329486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ivFOgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=423-427&author=G.+B.+Miglioriauthor=R.+Loddenkemperauthor=F.+Blasiauthor=M.+C.+Raviglione&title=125+years+after+Robert+Koch%E2%80%99s+discovery+of+the+tubercle+bacillus%3A+the+new+XDR-TB+threat.+Is+%E2%80%B3science%E2%80%B3+enough+to+tackle+the+epidemic%3F&doi=10.1183%2F09031936.00001307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic?</span></div><div class="casAuthors">Migliori G B; Loddenkemper R; Blasi F; Raviglione M C</div><div class="citationInfo"><span class="NLM_cas:title">The European respiratory journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">423-7</span>
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkJlxHGuTx0ZagfuraLLzSfW6udTcc2eZ2pm8G9YKE_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ivFOgtQ%253D%253D&md5=543c313805077a2c539bdb4c7cbc153e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1183%2F09031936.00001307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00001307%26sid%3Dliteratum%253Aachs%26aulast%3DMigliori%26aufirst%3DG.%2BB.%26aulast%3DLoddenkemper%26aufirst%3DR.%26aulast%3DBlasi%26aufirst%3DF.%26aulast%3DRaviglione%26aufirst%3DM.%2BC.%26atitle%3D125%2520years%2520after%2520Robert%2520Koch%25E2%2580%2599s%2520discovery%2520of%2520the%2520tubercle%2520bacillus%253A%2520the%2520new%2520XDR-TB%2520threat.%2520Is%2520%25E2%2580%25B3science%25E2%2580%25B3%2520enough%2520to%2520tackle%2520the%2520epidemic%253F%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2007%26volume%3D29%26spage%3D423%26epage%3D427%26doi%3D10.1183%2F09031936.00001307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Velayati, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farnia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masjedi, M. R.</span><span> </span><span class="NLM_article-title">The totally drug resistant tuberculosis (TDR-TB)</span> <span class="citation_source-journal">Int. J. Clin. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=23641309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BC3sngsF2htQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=307-309&author=A.+A.+Velayatiauthor=P.+Farniaauthor=M.+R.+Masjedi&title=The+totally+drug+resistant+tuberculosis+%28TDR-TB%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The totally drug resistant tuberculosis (TDR-TB)</span></div><div class="casAuthors">Velayati Ali Akbar; Farnia Parissa; Masjedi Mohammad Reza</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-9</span>
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSj--hoFhw8vIxhnOQkIHOxfW6udTcc2eYHSJJR0UaHnLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sngsF2htQ%253D%253D&md5=792fd0a06fd4e326f0ca4acc944600b4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVelayati%26aufirst%3DA.%2BA.%26aulast%3DFarnia%26aufirst%3DP.%26aulast%3DMasjedi%26aufirst%3DM.%2BR.%26atitle%3DThe%2520totally%2520drug%2520resistant%2520tuberculosis%2520%2528TDR-TB%2529%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2013%26volume%3D6%26spage%3D307%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Biava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porretta, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deidda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompei, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molicotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward <i>Mycobacterium tuberculosis</i> and Low Cytotoxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4946</span><span class="NLM_x">–</span> <span class="NLM_lpage">4952</span><span class="refDoi"> DOI: 10.1021/jm0602662</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0602662" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4946-4952&author=M.+Biavaauthor=G.+C.+Porrettaauthor=G.+Poceauthor=S.+Supinoauthor=D.+Deiddaauthor=R.+Pompeiauthor=P.+Molicottiauthor=F.+Manettiauthor=M.+Botta&title=Antimycobacterial+agents.+Novel+diarylpyrrole+derivatives+of+BM212+endowed+with+high+activity+toward+Mycobacterium+tuberculosis+and+Low+Cytotoxicity&doi=10.1021%2Fjm0602662"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm0602662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0602662%26sid%3Dliteratum%253Aachs%26aulast%3DBiava%26aufirst%3DM.%26aulast%3DPorretta%26aufirst%3DG.%2BC.%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DSupino%26aufirst%3DS.%26aulast%3DDeidda%26aufirst%3DD.%26aulast%3DPompei%26aufirst%3DR.%26aulast%3DMolicotti%26aufirst%3DP.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DAntimycobacterial%2520agents.%2520Novel%2520diarylpyrrole%2520derivatives%2520of%2520BM212%2520endowed%2520with%2520high%2520activity%2520toward%2520Mycobacterium%2520tuberculosis%2520and%2520Low%2520Cytotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4946%26epage%3D4952%26doi%3D10.1021%2Fjm0602662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Alfonso, S.</span><span> </span><span class="NLM_article-title">BM212-derived MmpL3 inhibitors enabling new possibilities for the treatment of TB and studies of mycobacterial iron assimilation as new potential target for drug discovery</span>. Ph.D. Thesis, <span class="NLM_publisher-name">Sapienza Università di Roma</span>, September 10,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://hdl.handle.net/10805/2145" class="extLink">http://hdl.handle.net/10805/2145</a>, accessed April 27, 2015.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Alfonso&title=BM212-derived+MmpL3+inhibitors+enabling+new+possibilities+for+the+treatment+of+TB+and+studies+of+mycobacterial+iron+assimilation+as+new+potential+target+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlfonso%26aufirst%3DS.%26atitle%3DBM212-derived%2520MmpL3%2520inhibitors%2520enabling%2520new%2520possibilities%2520for%2520the%2520treatment%2520of%2520TB%2520and%2520studies%2520of%2520mycobacterial%2520iron%2520assimilation%2520as%2520new%2520potential%2520target%2520for%2520drug%2520discovery%26pub%3DSapienza%2520Universit%25C3%25A0%2520di%2520Roma%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Biava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porretta, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battilocchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Logu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.1002/cmdc.201000526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1002%2Fcmdc.201000526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=21341373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslKhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=593-599&author=M.+Biavaauthor=G.+C.+Porrettaauthor=G.+Poceauthor=C.+Battilocchioauthor=S.+Alfonsoauthor=A.+de+Loguauthor=F.+Manettiauthor=M.+Botta&title=Developing+pyrrole-derived+antimycobacterial+agents%3A+a+rational+lead+optimization+approach&doi=10.1002%2Fcmdc.201000526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Developing Pyrrole-Derived Antimycobacterial Agents: a Rational Lead Optimization Approach</span></div><div class="casAuthors">Biava, Mariangela; Porretta, Giulio Cesare; Poce, Giovanna; Battilocchio, Claudio; Alfonso, Salvatore; de Logu, Alessandro; Manetti, Fabrizio; Botta, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">593-599</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Tuberculosis (TB) represents a never-ending challenge toward which research efforts are needed.  Drug resistance is the key problem that scientists in the field need to fight.  The development of new drugs endowed with novel modes of action against different biol. targets is of extreme importance; these new agents should also exhibit lower toxicity compared with the anti-TB drugs currently available.  Furthermore, new drugs should be inexpensive since most of the TB-infected population lives in developing nations.  In the last few years, numerous researchers have focused their attention on TB, leading to the discovery of some interesting compds.  Among these, the pyrrole-derived compds. we developed can be considered very promising antimycobacterial agents.  Aided by mol. modeling studies, we synthesized numerous compds. characterized by the same 1,5-diarylpyrrole scaffold and elucidated very interesting antitubercular/antimycobacterial properties.  Some compds. identified are extremely promising and represent a step towards the design of novel lead structures in the fight against TB.  Our efforts to this end are reviewed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmIVID45JnRLVg90H21EOLACvtfcHk0lg-jOkQf0YKbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslKhtbY%253D&md5=16918d5f02707b05907dd6faa732a764</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000526%26sid%3Dliteratum%253Aachs%26aulast%3DBiava%26aufirst%3DM.%26aulast%3DPorretta%26aufirst%3DG.%2BC.%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DBattilocchio%26aufirst%3DC.%26aulast%3DAlfonso%26aufirst%3DS.%26aulast%3Dde%2BLogu%26aufirst%3DA.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DDeveloping%2520pyrrole-derived%2520antimycobacterial%2520agents%253A%2520a%2520rational%2520lead%2520optimization%2520approach%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D593%26epage%3D599%26doi%3D10.1002%2Fcmdc.201000526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Poce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocozza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porretta, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rullas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Logu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rosa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasca, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rossi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wae, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biava, M.</span><span> </span><span class="NLM_article-title">Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e56980</span><span class="refDoi"> DOI: 10.1371/journal.pone.0056980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1371%2Fjournal.pone.0056980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=23437287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjs12ntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e56980&author=G.+Poceauthor=R.+H.+Batesauthor=S.+Alfonsoauthor=M.+Cocozzaauthor=G.+C.+Porrettaauthor=L.+Ballellauthor=J.+Rullasauthor=F.+Ortegaauthor=A.+De+Loguauthor=E.+Agusauthor=V.+La+Rosaauthor=M.+R.+Pascaauthor=E.+De+Rossiauthor=B.+Waeauthor=S.+G.+Franzblauauthor=F.+Manettiauthor=M.+Bottaauthor=M.+Biava&title=Improved+BM212+MmpL3+inhibitor+analogue+shows+efficacy+in+acute+murine+model+of+tuberculosis+infection&doi=10.1371%2Fjournal.pone.0056980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection</span></div><div class="casAuthors">Poce, Giovanna; Bates, Robert H.; Alfonso, Salvatore; Cocozza, Martina; Porretta, Giulio Cesare; Ballell, Lluis; Rullas, Joaquin; Ortega, Fatima; De Logu, Alessandro; Agus, Emanuela; La Rosa, Valentina; Pasca, Maria Rosalia; De Rossi, Edda; Wae, Baojie; Franzblau, Scott G.; Manetti, Fabrizio; Botta, Maurizio; Biava, Mariangela</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e56980</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">1,5-Di-Ph pyrroles were previously identified as a class of compds. endowed with high in vitro efficacy against M. tuberculosis.  To improve the phys. chem. properties and drug-like parameters of this class of compds., a medicinal chem. effort was undertaken.  By selecting the optimal substitution patterns for the Ph rings at N1 and C5 and by replacing the thiomorpholine moiety with a morpholine one, a new series of compds. was produced.  The replacement of the sulfur with oxygen gave compds. with lower lipophilicity and improved in vitro microsomal stability.  Moreover, since the parent compd. of this family has been shown to target MmpL3, mycobacterial mutants resistant to two compds. have been isolated and characterized by sequencing the mmpL3 gene; all the mutants showed point mutations in this gene.  The best compd. identified to date was progressed to dose-response studies in an acute murine TB infection model.  The resulting ED99 of 49 mg/Kg is within the range of commonly employed tuberculosis drugs, demonstrating the potential of this chem. series.  The in vitro and in vivo target validation evidence presented here adds further wt. to MmpL3 as a druggable target of interest for anti-tubercular drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyyLtc66FRAbVg90H21EOLACvtfcHk0lg-jOkQf0YKbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjs12ntr0%253D&md5=9dd29b729e6bdc9b94409bc1147e28e0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0056980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0056980%26sid%3Dliteratum%253Aachs%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DAlfonso%26aufirst%3DS.%26aulast%3DCocozza%26aufirst%3DM.%26aulast%3DPorretta%26aufirst%3DG.%2BC.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DOrtega%26aufirst%3DF.%26aulast%3DDe%2BLogu%26aufirst%3DA.%26aulast%3DAgus%26aufirst%3DE.%26aulast%3DLa%2BRosa%26aufirst%3DV.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DWae%26aufirst%3DB.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DBiava%26aufirst%3DM.%26atitle%3DImproved%2520BM212%2520MmpL3%2520inhibitor%2520analogue%2520shows%2520efficacy%2520in%2520acute%2520murine%2520model%2520of%2520tuberculosis%2520infection%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De56980%26doi%3D10.1371%2Fjournal.pone.0056980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onajole, O. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunosewoyo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipparaju, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammerman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishai, W. R.</span><span> </span><span class="NLM_article-title">Indoleamides are active against drug-resistant Mycobacterium tuberculosis</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2907</span><span class="refDoi"> DOI: 10.1038/ncomms3907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1038%2Fncomms3907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=24352433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslKgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2907&author=S.+Lunauthor=H.+Guoauthor=O.+K.+Onajoleauthor=M.+Pieroniauthor=H.+Gunosewoyoauthor=G.+Chenauthor=S.+K.+Tipparajuauthor=N.+C.+Ammermanauthor=A.+P.+Kozikowskiauthor=W.+R.+Bishai&title=Indoleamides+are+active+against+drug-resistant+Mycobacterium+tuberculosis&doi=10.1038%2Fncomms3907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamides are active against drug-resistant Mycobacterium tuberculosis</span></div><div class="casAuthors">Lun Shichun; Guo Haidan; Onajole Oluseye K; Gunosewoyo Hendra; Chen Gang; Kozikowski Alan P; Pieroni Marco; Tipparaju Suresh K; Ammerman Nicole C; Bishai William R</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2907</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Responsible for nearly two million deaths each year, the infectious disease tuberculosis remains a serious global health challenge.  The emergence of multidrug- and extensively drug-resistant strains of Mycobacterium tuberculosis confounds control efforts, and new drugs with novel molecular targets are desperately needed.  Here we describe lead compounds, the indoleamides, with potent activity against both drug-susceptible and drug-resistant strains of M. tuberculosis by targeting the mycolic acid transporter MmpL3.  We identify a single mutation in mmpL3, which confers high resistance to the indoleamide class while remaining susceptible to currently used first- and second-line tuberculosis drugs, indicating a lack of cross-resistance.  Importantly, an indoleamide derivative exhibits dose-dependent antimycobacterial activity when orally administered to M. tuberculosis-infected mice.  The bioavailability of the indoleamides, combined with their ability to kill tubercle bacilli, indicates great potential for translational developments of this structure class for the treatment of drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR4ame_FVdejL7NkxioyDXTfW6udTcc2eaM-Lp-AbrA4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslKgtw%253D%253D&md5=29323f5b10dff540b38973491545d1c5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fncomms3907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3907%26sid%3Dliteratum%253Aachs%26aulast%3DLun%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DOnajole%26aufirst%3DO.%2BK.%26aulast%3DPieroni%26aufirst%3DM.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DTipparaju%26aufirst%3DS.%2BK.%26aulast%3DAmmerman%26aufirst%3DN.%2BC.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DBishai%26aufirst%3DW.%2BR.%26atitle%3DIndoleamides%2520are%2520active%2520against%2520drug-resistant%2520Mycobacterium%2520tuberculosis%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D2907%26doi%3D10.1038%2Fncomms3907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">La Rosa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canseco, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buroni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasca, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porretta, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battilocchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javid, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorrentino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioerger, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchettini, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Logu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rossi, E.</span><span> </span><span class="NLM_article-title">MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span><span class="refDoi"> DOI: 10.1128/AAC.05270-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1128%2FAAC.05270-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=22024828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Gqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=324-331&author=V.+La+Rosaauthor=G.+Poceauthor=J.+O.+Cansecoauthor=S.+Buroniauthor=M.+R.+Pascaauthor=M.+Biavaauthor=R.+M.+Rajuauthor=G.+C.+Porrettaauthor=S.+Alfonsoauthor=C.+Battilocchioauthor=B.+Javidauthor=F.+Sorrentinoauthor=T.+R.+Ioergerauthor=J.+C.+Sacchettiniauthor=F.+Manettiauthor=M.+Bottaauthor=A.+De+Loguauthor=E.+J.+Rubinauthor=E.+De+Rossi&title=MmpL3+is+the+cellular+target+of+the+antitubercular+pyrrole+derivative+BM212&doi=10.1128%2FAAC.05270-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212</span></div><div class="casAuthors">La Rosa, Valentina; Poce, Giovanna; Canseco, Julio Ortiz; Buroni, Silvia; Pasca, Maria Rosalia; Biava, Mariangela; Raju, Ravikiran M.; Porretta, Giulio Cesare; Alfonso, Salvatore; Battilocchio, Claudio; Javid, Babak; Sorrentino, Flavia; Ioerger, Thomas R.; Sacchettini, James C.; Manetti, Fabrizio; Botta, Maurizio; De Logu, Alessandro; Rubin, Eric J.; De Rossi, Edda</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">324-331</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The 1,5-diarylpyrrole deriv. BM212 was previously shown to be active against multidrug-resistant clin. isolates and Mycobacterium tuberculosis residing within macrophages as well as against Mycobacterium avium and other atypical mycobacteria.  To det. its mechanism of action, the cellular target was identified.  Spontaneous Mycobacterium smegmatis, Mycobacterium bovis BCG, and M. tuberculosis H37Rv mutants that were resistant to BM212 were isolated.  By the screening of genomic libraries and by whole-genome sequencing, it was found that all the characterized mutants showed mutations in the mmpL3 gene, allowing the conclusion that resistance to BM212 maps to the MmpL3 protein, a member of the MmpL (mycobacterial membrane protein, large) family.  Susceptibility was unaffected by the efflux pump inhibitors reserpine, carbonylcyanide m-chlorophenylhydrazone, and verapamil.  Uptake/efflux expts. with [14C]BM212 demonstrated that resistance is not driven by the efflux of BM212.  Together, these data strongly suggest that the MmpL3 protein is the cellular target of BM212.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBpqZddgKhTLVg90H21EOLACvtfcHk0lhdKuMdqubNZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Gqtw%253D%253D&md5=f73b43cff2112c31ae27878eeb740d76</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FAAC.05270-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.05270-11%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BRosa%26aufirst%3DV.%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DCanseco%26aufirst%3DJ.%2BO.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DBiava%26aufirst%3DM.%26aulast%3DRaju%26aufirst%3DR.%2BM.%26aulast%3DPorretta%26aufirst%3DG.%2BC.%26aulast%3DAlfonso%26aufirst%3DS.%26aulast%3DBattilocchio%26aufirst%3DC.%26aulast%3DJavid%26aufirst%3DB.%26aulast%3DSorrentino%26aufirst%3DF.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DDe%2BLogu%26aufirst%3DA.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26atitle%3DMmpL3%2520is%2520the%2520cellular%2520target%2520of%2520the%2520antitubercular%2520pyrrole%2520derivative%2520BM212%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D324%26epage%3D331%26doi%3D10.1128%2FAAC.05270-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Protopopova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanrahan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikonenko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gearhart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacy, C. A.</span><span> </span><span class="NLM_article-title">Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">968</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span><span class="refDoi"> DOI: 10.1093/jac/dki319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1093%2Fjac%2Fdki319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=16172107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCjtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2005&pages=968-974&author=M.+Protopopovaauthor=C.+Hanrahanauthor=B.+Nikonenkoauthor=R.+Samalaauthor=P.+Chenauthor=J.+Gearhartauthor=L.+Einckauthor=C.+A.+Nacy&title=Identification+of+a+new+antitubercular+drug+candidate%2C+SQ109%2C+from+a+combinatorial+library+of+1%2C2-ethylenediamines&doi=10.1093%2Fjac%2Fdki319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines</span></div><div class="casAuthors">Protopopova, Marina; Hanrahan, Colleen; Nikonenko, Boris; Samala, Rowena; Chen, Ping; Gearhart, Jackie; Einck, Leo; Nacy, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">968-974</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: The aim of this study was to identify a candidate drug for clin. development from a previously synthesized combinatorial library based on the 1,2-ethylenediamine structure of ethambutol.  Methods: Sixty-nine of the most potent hits against Mycobacterium tuberculosis from the original studies were subjected to a sequential set of tests in vitro and in vivo-detn. of MIC for M. tuberculosis H37Rv, cytotoxicity, intracellular antimycobacterial activity, permeability evaluation and in vivo efficacy testing.  Results: Twenty-seven compds. with MICs of ≤15.6 μM were tested on Vero cells to det. in vitro cytotoxicity (IC50) and to establish a selectivity index (SI) (SI = IC50/MIC).  Ten compds. with acceptable SI were tested for activity against intracellular bacteria; all were equiv. (within 1%) or superior to ethambutol and several demonstrated bactericidal activity.  Five of the most potent compds. were tested for in vivo efficacy in a murine model of chronic tuberculosis infection.  Conclusion: Compd. SQ109 with an MIC of 0.7-1.56 μM (H37Rv, Erdman and drug-resistant strains of M. tuberculosis), an SI of 16.7 and 99% inhibition activity against intracellular bacteria, demonstrated potency in vivo and limited toxicity in vitro and in vivo, and was selected for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqvmYc-WY3LrVg90H21EOLACvtfcHk0lhdKuMdqubNZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCjtLjI&md5=2f3d82748de8a565112541b2aa4e5437</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdki319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdki319%26sid%3Dliteratum%253Aachs%26aulast%3DProtopopova%26aufirst%3DM.%26aulast%3DHanrahan%26aufirst%3DC.%26aulast%3DNikonenko%26aufirst%3DB.%26aulast%3DSamala%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DGearhart%26aufirst%3DJ.%26aulast%3DEinck%26aufirst%3DL.%26aulast%3DNacy%26aufirst%3DC.%2BA.%26atitle%3DIdentification%2520of%2520a%2520new%2520antitubercular%2520drug%2520candidate%252C%2520SQ109%252C%2520from%2520a%2520combinatorial%2520library%2520of%25201%252C2-ethylenediamines%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2005%26volume%3D56%26spage%3D968%26epage%3D974%26doi%3D10.1093%2Fjac%2Fdki319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Nikonenko, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protopopova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacy, C. A.</span><span> </span><span class="NLM_article-title">Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1563</span><span class="NLM_x">–</span> <span class="NLM_lpage">1565</span><span class="refDoi"> DOI: 10.1128/AAC.01326-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1128%2FAAC.01326-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=17242141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlOisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=1563-1565&author=B.+V.+Nikonenkoauthor=M.+Protopopovaauthor=R.+Samalaauthor=L.+Einckauthor=C.+A.+Nacy&title=Drug+therapy+of+experimental+tuberculosis+%28TB%29%3A+improved+outcome+by+combining+SQ109%2C+a+new+diamine+antibiotic%2C+with+existing+TB+drugs&doi=10.1128%2FAAC.01326-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs</span></div><div class="casAuthors">Nikonenko, Boris V.; Protopopova, Marina; Samala, Rowena; Einck, Leo; Nacy, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1563-1565</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Substitution of the new diamine antibiotic SQ109 for ethambutol in a mouse model of chronic tuberculosis (TB) improved efficacy of combination drug therapy with first-line TB drugs rifampin and isoniazid, with or without pyrazinamide: at 8 wk, lung bacteria were 1.5 log10 lower in SQ109-contg. regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrywULJFY6Xv7Vg90H21EOLACvtfcHk0li92mUFtNkLaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlOisr4%253D&md5=179cfc6a3256417b542fd64decba25c3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FAAC.01326-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01326-06%26sid%3Dliteratum%253Aachs%26aulast%3DNikonenko%26aufirst%3DB.%2BV.%26aulast%3DProtopopova%26aufirst%3DM.%26aulast%3DSamala%26aufirst%3DR.%26aulast%3DEinck%26aufirst%3DL.%26aulast%3DNacy%26aufirst%3DC.%2BA.%26atitle%3DDrug%2520therapy%2520of%2520experimental%2520tuberculosis%2520%2528TB%2529%253A%2520improved%2520outcome%2520by%2520combining%2520SQ109%252C%2520a%2520new%2520diamine%2520antibiotic%252C%2520with%2520existing%2520TB%2520drugs%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D1563%26epage%3D1565%26doi%3D10.1128%2FAAC.01326-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanrahan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coward, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikonenko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protopopova, M.</span><span> </span><span class="NLM_article-title">Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1038%2Fsj.bjp.0705984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=15644871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVelsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2005&pages=80-87&author=L.+Jiaauthor=J.+E.+Tomaszewskiauthor=C.+Hanrahanauthor=L.+Cowardauthor=P.+Nokerauthor=G.+Gormanauthor=B.+Nikonenkoauthor=M.+Protopopova&title=Pharmacodynamics+and+pharmacokinetics+of+SQ109%2C+a+new+diamine-based+antitubercular+drug&doi=10.1038%2Fsj.bjp.0705984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug</span></div><div class="casAuthors">Jia, Lee; Tomaszewski, Joseph E.; Hanrahan, Colleen; Coward, Lori; Noker, Patricia; Gorman, Gregory; Nikonenko, Boris; Protopopova, Marina</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-87</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SQ109 is a novel [1,2]-diamine-based ethambutol (EMB) analog developed from high-throughput combinatorial screening.  The present study aimed at characterizing its pharmacodynamics and pharmacokinetics.  The antimicrobial activity of SQ109 was confirmed in vitro (Mycobacterium tuberculosis-infected murine macrophages) and in vivo (M. tuberculosis-infected C57BL/6 mice) and compared to isoniazid (INH) and EMB.  SQ109 showed potency and efficacy in inhibiting intracellular M. tuberculosis that was similar to INH, but superior to EMB.  In vivo oral administration of SQ109 (0.1-25 mg kg-1 day-1) to the mice for 28 days resulted in dose-dependent redns. of mycobacterial load in both spleen and lung comparable to that of EMB administered at 100 mg kg-1 day-1, but was less potent than INH at 25 mg kg-1 day-1.  Monitoring of SQ109 levels in mouse tissues on days 1, 14 and 28 following 28-day oral administration (10 mg kg-1 day-1) revealed that lungs and spleen contained the highest concn. of SQ109, at least 10 times above its MIC.  Pharmacokinetic profiles of SQ109 in mice following a single administration showed its Cmax as 1038 (i.v.) and 135 ng ml-1 (p.o.), with an oral Tmax of 0.31 h.  The elimination t1/2 of SQ109 was 3.5 (i.v.) and 5.2 h (p.o.).  The oral bioavailability was 4%.  However, SQ109 displayed a large vol. of distribution into various tissues.  The highest concn. of SQ109 was present in lung (>MIC), which was at least 120-fold (p.o.) and 180-fold (i.v.) higher than that in plasma.  The next ranked tissues were spleen and kidney.  SQ109 levels in most tissues after a single administration were significantly higher than that in blood.  High tissue concns. of SQ109 persisted for the observation period (10 h).This study demonstrated that SQ109 displays promising in vitro and in vivo antitubercular activity with favorable targeted tissue distribution properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr465Y-yxoiw7Vg90H21EOLACvtfcHk0li92mUFtNkLaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVelsA%253D%253D&md5=224a4ee49bae4c58ef8a0463848c5c12</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705984%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DL.%26aulast%3DTomaszewski%26aufirst%3DJ.%2BE.%26aulast%3DHanrahan%26aufirst%3DC.%26aulast%3DCoward%26aufirst%3DL.%26aulast%3DNoker%26aufirst%3DP.%26aulast%3DGorman%26aufirst%3DG.%26aulast%3DNikonenko%26aufirst%3DB.%26aulast%3DProtopopova%26aufirst%3DM.%26atitle%3DPharmacodynamics%2520and%2520pharmacokinetics%2520of%2520SQ109%252C%2520a%2520new%2520diamine-based%2520antitubercular%2520drug%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D144%26spage%3D80%26epage%3D87%26doi%3D10.1038%2Fsj.bjp.0705984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Heinrich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Bois, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narunsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horwith, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phipps, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacy, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aarnoutse, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeree, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelscher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diacon, A. H.</span><span> </span><span class="NLM_article-title">Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1558</span><span class="NLM_x">–</span> <span class="NLM_lpage">1566</span><span class="refDoi"> DOI: 10.1093/jac/dku553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1093%2Fjac%2Fdku553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=25630641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSru7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=1558-1566&author=N.+Heinrichauthor=R.+Dawsonauthor=J.+du+Boisauthor=K.+Narunskyauthor=G.+Horwithauthor=A.+J.+Phippsauthor=C.+A.+Nacyauthor=R.+E.+Aarnoutseauthor=M.+J.+Boereeauthor=S.+H.+Gillespieauthor=A.+Venterauthor=S.+Henneauthor=A.+Rachowauthor=P.+P.+Phillipsauthor=M.+Hoelscherauthor=A.+H.+Diacon&title=Early+phase+evaluation+of+SQ109+alone+and+in+combination+with+rifampicin+in+pulmonary+TB+patients&doi=10.1093%2Fjac%2Fdku553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients</span></div><div class="casAuthors">Heinrich, Norbert; Dawson, Rodney; du Bois, Jeannine; Narunsky, Kim; Horwith, Gary; Phipps, Andrew J.; Nacy, Carol A.; Aarnoutse, Rob E.; Boeree, Martin J.; Gillespie, Stephen H.; Venter, Amour; Henne, Sonja; Rachow, Andrea; Phillips, Patrick P. J.; Hoelscher, Michael; Diacon, Andreas H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1558-1566</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: SQ109, an asym. diamine, is a novel anti-TB drug candidate.  This first study in patients was done to det. safety, tolerability, pharmacokinetics and bacteriol. effect of different doses of SQ109 alone and in combination with rifampicin when administered over 14 days.  Patients and methods: Smear-pos. pulmonary TB patients were randomized into six groups of 15 to receive once-daily oral treatment with 75, 150 or 300 mg of SQ109, rifampicin (10 mg/kg body wt.), rifampicin plus 150 mg of SQ109, or rifampicin plus 300 mg of SQ109 for 14 days.  Patients were hospitalized for supervised treatment, regular clin., biochem. and electrocardiog. safety assessments, pharmacokinetic profiling and daily overnight sputum collection.  Results: SQ109 was safe and generally well tolerated.  Mild to moderate dose-dependent gastrointestinal complaints were the most frequent adverse events.  No relevant QT prolongation was noted.  Maximum SQ109 plasma concns. were lower than MICs.  Exposure to SQ109 (AUC0-24) increased by drug accumulation upon repeated administration in the SQ109 monotherapy groups.  Co-administration of SQ109 150 mg with rifampicin resulted in decreasing SQ109 exposures from day 1 to day 14.  A higher (300 mg) dose of SQ109 largely outweighed the evolving inductive effect of rifampicin.  The daily fall in log cfu/mL of sputum (95% CI) was 0.093 (0.126-0.059) with rifampicin, 0.133 (0.166-0.100) with rifampicin plus 150 mg of SQ109 and 0.089 (0.121-0.057) with rifampicin plus 300 mg of SQ109.  Treatments with SQ109 alone showed no significant activity.  Conclusions: SQ109 alone or with rifampicin was safe over 14 days.  Upon co-administration with rifampicin, 300 mg of SQ109 yielded a higher exposure than the 150 mg dose.  SQ109 did not appear to be active alone or to enhance the activity of rifampicin during the 14 days of treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5XuvH1u_XnLVg90H21EOLACvtfcHk0liJOr3i-xs_OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSru7vO&md5=74383f8c0b9e897881ab69eb12b8e08f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdku553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdku553%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DN.%26aulast%3DDawson%26aufirst%3DR.%26aulast%3Ddu%2BBois%26aufirst%3DJ.%26aulast%3DNarunsky%26aufirst%3DK.%26aulast%3DHorwith%26aufirst%3DG.%26aulast%3DPhipps%26aufirst%3DA.%2BJ.%26aulast%3DNacy%26aufirst%3DC.%2BA.%26aulast%3DAarnoutse%26aufirst%3DR.%2BE.%26aulast%3DBoeree%26aufirst%3DM.%2BJ.%26aulast%3DGillespie%26aufirst%3DS.%2BH.%26aulast%3DVenter%26aufirst%3DA.%26aulast%3DHenne%26aufirst%3DS.%26aulast%3DRachow%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DP.%2BP.%26aulast%3DHoelscher%26aufirst%3DM.%26aulast%3DDiacon%26aufirst%3DA.%2BH.%26atitle%3DEarly%2520phase%2520evaluation%2520of%2520SQ109%2520alone%2520and%2520in%2520combination%2520with%2520rifampicin%2520in%2520pulmonary%2520TB%2520patients%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2015%26volume%3D70%26spage%3D1558%26epage%3D1566%26doi%3D10.1093%2Fjac%2Fdku553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnolo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passalacqua, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saddi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deidda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Logu, A.</span><span> </span><span class="NLM_article-title">Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of mycobacterium tuberculosis</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span><span class="refDoi"> DOI: 10.1002/cmdc.200600026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1002%2Fcmdc.200600026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=16892466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=973-989&author=F.+Manettiauthor=M.+Magnaniauthor=D.+Castagnoloauthor=L.+Passalacquaauthor=M.+Bottaauthor=F.+Corelliauthor=M.+Saddiauthor=D.+Deiddaauthor=A.+De+Logu&title=Ligand-based+virtual+screening%2C+parallel+solution-phase+and+microwave-assisted+synthesis+as+tools+to+identify+and+synthesize+new+inhibitors+of+mycobacterium+tuberculosis&doi=10.1002%2Fcmdc.200600026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of Mycobacterium tuberculosis</span></div><div class="casAuthors">Manetti, Fabrizio; Magnani, Matteo; Castagnolo, Daniele; Passalacqua, Laura; Botta, Maurizio; Corelli, Federico; Saddi, Manuela; Deidda, Delia; De Logu, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">973-989</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In an attempt to identify new inhibitors of the growth of Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis, a procedure for the generation, design, and screening of a ligand-based virtual library was applied.  This used both an in silico protocol centered on a recursive partitioning (RP) model described herein, and a pharmacophoric model for antitubercular agents previously generated by our research group.  Two candidates emerged from databases of com. available compds., both characterized by a min. inhibitory concn. (MIC) of 25 μg mL-1.  Based on these compds., two series of derivs. were synthesized by both parallel soln.-phase and microwave-assisted synthesis, leading to enhanced antimycobacterial activity.  During both the design and synthesis, attention was focused on the efficient allocation of available resources with the aim of reducing the overall costs assocd. with calcn. and synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqUbmJeLZ0_LVg90H21EOLACvtfcHk0liJOr3i-xs_OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVCmu7Y%253D&md5=9e44838cf10c39cb7a1d318749e482ab</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600026%26sid%3Dliteratum%253Aachs%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DMagnani%26aufirst%3DM.%26aulast%3DCastagnolo%26aufirst%3DD.%26aulast%3DPassalacqua%26aufirst%3DL.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DCorelli%26aufirst%3DF.%26aulast%3DSaddi%26aufirst%3DM.%26aulast%3DDeidda%26aufirst%3DD.%26aulast%3DDe%2BLogu%26aufirst%3DA.%26atitle%3DLigand-based%2520virtual%2520screening%252C%2520parallel%2520solution-phase%2520and%2520microwave-assisted%2520synthesis%2520as%2520tools%2520to%2520identify%2520and%2520synthesize%2520new%2520inhibitors%2520of%2520mycobacterium%2520tuberculosis%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D973%26epage%3D989%26doi%3D10.1002%2Fcmdc.200600026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Badiola, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triccas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, M. H.</span><span> </span><span class="NLM_article-title">Efficient synthesis and anti-tubercular activity of a series of spirocycles: an exercise in open science</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e111782</span><span class="refDoi"> DOI: 10.1371/journal.pone.0111782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1371%2Fjournal.pone.0111782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=25493550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyjs7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e111782&author=K.+A.+Badiolaauthor=D.+H.+Quanauthor=J.+A.+Triccasauthor=M.+H.+Todd&title=Efficient+synthesis+and+anti-tubercular+activity+of+a+series+of+spirocycles%3A+an+exercise+in+open+science&doi=10.1371%2Fjournal.pone.0111782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis and anti-tubercular activity of a series of spirocycles: an exercise in open science</span></div><div class="casAuthors">Badiola, Katrina A.; Quan, Diana H.; Triccas, James A.; Todd, Matthew H.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e111782/1-e111782/20, 20 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">An efficient synthesis of a series of spirocyclic pyrans I [R = benzodioxan-6-yl, benzodioxol-5-yl, 4-hydroxy-3-methoxyphenyl, etc.] and II [R1 = C6H5, 4-BrC6H4, 2-BrC6H4] via oxa-Pictet-Spengler reaction is developed.  The oxa-Pictet-Spengler reaction of 4-benzylpiperidone and 2-thiopheneethanol gives N-benzylated intermediate III, which on further debenzylation produces secondary amine IV.  Secondary amine IV upon reductive amination with aldehydes/ketones yielded spirocyclic pyrans I and upon acylation with acyl chlorides yielded spirocyclic pyrans II in moderate to good yields.  The synthesized spirocyclic pyrans I and II were tested against the virulent M. tuberculosis strain (H37Rv), of which compds. I [R = benzodioxan-6-yl, benzodioxol-5-yl, 4-chlorophenyl, 1-(4-fluorophenyl)-2,5-dimethylpyrrol-3-yl] and III showd excellent anti-tubercular activity.  The toxicity of spirocyclic pyrans I displaying anti-H37Rv activity was assessed using the human monocytic cell line THP1, results showed that spirocyclic pyrans I [R = benzodioxan-6-yl, benzodioxol-5-yl, 4-chlorophenyl] and III displayed THP1 toxicty at relatively high concns.(>50 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7oCV08HTMArVg90H21EOLACvtfcHk0lhL31ZVEqjaFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyjs7nE&md5=ffff8fe33d16469205ea56402be70da2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0111782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0111782%26sid%3Dliteratum%253Aachs%26aulast%3DBadiola%26aufirst%3DK.%2BA.%26aulast%3DQuan%26aufirst%3DD.%2BH.%26aulast%3DTriccas%26aufirst%3DJ.%2BA.%26aulast%3DTodd%26aufirst%3DM.%2BH.%26atitle%3DEfficient%2520synthesis%2520and%2520anti-tubercular%2520activity%2520of%2520a%2520series%2520of%2520spirocycles%253A%2520an%2520exercise%2520in%2520open%2520science%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De111782%26doi%3D10.1371%2Fjournal.pone.0111782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span> <span class="citation_source-book">Phase</span>, version 3.3, <span class="NLM_publisher-name">Schrodinger LLC</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Phase%2C+version+3.3%2C+Schrodinger+LLC%2C+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPhase%26pub%3DSchrodinger%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wermuth, C. G.; Aldous, D.; Raboisson, P.; Rognan, D.</span>, Eds.  <span class="citation_source-book">The Practice of Medicinal Chemistry</span>, <span class="NLM_edition">4</span>th ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">385</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=385&author=C.+G.+Wermuth&author=D.+Aldous&author=P.+Raboisson&author=D.+Rognan&title=The+Practice+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26btitle%3DThe%2520Practice%2520of%2520Medicinal%2520Chemistry%26pub%3DAcademic%2520Press%26date%3D2015%26spage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insight by examining carbo- and hetero-aromatic and – aliphatic ring types</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1016/j.drudis.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchieauthor=S.+J.+Macdonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insight+by+examining+carbo-+and+hetero-aromatic+and+%E2%80%93+aliphatic+ring+types&doi=10.1016%2Fj.drudis.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insight%2520by%2520examining%2520carbo-%2520and%2520hetero-aromatic%2520and%2520%25E2%2580%2593%2520aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.drudis.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Castagnolo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Logu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meleddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chisu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8587</span><span class="NLM_x">–</span> <span class="NLM_lpage">8591</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.08.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1016%2Fj.bmc.2008.08.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=18752962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFantLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8587-8591&author=D.+Castagnoloauthor=A.+De+Loguauthor=M.+Radiauthor=B.+Bechiauthor=F.+Manettiauthor=M.+Magnaniauthor=S.+Supinoauthor=R.+Meledduauthor=L.+Chisuauthor=M.+Botta&title=Synthesis%2C+biological+evaluation+and+SAR+study+of+novel+pyrazole+analogues+as+inhibitors+of+Mycobacterium+tuberculosis&doi=10.1016%2Fj.bmc.2008.08.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis</span></div><div class="casAuthors">Castagnolo, Daniele; De Logu, Alessandro; Radi, Marco; Bechi, Beatrice; Manetti, Fabrizio; Magnani, Matteo; Supino, Sibilla; Meleddu, Rita; Chisu, Lorenza; Botta, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8587-8591</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">As a continuation of the previous work that turned toward the identification of antimycobacterial compds. with innovative structures, two series of pyrazole derivs. were synthesized by parallel soln.-phase synthesis and were assayed as inhibitors of Mycobacterium tuberculosis (MTB), which is the causative agent of tuberculosis.  One of these compds. showed high activity against MTB (MIC = 4 μg/mL).  The newly synthesized pyrazoles were also computationally investigated to analyze their fit properties to the pharmacophoric model for antitubercular compds. previously built by us and to refine structure-activity relationship anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjG2KfIIt_W7Vg90H21EOLACvtfcHk0lj9iHapx1k2fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFantLrK&md5=57ff11988bedd828072c4940e1272982</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.08.016%26sid%3Dliteratum%253Aachs%26aulast%3DCastagnolo%26aufirst%3DD.%26aulast%3DDe%2BLogu%26aufirst%3DA.%26aulast%3DRadi%26aufirst%3DM.%26aulast%3DBechi%26aufirst%3DB.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DMagnani%26aufirst%3DM.%26aulast%3DSupino%26aufirst%3DS.%26aulast%3DMeleddu%26aufirst%3DR.%26aulast%3DChisu%26aufirst%3DL.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520SAR%2520study%2520of%2520novel%2520pyrazole%2520analogues%2520as%2520inhibitors%2520of%2520Mycobacterium%2520tuberculosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8587%26epage%3D8591%26doi%3D10.1016%2Fj.bmc.2008.08.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Castagnolo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Logu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meleddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saddi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Synthesis biological evaluation and SAR study of novel pyrazole analogues as inhibitors of <i>Mycobacterium tuberculosis</i>: Part 2. Synthesis of rigid pyrazolones</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5716</span><span class="NLM_x">–</span> <span class="NLM_lpage">5721</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.05.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1016%2Fj.bmc.2009.05.058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=5716-5721&author=D.+Castagnoloauthor=F.+Manettiauthor=M.+Radiauthor=B.+Bechiauthor=M.+Paganoauthor=A.+De+Loguauthor=R.+Meledduauthor=M.+Saddiauthor=M.+Botta&title=Synthesis+biological+evaluation+and+SAR+study+of+novel+pyrazole+analogues+as+inhibitors+of+Mycobacterium+tuberculosis%3A+Part+2.+Synthesis+of+rigid+pyrazolones&doi=10.1016%2Fj.bmc.2009.05.058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.05.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.05.058%26sid%3Dliteratum%253Aachs%26aulast%3DCastagnolo%26aufirst%3DD.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DRadi%26aufirst%3DM.%26aulast%3DBechi%26aufirst%3DB.%26aulast%3DPagano%26aufirst%3DM.%26aulast%3DDe%2BLogu%26aufirst%3DA.%26aulast%3DMeleddu%26aufirst%3DR.%26aulast%3DSaddi%26aufirst%3DM.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DSynthesis%2520biological%2520evaluation%2520and%2520SAR%2520study%2520of%2520novel%2520pyrazole%2520analogues%2520as%2520inhibitors%2520of%2520Mycobacterium%2520tuberculosis%253A%2520Part%25202.%2520Synthesis%2520of%2520rigid%2520pyrazolones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D5716%26epage%3D5721%26doi%3D10.1016%2Fj.bmc.2009.05.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Phelan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNerney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T. G.</span><span> </span><span class="NLM_article-title">The draft genome of <i>Mycobacterium Aurum</i>, a potential model organism for investigating drugs against <i>Mycobacterium tuberculosis</i> and <i>Mycobacterium leprae</i></span> <span class="citation_source-journal">Int. J. Mycobacteriology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/j.ijmyco.2015.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1016%2Fj.ijmyco.2015.05.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=207-216&author=J.+Phelanauthor=A.+Maitraauthor=R.+McNerneyauthor=M.+Nairauthor=A.+Guptaauthor=F.+Collauthor=A.+Painauthor=S.+Bhaktaauthor=T.+G.+Clark&title=The+draft+genome+of+Mycobacterium+Aurum%2C+a+potential+model+organism+for+investigating+drugs+against+Mycobacterium+tuberculosis+and+Mycobacterium+leprae&doi=10.1016%2Fj.ijmyco.2015.05.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ijmyco.2015.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijmyco.2015.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DPhelan%26aufirst%3DJ.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DMcNerney%26aufirst%3DR.%26aulast%3DNair%26aufirst%3DM.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DColl%26aufirst%3DF.%26aulast%3DPain%26aufirst%3DA.%26aulast%3DBhakta%26aufirst%3DS.%26aulast%3DClark%26aufirst%3DT.%2BG.%26atitle%3DThe%2520draft%2520genome%2520of%2520Mycobacterium%2520Aurum%252C%2520a%2520potential%2520model%2520organism%2520for%2520investigating%2520drugs%2520against%2520Mycobacterium%2520tuberculosis%2520and%2520Mycobacterium%2520leprae%26jtitle%3DInt.%2520J.%2520Mycobacteriology%26date%3D2015%26volume%3D4%26spage%3D207%26epage%3D216%26doi%3D10.1016%2Fj.ijmyco.2015.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Naik, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohanty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padhi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonawane, A.</span><span> </span><span class="NLM_article-title">Evaluation of antibacterial and cytotoxic activity of <i>Artemisia nilagirica</i> and <i>Murraya koenigii</i> leaf extracts against mycobacteria and macrophages</span> <span class="citation_source-journal">BMC Complementary Altern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="refDoi"> DOI: 10.1186/1472-6882-14-87</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1186%2F1472-6882-14-87" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=24597853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A280%3ADC%252BC2crgvFalsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=87&author=S.+K.+Naikauthor=S.+Mohantyauthor=A.+Padhiauthor=R.+Patiauthor=A.+Sonawane&title=Evaluation+of+antibacterial+and+cytotoxic+activity+of+Artemisia+nilagirica+and+Murraya+koenigii+leaf+extracts+against+mycobacteria+and+macrophages&doi=10.1186%2F1472-6882-14-87"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of antibacterial and cytotoxic activity of Artemisia nilagirica and Murraya koenigii leaf extracts against mycobacteria and macrophages</span></div><div class="casAuthors">Naik Sumanta Kumar; Mohanty Soumitra; Padhi Avinash; Pati Rashmirekha; Sonawane Avinash</div><div class="citationInfo"><span class="NLM_cas:title">BMC complementary and alternative medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Artemisia nilagirica (Asteraceae) and Murraya koenigii (Rutaceae) are widely distributed in eastern region of India.  Leaves of Artemisia nilagirica plant are used to treat cold and cough by the local tribal population in east India.  Murraya koenigii is an edible plant previously reported to have an antibacterial activity.  Pathogenic strains of mycobacteria are resistant to most of the conventional antibiotics.  Therefore, it is imperative to identify novel antimycobacterial molecules to treat mycobacterial infection.  METHODS:  In this study, ethanol, petroleum ether and water extracts of Artemisia nilagirica and Murraya koenigii were tested for antibacterial activity against Mycobacterium smegmatis and Mycobacterium bovis BCG in synergy with first line anti-tuberculosis (TB) drugs, and for cytotoxic activities on mouse macrophage RAW264.7 cells.  Antibacterial activity was determined by colony forming unit (CFU) assay.  Intracellular survival assay was performed by infecting RAW264.7 cells with M. smegmatis before and after treatment with plant extracts.  Cytotoxity was checked by MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide] assay.  Genotoxicity was studied by DAPI staining and COMET assay using mouse macrophage RAW264.7 cell line.  Cell apoptosis was checked by Annexin-V/FITC dual staining method.  Reactive oxygen species and nitric oxide production was checked by DCFH staining and Griess reagent, respectively.  RESULTS:  Ethanol extracts of A. nilagirica (IC50 300 μg/ml) and M. koenigii (IC50 400 μg/ml) were found to be more effective against Mycobacterium smegmatis as compared to petroleum ether and water extracts.  M. koenigii extract showed maximum activity against M. bovis BCG in combination with a first line anti-TB drug rifampicin.  M. koenigii leaf extract also exerted more cytototoxic (IC50 20 μg/ml), genotoxic and apoptosis in mouse macrophage RAW 264.7 cell line.  Treatment of mouse macrophages with A. nilagirica extract increased intracellular killing of M. smegmatis by inducing production of reactive oxygen species and nitric oxide.  CONCLUSIONS:  Ethanol extracts of A. nilagirica and M. koenigii were found to be more effective against mycobacteria.  As compared to A. nilagirica, M. koenigii ethanol extract exhibited significant synergistic antibacterial activity against M. smegmatis and M. bovis BCG in combination with anti-tuberculosis drug rifampicin, and also showed increased cytotoxicity, DNA damage and apoptosis in mouse macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbDFbEMLxp1DEC-75aqa5AfW6udTcc2eYsNCJ2Ky5_rbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crgvFalsA%253D%253D&md5=dd86e217eb45d9d4fd404bbeee763184</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2F1472-6882-14-87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6882-14-87%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DS.%2BK.%26aulast%3DMohanty%26aufirst%3DS.%26aulast%3DPadhi%26aufirst%3DA.%26aulast%3DPati%26aufirst%3DR.%26aulast%3DSonawane%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520antibacterial%2520and%2520cytotoxic%2520activity%2520of%2520Artemisia%2520nilagirica%2520and%2520Murraya%2520koenigii%2520leaf%2520extracts%2520against%2520mycobacteria%2520and%2520macrophages%26jtitle%3DBMC%2520Complementary%2520Altern.%2520Med.%26date%3D2014%26volume%3D14%26spage%3D87%26doi%3D10.1186%2F1472-6882-14-87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span> </span><span class="NLM_article-title">An integrated surrogate model for screening of drugs against <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1391</span><span class="refDoi"> DOI: 10.1093/jac/dks056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1093%2Fjac%2Fdks056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=22398649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2qs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=1380-1391&author=A.+Guptaauthor=S.+Bhakta&title=An+integrated+surrogate+model+for+screening+of+drugs+against+Mycobacterium+tuberculosis&doi=10.1093%2Fjac%2Fdks056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">An integrated surrogate model for screening of drugs against Mycobacterium tuberculosis</span></div><div class="casAuthors">Gupta, Antima; Bhakta, Sanjib</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1380-1391</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The intracellularly surviving and slow-growing pathogen, Mycobacterium tuberculosis, adapts the host cell environment for its active and dormant life cycle.  It is evident that the lack of appropriate high-throughput screening of inhibitors within host cells is an impediment for the early stages of anti-tubercular drug discovery.  The authors developed an integrated surrogate model that enhances the screening of large inhibitor libraries.  Different mycobacterial species were compared for their growth, drug susceptibility and intracellular uptake.  A 6-well plate solid agar-based spot culture growth inhibition (SPOTi) assay was developed into a higher throughput format.  The uptake and intracellular survival of Mycobacterium aurum within mouse macrophage cells (RAW 264.7) were optimized using 24/96-well plate formats.  Fast-growing, non-pathogenic M. aurum was found to have an antibiotic-susceptibility profile similar to that of M. tuberculosis.  The sensitivity to an acidic pH environment and the ability to multiply inside RAW 264.7 macrophages provided addnl. advantages for employing M. aurum in intracellular drug screening methods.  A selection of anti-tubercular drugs inhibited the growth and viability of M. aurum inside the macrophages at different levels.  Thus, the authors present a rapid, convenient, high-throughput surrogate model that provides a comprehensive evaluation platform for new chem. scaffolds against different physiol. stages of mycobacteria within the primary cell environment of the host.  The results using anti-tubercular drugs validate this model for screening libraries of existing and novel chem. entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprxqZBGNLxD7Vg90H21EOLACvtfcHk0lgxnpWkKyqiUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2qs7w%253D&md5=18f51e99ee3ca84a8bde1c0e6ffe5631</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks056%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DBhakta%26aufirst%3DS.%26atitle%3DAn%2520integrated%2520surrogate%2520model%2520for%2520screening%2520of%2520drugs%2520against%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D1380%26epage%3D1391%26doi%3D10.1093%2Fjac%2Fdks056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span> <span class="citation_source-book">Maestro</span>, version 9.2; <span class="NLM_publisher-name">Schrodinger LLC</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+9.2%3B+Schrodinger+LLC%2C+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%26pub%3DSchrodinger%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span> <span class="citation_source-book">MacroModel</span>, version 9.9; <span class="NLM_publisher-name">Schrodinger LLC</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MacroModel%2C+version+9.9%3B+Schrodinger+LLC%2C+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMacroModel%26pub%3DSchrodinger%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Sambandamurthy, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalapathy, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcelli, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, W. R.,  Jr.</span><span> </span><span class="NLM_article-title"><i>Mycobacterium tuberculosis</i> DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis</span> <span class="citation_source-journal">Vaccine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">6309</span><span class="NLM_x">–</span> <span class="NLM_lpage">6320</span><span class="refDoi"> DOI: 10.1016/j.vaccine.2006.05.097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1016%2Fj.vaccine.2006.05.097" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=6309-6320&author=V.+K.+Sambandamurthyauthor=S.+C.+Derrickauthor=T.+Hsuauthor=B.+Chenauthor=M.+H.+Larsenauthor=K.+V.+Jalapathyauthor=M.+Chenauthor=J.+Kimauthor=S.+A.+Porcelliauthor=J.+Chanauthor=S.+L.+Morrisauthor=W.+R.+Jacobs&title=Mycobacterium+tuberculosis+DeltaRD1+DeltapanCD%3A+a+safe+and+limited+replicating+mutant+strain+that+protects+immunocompetent+and+immunocompromised+mice+against+experimental+tuberculosis&doi=10.1016%2Fj.vaccine.2006.05.097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2006.05.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2006.05.097%26sid%3Dliteratum%253Aachs%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DDerrick%26aufirst%3DS.%2BC.%26aulast%3DHsu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DLarsen%26aufirst%3DM.%2BH.%26aulast%3DJalapathy%26aufirst%3DK.%2BV.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DPorcelli%26aufirst%3DS.%2BA.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DMorris%26aufirst%3DS.%2BL.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26atitle%3DMycobacterium%2520tuberculosis%2520DeltaRD1%2520DeltapanCD%253A%2520a%2520safe%2520and%2520limited%2520replicating%2520mutant%2520strain%2520that%2520protects%2520immunocompetent%2520and%2520immunocompromised%2520mice%2520against%2520experimental%2520tuberculosis%26jtitle%3DVaccine%26date%3D2006%26volume%3D24%26spage%3D6309%26epage%3D6320%26doi%3D10.1016%2Fj.vaccine.2006.05.097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Larsen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambandamurthy, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackner, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aye, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letvin, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frothingham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, W. R.,  Jr.</span><span> </span><span class="NLM_article-title">Efficacy and safety of live attenuated persistent and rapidly cleared <i>Mycobacterium tuberculosis</i> vaccine candidates in non-human primates</span> <span class="citation_source-journal">Vaccine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4709</span><span class="NLM_x">–</span> <span class="NLM_lpage">4717</span><span class="refDoi"> DOI: 10.1016/j.vaccine.2009.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1016%2Fj.vaccine.2009.05.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=4709-4717&author=M.+H.+Larsenauthor=K.+Biermannauthor=B.+Chenauthor=T.+Hsuauthor=V.+K.+Sambandamurthyauthor=A.+A.+Lacknerauthor=P.+P.+Ayeauthor=P.+Didierauthor=D.+Huangauthor=L.+Shaoauthor=H.+Weiauthor=N.+L.+Letvinauthor=R.+Frothinghamauthor=B.+F.+Haynesauthor=Z.+W.+Chenauthor=W.+R.+Jacobs&title=Efficacy+and+safety+of+live+attenuated+persistent+and+rapidly+cleared+Mycobacterium+tuberculosis+vaccine+candidates+in+non-human+primates&doi=10.1016%2Fj.vaccine.2009.05.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2009.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2009.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DM.%2BH.%26aulast%3DBiermann%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DHsu%26aufirst%3DT.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DLackner%26aufirst%3DA.%2BA.%26aulast%3DAye%26aufirst%3DP.%2BP.%26aulast%3DDidier%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLetvin%26aufirst%3DN.%2BL.%26aulast%3DFrothingham%26aufirst%3DR.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26aulast%3DChen%26aufirst%3DZ.%2BW.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520live%2520attenuated%2520persistent%2520and%2520rapidly%2520cleared%2520Mycobacterium%2520tuberculosis%2520vaccine%2520candidates%2520in%2520non-human%2520primates%26jtitle%3DVaccine%26date%3D2009%26volume%3D27%26spage%3D4709%26epage%3D4717%26doi%3D10.1016%2Fj.vaccine.2009.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Sambandamurthy, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, W. R.,  Jr.</span><span> </span><span class="NLM_article-title">A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1171</span><span class="NLM_x">–</span> <span class="NLM_lpage">1174</span><span class="refDoi"> DOI: 10.1038/nm765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1038%2Fnm765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=12219086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVGrt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1171-1174&author=V.+K.+Sambandamurthyauthor=X.+Wangauthor=B.+Chenauthor=R.+G.+Russellauthor=S.+Derrickauthor=F.+M.+Collinsauthor=S.+L.+Morrisauthor=W.+R.+Jacobs&title=A+pantothenate+auxotroph+of+Mycobacterium+tuberculosis+is+highly+attenuated+and+protects+mice+against+tuberculosis&doi=10.1038%2Fnm765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis</span></div><div class="casAuthors">Sambandamurthy, Vasan K.; Wang, Xiaojuan; Chen, Bing; Russell, Robert G.; Derrick, Steven; Collins, Frank M.; Morris, Sheldon L.; Jacobs, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1171-1174</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">With the advent of HIV and the widespread emergence of drug-resistant strains of Mycobacterium tuberculosis, newer control strategies in the form of a better vaccine could decrease the global incidence of tuberculosis.  A desirable trait in an effective live attenuated vaccine strain is an ability to persist within the host in a limited fashion in order to produce important protective antigens in vivo.  Attenuated M. tuberculosis vaccine candidates have been constructed by deleting genes required for growth in mice.  These candidate vaccines did not elicit adequate protective immunity in animal models, due to their inability to persist sufficiently long within the host tissues.  Here we report that an auxotrophic mutant of M. tuberculosis defective in the de novo biosynthesis of pantothenic acid (vitamin B5) is highly attenuated in immunocompromised SCID mice and in immunocompetent BALB/c mice.  SCID mice infected with the pantothenate auxotroph survived significantly longer (250 days) than mice infected with either bacille Calmette-Guerin (BCG) vaccine or virulent M. tuberculosis (77 and 35 days, resp.).  S.c. immunization with this auxotroph conferred protection in C57BL/6J mice against an aerosol challenge with virulent M. tuberculosis, which was comparable with that afforded by BCG vaccination.  Our findings highlight the importance of de novo pantothenate biosynthesis in limiting the intracellular survival and pathogenesis of M. tuberculosis without reducing its immunogenicity in vaccinated mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOxuoVg9k--rVg90H21EOLACvtfcHk0lhseADvXJwgeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVGrt7c%253D&md5=2f6a03e8699952251f88064484ad48f5</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnm765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm765%26sid%3Dliteratum%253Aachs%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DRussell%26aufirst%3DR.%2BG.%26aulast%3DDerrick%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DF.%2BM.%26aulast%3DMorris%26aufirst%3DS.%2BL.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26atitle%3DA%2520pantothenate%2520auxotroph%2520of%2520Mycobacterium%2520tuberculosis%2520is%2520highly%2520attenuated%2520and%2520protects%2520mice%2520against%2520tuberculosis%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D1171%26epage%3D1174%26doi%3D10.1038%2Fnm765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Evangelopoulos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span> </span><span class="NLM_article-title">Rapid methods for testing inhibitors of mycobacterial growth</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">642</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1007/978-1-60327-279-7_15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1007%2F978-1-60327-279-7_15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=20401596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFWntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=642&publication_year=2010&pages=193-201&author=D.+Evangelopoulosauthor=S.+Bhakta&title=Rapid+methods+for+testing+inhibitors+of+mycobacterial+growth&doi=10.1007%2F978-1-60327-279-7_15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid methods for testing inhibitors of mycobacterial growth</span></div><div class="casAuthors">Evangelopoulos, Dimitrios; Bhakta, Sanjib</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">642</span>
        (<span class="NLM_cas:issue">Antibiotic Resistance Protocols</span>),
    <span class="NLM_cas:pages">193-201</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Considering the increased concerns with controlling infectious epidemics such as tuberculosis, a global concerted effort (WHO) is now dead-lined to tackle the emergence of extensive drug resistance through identifying a novel line of therapeutics which will on the one hand shorten the course of treatment and on the other is also expected to be effective against the emerging resistant strains.  Major problems with the preclin. drug screening against the uniquely slow-growing pathogen Mycobacterium tuberculosis are either found expensive, time-consuming, or require a highly complex lab. setup.  A rapid and convenient, although relatively inexpensive, method requiring very little consumption of inhibitors within a simple microbiol. setup for antimycobacterial screening is thus timely.  The spot-culture growth inhibition assay aims to test the biol. activity of a no. of newly discovered natural products and thousands of novel chems. synthesized on the basis of basic structural and mol. biol. studies.  Many different classes of novel chem. entities are now independently prepd. around the world by distinguished chemists on the chem. behavior of the group of mols.  To serve the purpose of antimycobacterials screening, we aim to describe a method in this chapter performed in a six-well plate format.  This method can also be extended accurately to a 96-well plate format according to the necessity of the project.  In addn. to evaluating a range of prospective drug candidates, this method would also contribute to elucidate substrates for many putative endogenous pathways through comparing the chem. inhibition with the corresponding genetic modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEpGGZLtvhnLVg90H21EOLACvtfcHk0lhseADvXJwgeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFWntb4%253D&md5=2469ab085e062cadb8324837611954a7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2F978-1-60327-279-7_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-60327-279-7_15%26sid%3Dliteratum%253Aachs%26aulast%3DEvangelopoulos%26aufirst%3DD.%26aulast%3DBhakta%26aufirst%3DS.%26atitle%3DRapid%2520methods%2520for%2520testing%2520inhibitors%2520of%2520mycobacterial%2520growth%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2010%26volume%3D642%26spage%3D193%26epage%3D201%26doi%3D10.1007%2F978-1-60327-279-7_15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Guzman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evangelopoulos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwaigwisya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span> </span><span class="NLM_article-title">Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay</span> <span class="citation_source-journal">BMJ. Open</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e002672</span><span class="refDoi"> DOI: 10.1136/bmjopen-2013-002672</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1136%2Fbmjopen-2013-002672" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=e002672&author=J.+D.+Guzmanauthor=D.+Evangelopoulosauthor=A.+Guptaauthor=K.+Birchallauthor=S.+Mwaigwisyaauthor=B.+Saxtyauthor=T.+D.+McHughauthor=S.+Gibbonsauthor=J.+Malkinsonauthor=S.+Bhakta&title=Antitubercular+specific+activity+of+ibuprofen+and+the+other+2-arylpropanoic+acids+using+the+HT-SPOTi+whole-cell+phenotypic+assay&doi=10.1136%2Fbmjopen-2013-002672"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1136%2Fbmjopen-2013-002672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmjopen-2013-002672%26sid%3Dliteratum%253Aachs%26aulast%3DGuzman%26aufirst%3DJ.%2BD.%26aulast%3DEvangelopoulos%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DBirchall%26aufirst%3DK.%26aulast%3DMwaigwisya%26aufirst%3DS.%26aulast%3DSaxty%26aufirst%3DB.%26aulast%3DMcHugh%26aufirst%3DT.%2BD.%26aulast%3DGibbons%26aufirst%3DS.%26aulast%3DMalkinson%26aufirst%3DJ.%26aulast%3DBhakta%26aufirst%3DS.%26atitle%3DAntitubercular%2520specific%2520activity%2520of%2520ibuprofen%2520and%2520the%2520other%25202-arylpropanoic%2520acids%2520using%2520the%2520HT-SPOTi%2520whole-cell%2520phenotypic%2520assay%26jtitle%3DBMJ.%2520Open%26date%3D2013%26volume%3D3%26spage%3De002672%26doi%3D10.1136%2Fbmjopen-2013-002672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Danquah, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhakta, S.</span><span> </span><span class="NLM_article-title">HT-SPOTi: a rapid, drug susceptibility test (DST), to evaluate antibiotic resistance profiles and novel chemicals for anti-infective drug discovery</span> <span class="citation_source-journal">Curr. Protoc. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">17.8.1</span><span class="NLM_x">–</span> <span class="NLM_lpage">17.8.12</span><span class="refDoi"> DOI: 10.1002/9780471729259.mc1708s40</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1002%2F9780471729259.mc1708s40" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2016&pages=17.8.1-17.8.12&author=C.+A.+Danquahauthor=A.+Maitraauthor=S.+Gibbonsauthor=J.+Faullauthor=S.+Bhakta&title=HT-SPOTi%3A+a+rapid%2C+drug+susceptibility+test+%28DST%29%2C+to+evaluate+antibiotic+resistance+profiles+and+novel+chemicals+for+anti-infective+drug+discovery&doi=10.1002%2F9780471729259.mc1708s40"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2F9780471729259.mc1708s40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780471729259.mc1708s40%26sid%3Dliteratum%253Aachs%26aulast%3DDanquah%26aufirst%3DC.%2BA.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DGibbons%26aufirst%3DS.%26aulast%3DFaull%26aufirst%3DJ.%26aulast%3DBhakta%26aufirst%3DS.%26atitle%3DHT-SPOTi%253A%2520a%2520rapid%252C%2520drug%2520susceptibility%2520test%2520%2528DST%2529%252C%2520to%2520evaluate%2520antibiotic%2520resistance%2520profiles%2520and%2520novel%2520chemicals%2520for%2520anti-infective%2520drug%2520discovery%26jtitle%3DCurr.%2520Protoc.%2520Microbiol.%26date%3D2016%26volume%3D40%26spage%3D17.8.1%26epage%3D17.8.12%26doi%3D10.1002%2F9780471729259.mc1708s40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Rodrigues, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viveiros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampaio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vavra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, W. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaral, L.</span><span> </span><span class="NLM_article-title">Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in <i>Mycobacterium avium</i> and <i>Mycobacterium smegmatis</i></span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1076</span><span class="NLM_x">–</span> <span class="NLM_lpage">1082</span><span class="refDoi"> DOI: 10.1093/jac/dkn070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=10.1093%2Fjac%2Fdkn070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=18310137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksF2ltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2008&pages=1076-1082&author=L.+Rodriguesauthor=D.+Wagnerauthor=M.+Viveirosauthor=D.+Sampaioauthor=I.+Coutoauthor=M.+Vavraauthor=W.+V.+Kernauthor=L.+Amaral&title=Thioridazine+and+chlorpromazine+inhibition+of+ethidium+bromide+efflux+in+Mycobacterium+avium+and+Mycobacterium+smegmatis&doi=10.1093%2Fjac%2Fdkn070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis</span></div><div class="casAuthors">Rodrigues, Liliana; Wagner, Dirk; Viveiros, Miguel; Sampaio, Daniela; Couto, Isabel; Vavra, Martina; Kern, Winfried V.; Amaral, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1076-1082</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Therapy of AIDS patients infected with Mycobacterium avium is problematic due to its intrinsic resistance to antibiotics.  We have characterized the efflux pump activity of M. avium wild-type strain through an automated fluorometric method and correlated it with intrinsic resistance to antibiotics.  M. avium ATCC 25291T and Mycobacterium smegmatis Mc2155 were evaluated for accumulation and efflux of ethidium bromide in the presence or absence of the efflux pump inhibitors (EPIs) thioridazine, chlorpromazine, verapamil and the proton uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP).  For this purpose, a new automated fluorometric method was used that sep. assesses accumulation and extrusion of ethidium bromide.  The automated fluorometric method described in this paper allowed the detection and quantification of ethidium bromide transport across M. avium and M. smegmatis cell walls.  Accumulation of ethidium bromide was found to be temp.-dependent and significantly increased by EPIs thioridazine, chlorpromazine, verapamil and CCCP in a concn.-dependent manner.  Efflux of ethidium bromide under optimum conditions of temp. and glucose is inhibited by the above agents.  At half their intrinsic MICs, both thioridazine and chlorpromazine, similarly to verapamil and CCCP, significantly increased the susceptibility of M. avium to erythromycin, suggesting an effect upon an efflux pump with ethidium bromide and erythromycin as substrates.  A similar effect was obsd. for M. smegmatis with verapamil only.  Conclusions: M. avium and M. smegmatis intrinsic resistance is affected by EPIs such as thioridazine or chlorpromazine, an effect that might be important in research and development of new, more effective antimycobacterial therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq68k1124KkJ7Vg90H21EOLACvtfcHk0linw5F20Ia3Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksF2ltr8%253D&md5=d5515d376e9e1eb60099948762e6918e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkn070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkn070%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DL.%26aulast%3DWagner%26aufirst%3DD.%26aulast%3DViveiros%26aufirst%3DM.%26aulast%3DSampaio%26aufirst%3DD.%26aulast%3DCouto%26aufirst%3DI.%26aulast%3DVavra%26aufirst%3DM.%26aulast%3DKern%26aufirst%3DW.%2BV.%26aulast%3DAmaral%26aufirst%3DL.%26atitle%3DThioridazine%2520and%2520chlorpromazine%2520inhibition%2520of%2520ethidium%2520bromide%2520efflux%2520in%2520Mycobacterium%2520avium%2520and%2520Mycobacterium%2520smegmatis%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2008%26volume%3D61%26spage%3D1076%26epage%3D1082%26doi%3D10.1093%2Fjac%2Fdkn070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i63"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00031">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_85426"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00031">10.1021/acs.jmedchem.6b00031</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Copies of <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra for compounds <b>7g</b>, <b>7j</b>, <b>9a</b>, <b>9b</b>, and <b>9c</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00031/suppl_file/jm6b00031_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all the new compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00031/suppl_file/jm6b00031_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00031/suppl_file/jm6b00031_si_001.pdf">jm6b00031_si_001.pdf (0.99 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00031/suppl_file/jm6b00031_si_002.csv">jm6b00031_si_002.csv (2.84 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00031&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-6%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00031" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00031" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ee3e38393d3c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
